Institutes
Refine
Year of publication
Document Type
- Article (1820)
- Doctoral Thesis (444)
- Preprint (158)
- Conference Proceeding (108)
- Review (32)
- Book (17)
- Part of Periodical (12)
- Contribution to a Periodical (9)
- Part of a Book (7)
- Report (3)
Is part of the Bibliography
- no (2612)
Keywords
- COVID-19 (45)
- SARS-CoV-2 (37)
- inflammation (32)
- Epilepsy (19)
- Video (19)
- Inflammation (17)
- prostate cancer (17)
- ADHD (13)
- Cancer (12)
- autophagy (12)
- bladder cancer (12)
- cancer (12)
- Capsule endoscopy (11)
- radical prostatectomy (11)
- Genetics (10)
- Quality of life (10)
- Seizure (10)
- apoptosis (10)
- data science (10)
- tumor microenvironment (10)
- Magnetic resonance imaging (9)
- Small bowel (9)
- Surgery (9)
- glioblastoma (9)
- hypoxia (9)
- macrophage (9)
- microRNA (9)
- stroke (9)
- Apoptosis (8)
- Depression (8)
- EEG (8)
- Endoscopy (8)
- Mortality (8)
- TAVI (8)
- breast cancer (8)
- endothelial cells (8)
- epilepsy (8)
- immunotherapy (8)
- mortality (8)
- survival (8)
- vaccination (8)
- Angiogenesis (7)
- Biomarker (7)
- Diagnostik (7)
- Immunological methods (7)
- Immunologische Methoden (7)
- Immunology (7)
- MRI (7)
- Outcome (7)
- Prostate cancer (7)
- Radiotherapy (7)
- Treatment (7)
- aging (7)
- angiogenesis (7)
- chemotherapy (7)
- children (7)
- fMRI (7)
- oxidative stress (7)
- Balloon enteroscopy (6)
- Diagnostics (6)
- Enteroscopy (6)
- Epilepsie (6)
- Goethe-Universität Frankfurt am Main. Fachbereich Humanmedizin (6)
- Heart failure (6)
- Hepatitis C (6)
- Medical research (6)
- Medizin und Gesundheit (6)
- PCR (6)
- Sepsis (6)
- artificial intelligence (6)
- biomarker (6)
- colorectal cancer (6)
- glioma (6)
- mTOR (6)
- machine learning (6)
- miRNA (6)
- osteoarthritis (6)
- prevalence (6)
- proliferation (6)
- risk factors (6)
- targeted therapy (6)
- thrombosis (6)
- AML (5)
- Autopsy (5)
- Bipolar disorder (5)
- Breast cancer (5)
- Calliphoridae (5)
- Comorbidity (5)
- Epidemiology (5)
- Forensic entomology (5)
- HIV (5)
- Herb induced liver injury (5)
- Hypoxia (5)
- Immunotherapy (5)
- Machine learning (5)
- Macrophages (5)
- NADPH oxidase (5)
- Omicron (5)
- Pandemic (5)
- Physical activity (5)
- Polytrauma (5)
- Postural control (5)
- Rare diseases (5)
- Risk factors (5)
- Status epilepticus (5)
- coronavirus (5)
- depression (5)
- digital medicine (5)
- epidemiology (5)
- gene therapy (5)
- hippocampus (5)
- influenza (5)
- integrins (5)
- iron deficiency (5)
- lung cancer (5)
- machine-learning (5)
- outcome (5)
- pain (5)
- polypharmacy (5)
- quality of life (5)
- reactive oxygen species (5)
- treatment (5)
- 177Lu-PSMA-617 (4)
- ACLF (4)
- Adenocarcinoma (4)
- Alcohol (4)
- Animal models (4)
- Antiviral therapy (4)
- Aortic stenosis (4)
- Ataxia telangiectasia (4)
- CRP (4)
- Cochlear implant (4)
- Critical care (4)
- Diagnosis (4)
- Drug induced liver injury (4)
- ELISA (4)
- Elderly (4)
- Endoscopic retrograde cholangiopancreatography (4)
- Endothelial cells (4)
- Epileptischer Anfall (4)
- Gesundheitsökonomie (4)
- Glioma (4)
- HCV (4)
- Health economics (4)
- Hepatotoxicity (4)
- Herbal hepatotoxicity (4)
- IntelliCage (4)
- Interleukin (4)
- Medizinstudenten (4)
- Medizinstudium (4)
- Melanoma (4)
- Neurology (4)
- Oncology (4)
- PSMA (4)
- Pain (4)
- Pandemie (4)
- Prevalence (4)
- Prostatakarzinom (4)
- Proteomics (4)
- Prävention (4)
- RNA (4)
- ROS (4)
- Registry (4)
- Rheumatoid arthritis (4)
- Sensitivity and Specificity (4)
- Sport (4)
- Stroke (4)
- Suicide (4)
- Transfusion (4)
- Trauma (4)
- Vaccination (4)
- acute myeloid leukemia (4)
- anemia (4)
- antiviral therapy (4)
- bibliometrics (4)
- child (4)
- cirrhosis (4)
- classification (4)
- colon cancer (4)
- cytokines (4)
- diabetes (4)
- drug resistance (4)
- elderly (4)
- epigenetics (4)
- external beam radiotherapy (4)
- extracellular matrix (4)
- growth (4)
- haemophilia treatment (4)
- hepatitis C virus (4)
- hepatocellular carcinoma (4)
- infection (4)
- iron (4)
- liver (4)
- long non-coding RNA (4)
- macrophage polarization (4)
- macrophages (4)
- medical students (4)
- metastasis (4)
- metastatic prostate cancer (4)
- microglia (4)
- mitochondria (4)
- multimorbidity (4)
- neuropathic pain (4)
- patients (4)
- phosphorylation (4)
- psoriasis (4)
- synaptic plasticity (4)
- systematic review (4)
- thrombolysis (4)
- tooth loss (4)
- treatment centres (4)
- 3D printing (3)
- ARDS (3)
- Acute kidney injury (3)
- Acute lymphoblastic leukemia (3)
- Acute myeloid leukemia (3)
- Adhesion (3)
- Angiography (3)
- Antikörper (3)
- Artificial intelligence (3)
- Autism spectrum disorder (3)
- BMC (3)
- Biochemistry (3)
- Biographie (3)
- Brain (3)
- Burden of illness (3)
- COMP (3)
- Cardiovascular diseases (3)
- Cell biology (3)
- Chronic hepatitis C (3)
- Cirrhosis (3)
- Classification (3)
- Clinical decision support systems (3)
- Cochlear implantation (3)
- Collagen (3)
- Colorectal cancer (3)
- Complications (3)
- Computer-assisted diagnosis (3)
- Corona (3)
- DMEK (3)
- Data science (3)
- Dental implant (3)
- Dental students (3)
- Diagnostic markers (3)
- Drugs (3)
- ER stress (3)
- Edema (3)
- Education (3)
- Emergency room (3)
- Encephalopathy (3)
- Endocrinology (3)
- Entscheidungsassistenz (3)
- Entzündung (3)
- Epigenetics (3)
- Evidence-based medicine (3)
- Extracellular vesicles (3)
- Fasting (3)
- Forensic medicine (3)
- Gene regulation (3)
- Glioblastoma (3)
- HBV (3)
- HCC (3)
- Health care (3)
- Healthcare costs (3)
- Healthy adults (3)
- HoLEP (3)
- Human behaviour (3)
- Hypertension (3)
- IFT (3)
- Immunohistochemistry (3)
- Immunsuppression (3)
- Incidence (3)
- Induction chemotherapy (3)
- Infections (3)
- Knochenersatzmaterial (3)
- Kommunikation (3)
- Lebensqualität (3)
- Lung failure (3)
- Major depressive disorder (3)
- Medizingeschichte (3)
- Medizinstudierende (3)
- Metabolomics (3)
- Microbiology (3)
- Microwave ablation (3)
- Molecular biology (3)
- Multianalyte detection (3)
- Multiplate (3)
- Musculoskeletal system (3)
- NK cells (3)
- NSCLC (3)
- Neuroblastom (3)
- Neuroscience (3)
- Nierentransplantation (3)
- Non-coding RNA (3)
- Osteoporosis (3)
- Parkinson’s disease (3)
- Patient blood management (3)
- Patient safety (3)
- Peri-implantitis (3)
- Physiology (3)
- Platelet-rich fibrin (3)
- Pneumonia (3)
- Polypharmacy (3)
- Pre-analytics (3)
- Prevention (3)
- Prostataspezifisches Antigen (3)
- Pulmonary embolism (3)
- Qualitätssicherung (3)
- Radiomics (3)
- Rectal cancer (3)
- Rehabilitation (3)
- Rezidiv (3)
- Rhabdomyosarcoma (3)
- SUDEP (3)
- Safety (3)
- Seltene Erkrankungen (3)
- Sensitivity (3)
- Sensitivität und Spezifität (3)
- Serodiagnosis (3)
- Sex (3)
- Surveillance (3)
- Survival (3)
- Systematic review (3)
- TIPS (3)
- Teaching (3)
- Therapie (3)
- Thrombozytenkonzentrat (3)
- Translational research (3)
- Treatment outcome (3)
- Tumor microenvironment (3)
- Tumormarker (3)
- Ultrasound (3)
- VEGF (3)
- Versorgungsqualität (3)
- Vitamin D (3)
- adhesion (3)
- adult (3)
- adverse events (3)
- animal model (3)
- aortic stenosis (3)
- atherosclerosis (3)
- bleeding (3)
- brain metastases (3)
- cancer specific survival (3)
- cartilage (3)
- cervical cancer (3)
- chronic kidney disease (3)
- cognition (3)
- complication (3)
- critical care (3)
- curcumin (3)
- dental implant (3)
- dentate gyrus (3)
- diabetes mellitus (3)
- diagnosis (3)
- electrophysiology (3)
- ergonomics (3)
- exercise (3)
- exosomes (3)
- extracellular vesicles (3)
- fibrosis (3)
- flow cytometry (3)
- functional outcome (3)
- gene expression (3)
- haemophilia care (3)
- heart (3)
- heart failure (3)
- hematopoietic stem cell transplantation (3)
- hemorrhage (3)
- immune cells (3)
- immunity (3)
- immunohistochemistry (3)
- immunologische Methoden (3)
- innate immunity (3)
- liver cirrhosis (3)
- liver transplantation (3)
- lncRNA (3)
- magnetic resonance imaging (3)
- mesenchymal stromal/stem cells (3)
- metabolomics (3)
- multiple myeloma (3)
- multiple sclerosis (3)
- neurodegeneration (3)
- nociception (3)
- obesity (3)
- occupational infections (3)
- outcomes (3)
- overall survival (3)
- oxidative phosphorylation (3)
- p53 (3)
- pandemic (3)
- pediatric (3)
- periodontitis (3)
- platelets (3)
- polytrauma (3)
- portal hypertension (3)
- pregnancy (3)
- prevention (3)
- primary care (3)
- proteomics (3)
- public health (3)
- qualitative research (3)
- quantitative MRI (3)
- radiotherapy (3)
- seizure (3)
- sphingolipids (3)
- sphingosine 1-phosphate (3)
- sphingosine-1-phosphate (3)
- stress (3)
- sulforaphane (3)
- supportive periodontal therapy (3)
- tissue engineering (3)
- toll-like receptor (3)
- trauma (3)
- traumatic brain injury (3)
- tyrosine kinase inhibitor (3)
- vaccine (3)
- yeast (3)
- 3D rapid prototyping (2)
- ADAM15 (2)
- ADHS (2)
- ALK (2)
- ATM (2)
- Abdominal aortic aneurysm (2)
- Abort (2)
- Accidental reaction (2)
- Acinetobacter baumannii (2)
- Acne inversa (2)
- Acuris (2)
- Acute seizure plan (2)
- Addiction (2)
- Affinity Labeling (2)
- Age estimation (2)
- Aging (2)
- Akuter Anfallsplan (2)
- Allergen avoidance (2)
- Alzheimer’s disease (2)
- Anandamide (2)
- Anemia (2)
- Animal model (2)
- Anschlussheilbehandlung (2)
- Anti-IgE (2)
- Anti-seizure medication (2)
- Antibiotics (2)
- Anticonvulsants (2)
- Antigen test (2)
- Antikonvulsiva (2)
- Antikörpertest (2)
- Anxiety (2)
- Anämie (2)
- Arteriosklerose (2)
- Aspergillus (2)
- Ataxia-telangiectasia (2)
- Attention-deficit/hyperactivity disorder (2)
- Attitude (2)
- Auditory rehabilitation (2)
- Autismus (2)
- Autologous biomaterial (2)
- Autophagy (2)
- BA.1 (2)
- BAG3 (2)
- BCOR (2)
- BMI (2)
- BMNC (2)
- BNT162b2 (2)
- BPH (2)
- Bacterial infection (2)
- Bartonella henselae (2)
- Bauchaortenaneurysma (2)
- Behandlungsposition (2)
- Behavior (2)
- Betriebliche Gesundheitsförderung (2)
- Bibliometrics (2)
- Bile duct stone (2)
- Biological profile (2)
- Biomedical informatics (2)
- Biopsy (2)
- Biorecognition strategies (2)
- Bladder cancer (2)
- Bleeding (2)
- Blood (2)
- Blood loss estimation (2)
- Blow flies (2)
- Blutübertragbare Virusinfektionen (2)
- Body modification (2)
- Body posture (2)
- Bone density (2)
- Bone marrow (2)
- Bone metastases (2)
- Borrelia (2)
- Bowel obstruction (2)
- C-reactive protein (2)
- CD14 (2)
- CMV (2)
- COVID 19 (2)
- COVID-19 surveillance (2)
- CRM (2)
- CSM (2)
- CT (2)
- Calpain (2)
- Calprotectin (2)
- Cancer therapy (2)
- Cancer-specific mortality (2)
- Candida (2)
- Cannabis (2)
- Carbapenemase (2)
- Cardiovascular magnetic resonance (2)
- Case report (2)
- Cell culture (2)
- Cell death (2)
- Cell death and immune response (2)
- Cerebellum (2)
- Cesarean section (2)
- Chemoprevention (2)
- Chemoradiotherapy (2)
- Child (2)
- Chirurgie (2)
- Cholangiography (2)
- Cholangiopancreatography (2)
- Chronic kidney disease (2)
- Clinical Trials and Observations (2)
- Cochleaimplantation (2)
- Cognition (2)
- Colonoscopy (2)
- Comparative analysis (2)
- Complex Formation (2)
- Computational models (2)
- Computer software (2)
- Consensus (2)
- Coronavirus (2)
- Covid-19 (2)
- Cre-recombinase (2)
- Cryoelectron microscopy (2)
- DAA (2)
- DNA (2)
- DNA methylation (2)
- Deep brain stimulation (2)
- Degradation (2)
- Dehydrogenases (2)
- Delegation (2)
- Dentists (2)
- Development (2)
- Diabetes mellitus (2)
- Diagnose (2)
- Diagnostic algorithm (2)
- Diagnostic imaging (2)
- Differential diagnosis (2)
- Digitalisierung (2)
- Directly acting antiviral agent (2)
- Dopamine (2)
- Double-balloon enteroscopy (2)
- Dravet syndrome (2)
- Drug hepatotoxicity (2)
- Dynamic MRI (2)
- EET (2)
- EGFR (2)
- EWSR1 (2)
- Emotion regulation (2)
- Endocannabinoid (2)
- Endocannabinoids (2)
- Endoscopic retrograde (2)
- Endothelium (2)
- Endovascular repair (2)
- Enterscopy (2)
- Environmental support (2)
- Enzyme-linked Immunosorbent Assay (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epidemiologie (2)
- Epidemiology and End Results (2)
- Epileptische Anfälle (2)
- Erwachsene (2)
- Erweiterter Suizid (2)
- Everolimus (2)
- Evidence-based (2)
- Evidenz (2)
- Exercise (2)
- Exosomes (2)
- Extended suicide (2)
- Extracellular matrix (2)
- FFLU (2)
- FHIR (2)
- FLT3-ITD (2)
- Feedback (2)
- Fibronectin (2)
- Follow-up treatment (2)
- Forensische Osteologie (2)
- Function (2)
- GEMs (2)
- GPCR (2)
- Gastroschisis (2)
- Gemeinschaftliche Selbsttötung (2)
- Gene Regulation (2)
- Gene expression (2)
- Gene fusion (2)
- Genetics research (2)
- Geographic variation (2)
- Geriatric patients (2)
- Germany (2)
- Geschichte (2)
- Geschlecht (2)
- Gesetz zur Verhütung erbkranken Nachwuchses (2)
- Gleason score (2)
- Glioblastom (2)
- Glucose (2)
- Guideline (2)
- H1N1 (2)
- HBsAg (2)
- HES (2)
- HL7 FHIR (2)
- HNSCC (2)
- Healthcare personnel (2)
- Healthcare resource utilization (2)
- Healthcare worker (2)
- Heart (2)
- Hepatitis (2)
- Hepatitis B (2)
- Hepatitis C virus (2)
- Hepatocellular carcinoma (2)
- Herpes Zoster Infektion (2)
- High oblique sagittal osteotomy (2)
- Hippocampus (2)
- Hörrehabilitation (2)
- ISR (2)
- Identification (2)
- Ileus (2)
- Immune cells (2)
- Immune system (2)
- Immunenzymtechniken (2)
- Immunoenzyme Techniques (2)
- Immunogenicity (2)
- Immunologic methods (2)
- Immunosuppression (2)
- Immunsystem (2)
- Immunturbidimetrie (2)
- Impfraten (2)
- Impfstoff (2)
- Impfung (2)
- Infection (2)
- Influenza (2)
- Innate Immunity (2)
- Insulin signalling (2)
- Integrin (2)
- Intensive care treatment (2)
- Intensive care units (2)
- Interferon (2)
- Interleukin-1 (2)
- Interleukin-6 (2)
- Iron (2)
- Ketogenic diet (2)
- Kinderwunsch (2)
- Klassifikation (2)
- Kolonkarzinom (2)
- Kolorektales Karzinom (2)
- Komplementsystem (2)
- Körperhaltung (2)
- L-DOPA (2)
- Labor and delivery (2)
- Labordiagnostik (2)
- Lactate Dehydrogenase (2)
- Legs (2)
- Lehre (2)
- Leitlinien (2)
- Leptin (2)
- Leukämie (2)
- Lipidomics (2)
- LncRNA (2)
- Local therapy (2)
- Long-COVID (2)
- Long-term potentiation (2)
- Low-molecular-weight heparin (2)
- Lucilia sericata (2)
- Lymphectasia (2)
- M2-PK (2)
- Machine-learning (2)
- Macrophage polarization (2)
- Makrophagen (2)
- Malnutrition (2)
- Medical consultation (2)
- Medical diagnostics (2)
- Medical risk factors (2)
- Memory (2)
- Mental health (2)
- Metabolic diseases (2)
- Migration (2)
- Mitochondria (2)
- Mitochondrial dysfunction (2)
- Model (2)
- Molecular autopsy (2)
- Molecular neuroscience (2)
- Monocytes (2)
- Morphology (2)
- Multidetector computed tomography (2)
- Multimorbidity (2)
- Multiple Sklerose (2)
- Multiple sclerosis (2)
- Musculoskeletal diseases (2)
- Muskuloskeletale Erkrankungen (2)
- Myeloid Neoplasia (2)
- Myocardial infarction (2)
- Myocarditis (2)
- Myokarditis (2)
- NADH dehydrogenase (2)
- NAFLD (2)
- NASH (2)
- NCCN (2)
- NCoR1 (2)
- NF-κB (2)
- NS-Medizin (2)
- NS5A (2)
- Nachweismethoden (2)
- Nachweisverfahren (2)
- Nadelstichverletzungen (2)
- Neurodegeneration (2)
- Neuron (2)
- Neurotransmitter (2)
- Next-generation sequencing (2)
- Notaufnahme (2)
- Nrf2 (2)
- Nucleic acid biomarkers (2)
- OSCE (2)
- OXA-48 (2)
- Obesity (2)
- Occupational health (2)
- Offene Versorgung (2)
- Open repair (2)
- Oral immunotherapy (2)
- Orthognathic surgery (2)
- Osteoarthritis (2)
- Osteocalcin (2)
- Outcomes (2)
- PD-L1 (2)
- PLGA (2)
- PRF (2)
- PSA (2)
- Pathogenesis (2)
- Pathologic complete response (2)
- Patient information (2)
- Patient needs (2)
- Patient*inneninformation (2)
- Patientenbedürfnisse (2)
- Patterns of care (2)
- Pediatric (2)
- Pediatrics (2)
- Pelargonium sidoides (2)
- Penile cancer (2)
- Penile carcinomas (2)
- Perikarditis (2)
- Periodontal treatment (2)
- Person-Umwelt-Passung (2)
- Person-environment fit (2)
- Phagocytosis (2)
- Pharmacology (2)
- Plasticity (2)
- Point-of-care testing (2)
- Portal hypertension (2)
- Positron emission tomography (2)
- Post-mortem interval (2)
- Preclinical research (2)
- Predictive coding (2)
- Predictive markers (2)
- Pregnancy (2)
- Preterm birth (2)
- Preventive medicine (2)
- Primary health care (2)
- Procalcitonin (2)
- Professional dance (2)
- Prognostic tool (2)
- Prophylaxis (2)
- Protein biomarkers (2)
- Pseudomonas aeruginosa (2)
- Psoriasis (2)
- Psychedelics (2)
- Psychology (2)
- Pädiatrie (2)
- Quality of care (2)
- Questionnaire (2)
- RCT (2)
- RNA therapeutics (2)
- RNAseq (2)
- Radiation (2)
- Radical prostatectomy (2)
- Reactive oxygen species (2)
- Reanimation (2)
- Rechtsmedizin (2)
- Redoxin (2)
- Rehabilitation outcome (2)
- Rehabilitationsergebnis (2)
- Reliability (2)
- Remuneration (2)
- Rescue medication (2)
- Research Article (2)
- Respiratory distress syndrome (2)
- Reward (2)
- Ribavirin (2)
- Risikokommunikation (2)
- Risk communication (2)
- S1P receptors (2)
- SARS-CoV-2 monitoring (2)
- SARS-CoV-2 testing (2)
- SARS-CoV‑2 (2)
- SCC (2)
- SPM (2)
- SUMO (2)
- SV2A (2)
- SVR (2)
- Schilddrüsenknoten (2)
- Schizophrenia (2)
- Schwangerschaft (2)
- Screening (2)
- Selbstmanagement (2)
- Self-management (2)
- Sensitivität (2)
- Serodiagnose (2)
- Signaling (2)
- Specificity (2)
- Speech discrimination (2)
- Spezifität (2)
- Spine (2)
- Sprache (2)
- Sprachstörung (2)
- Sprachverstehen (2)
- Sprechen (2)
- Sprechstörung (2)
- Squamous cell carcinoma (2)
- Standard endoscopy (2)
- Standard value (2)
- Standardization (2)
- Stem cell (2)
- Stereotaxie (2)
- Sudden death (2)
- Suicidality (2)
- Suicide pact (2)
- Superficial vein thrombosis (2)
- Supported decision making (2)
- Synaptic transmission (2)
- Systemic inflammation (2)
- Systemic therapy (2)
- T-cell (2)
- TACE (2)
- TGF-β (2)
- TSC (2)
- Telemedicine (2)
- Temozolomide (2)
- Therapy (2)
- Thrombose (2)
- Tight junctions (2)
- Todesart (2)
- Tomography (x-ray computed) (2)
- Tooth loss (2)
- Training (2)
- Transfusionsmedizin (2)
- Treatment position (2)
- Tumor marker (2)
- Type 2 diabetes (2)
- Undergraduate medical education (2)
- Universitätskliniken (2)
- Unterstützung der Umwelt (2)
- Upper body posture (2)
- Usability (2)
- Uteroglobin (2)
- VT (2)
- Vaccine uptake rate (2)
- Validierung (2)
- Validity (2)
- Variant histology (2)
- Vascular endothelial growth factor (VEGF) (2)
- Vasculitis (2)
- Vergütung (2)
- Versorgung (2)
- Virologie (2)
- Viruslast (2)
- Virussicherheit (2)
- Visual estimation (2)
- Volume therapy (2)
- Wearable cardioverter-defibrillator (2)
- Weiterbildung (2)
- Western blot (2)
- Women (2)
- Wound healing (2)
- Wounds (2)
- Zigarette (2)
- Zink (2)
- acute coronary syndromes (2)
- adaptation (2)
- adipose-derived stromal/stem cells (2)
- adjuvant chemotherapy (2)
- age (2)
- alcohol use disorder (2)
- algorithm (2)
- alpha power (2)
- animal experiments (2)
- antibiotic resistance (2)
- antibody test (2)
- antiseizure medication (2)
- aortic valve stenosis (2)
- attention (2)
- automation (2)
- bacteria (2)
- biliary stricture (2)
- bioenergetics (2)
- biomarkers (2)
- biopsy cores (2)
- blood borne infection (2)
- blood pressure (2)
- blood transfusion (2)
- bloodborne viruses (2)
- blutübertragbare Infektionskrankheiten (2)
- bone (2)
- bone regeneration (2)
- bortezomib (2)
- brain cancer (2)
- brain metastasis (2)
- cabozantinib (2)
- calprotectin (2)
- campesterol (2)
- cancer treatment (2)
- cancer-specific mortality (2)
- cardiolipin (2)
- cardiovascular disease (2)
- caregivers (2)
- cell culture (2)
- cell cycle (2)
- cell death (2)
- cell migration (2)
- ceramides (2)
- cerebral hemorrhage (2)
- cerebral venous thrombosis (2)
- cerebrospinal fluid (2)
- cesarean section (2)
- chemoradiotherapy (2)
- childhood acute myeloid leukemia (2)
- cholestanol (2)
- cholesterol absorption (2)
- cholesterol synthesis (2)
- clinical isolates (2)
- clinical trial (2)
- clinical trials (2)
- co-infection (2)
- coagulopathy (2)
- cochlear implant (2)
- comorbidity (2)
- complementary medicine (2)
- complexome profiling (2)
- computed tomography (2)
- confinement (2)
- congenital diaphragmatic hernia (2)
- constipation (2)
- contemporary (2)
- counseling (2)
- critical size defect (2)
- critically ill patients (2)
- dance (2)
- deubiquitinase (DUB) (2)
- development (2)
- dexamethasone (2)
- diabetic nephropathy (2)
- diagnostic algorithm (2)
- diagnostics (2)
- disease burden (2)
- dopamine (2)
- dysphagia (2)
- efficacy (2)
- endodontic curriculum (2)
- endodontic education (2)
- endovascular treatment (2)
- ephrinB2 (2)
- epidermal growth factor receptor (2)
- epithelial to mesenchymal transition (2)
- erastin (2)
- everolimus (2)
- executive function (2)
- fall (2)
- fecal occult blood test (2)
- ferroptosis (2)
- fibroblasts (2)
- follow-up (2)
- furcation involvement class III (2)
- fusion biopsy (2)
- fäkaler okkulter Stuhltest (2)
- general practice (2)
- genetic variants (2)
- glycolysis (2)
- guided bone regeneration (2)
- healthcare worker (2)
- hepatitis C virus (HCV) (2)
- herpes zoster (2)
- histology (2)
- homeostatic plasticity (2)
- hyperglycemia (2)
- immune checkpoint inhibitors (2)
- immune response (2)
- immunosuppression (2)
- in vitro (2)
- infections (2)
- inflammatory bowel disease (2)
- insulin (2)
- integrative medicine (2)
- intermediate risk (2)
- invasion (2)
- iron metabolism (2)
- kidney (2)
- kidney cancer (2)
- kinematic analysis (2)
- laboratory testing (2)
- language (2)
- lathosterol (2)
- leptin (2)
- levetiracetam (2)
- lifestyle intervention (2)
- lipids (2)
- lipocalin-2 (2)
- lipoxygenase (2)
- liver fibrosis (2)
- localized prostate cancer (2)
- lockdown (2)
- long-term success (2)
- long-term tooth survival (2)
- low molecular weight heparin (2)
- low-glycaemic meal replacement (2)
- lung development (2)
- lymph node dissection (2)
- mRNA (2)
- mTORC1 (2)
- mast cells (2)
- medication management (2)
- melanoma (2)
- metabolism (2)
- metastatic castration-resistant prostate cancer (2)
- mice (2)
- monitoring (2)
- monoclonal antibody (2)
- monocytes (2)
- motility (2)
- multicentre study (2)
- multidetector computed tomography (2)
- musculoskeletal disorders (2)
- myocarditis (2)
- ncRNA (2)
- needlestick injury (2)
- nephropathy (2)
- neural oscillations (2)
- neurocognitive (2)
- neuropathy (2)
- neutralization (2)
- neutralizing antibodies (2)
- next-generation sequencing (2)
- niche (2)
- nitric oxide (2)
- nivolumab (2)
- olfaction (2)
- oligomerisation (2)
- online survey (2)
- other-cause mortality (2)
- out-patient paediatrics (2)
- patient blood management (2)
- pediatric patients (2)
- pediatric surgery (2)
- penile cancer (2)
- pentose phosphate pathway (2)
- perception (2)
- peri-implant diseases (2)
- peri-implantitis (2)
- pericarditis (2)
- periodontitis stage III and IV (2)
- pertussis (2)
- phagocytosis (2)
- pharmacokinetics (2)
- physical activity (2)
- pneumonia (2)
- post-translational modifications (2)
- postoperative pain (2)
- prediction (2)
- predictive (2)
- predictive coding (2)
- predictor (2)
- preeclampsia (2)
- primary cilium (2)
- primary prostate cancer (2)
- process evaluation (2)
- prognosis (2)
- prognostic (2)
- prostaglandin E (2)
- prostaglandins (2)
- prostate carcinoma cells (2)
- proteasome (2)
- protein-protein interaction (2)
- protein-rich (2)
- pulmonary embolism (2)
- quality assurance (2)
- questionnaire (2)
- radiation (2)
- radical cystectomy (2)
- radical prostatecomy (2)
- receptor (2)
- refractory (2)
- regenerative medicine (2)
- relapse (2)
- renal cell carcinoma (2)
- residual myometrial thickness (2)
- resistance mutation (2)
- resistant cell lines (2)
- resolution of inflammation (2)
- respiratory chain (2)
- respiratory infections (2)
- respiratory tract infection (2)
- resting-state (2)
- rheumatoid arthritis (2)
- risk group (2)
- salvage radical prostatectomy (2)
- salvage therapy (2)
- scaffold (2)
- schizophrenia (2)
- screening (2)
- second-line (2)
- serine protease (NS3-4A) (2)
- serum (2)
- simulation training (2)
- sitosterol (2)
- smooth muscle cells (2)
- soft tissue (2)
- speech (2)
- speech and language disorder (2)
- speech perception (2)
- spinal dural leaks (2)
- spine head (2)
- stakeholder analysis (2)
- status epilepticus (2)
- stereotactic radiosurgery (2)
- strength training (2)
- stress granules (2)
- sub-lineage (2)
- subchondral bone (2)
- superficial siderosis (2)
- surgery (2)
- synaptopodin (2)
- systematic biopsy (2)
- systemic antibiotics (2)
- temozolomide (2)
- temporal lobe epilepsy (2)
- test methods (2)
- therapeutics (2)
- therapy (2)
- thymus (2)
- total hip replacement (2)
- transcription factor (2)
- triple-negative breast cancer (2)
- tumor necrosis factor (2)
- tumor-associated macrophages (2)
- tyrosine kinase inhibitors (2)
- ubiquitin (2)
- ubiquitination (2)
- upgrading (2)
- urinary incontinence (2)
- urological cancer (2)
- vaccine uptake rates (2)
- vascular biology (2)
- venous thrombosis (2)
- very high risk (2)
- viruses (2)
- waiting time (2)
- walking (2)
- weight reduction (2)
- white matter hyperintensity (2)
- working memory (2)
- Ärztliche Aufklärung (2)
- "NS"-Euthanasie (1)
- "alternative" technology (1)
- "conventional" analysis technics (1)
- (lyso)phospholipids (1)
- (sub-) luxation (1)
- 1-propanol (1)
- 177Lu-PSMA (1)
- 18-Hydroxycorticosteron (1)
- 18-OH corticosterone (1)
- 1H NMR; Conformational Properties (1)
- 2-AG (1)
- 2-Arachidonoyl glycerol (1)
- 2-deoxy-d-glucose (1)
- 223Radium-dichloride (1)
- 26 LncRNA (1)
- 2′,3′-cGAMP (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3-year survival (1)
- 3D culture (1)
- 3D gait analysis (1)
- 3D laparoscopy (1)
- 3D printing using composite resin (1)
- 3D printing using zirconia (1)
- 3D-Druck (1)
- 3D-models (1)
- 3D-printing (1)
- 3T3-L1 mouse fibroblasts (1)
- 4-fluoroamphetamine (1)
- 5-lipoxygenase (1)
- 8 weeks (1)
- 9-aminoacridine (1)
- 98/79/EC (1)
- A498 cells (1)
- AAA (1)
- AAA+ disaggregase (1)
- ABC transporter (1)
- ABCB5 (1)
- ACE inhibitor (1)
- ACKR (1)
- ACL (1)
- ACT-777991 (1)
- ACTH (1)
- ADAMTS13 (1)
- ADCC (1)
- ADGRE1 (1)
- AGMO (1)
- AIDS (1)
- AKT (1)
- AKT signaling (1)
- AKT-mTOR pathway (1)
- ALD (1)
- ALDH2 (1)
- ALL (1)
- ALLO (1)
- AMH (1)
- AMP-activated kinase (AMPK) (1)
- AO-PCCF (1)
- APT-CEST (1)
- ARFI (1)
- ASA (1)
- ASA-Klassifikation (1)
- ASPECTS (1)
- AT1 receptor antagonist (1)
- ATG3 (1)
- ATG4 (1)
- ATG8 (1)
- ATP (1)
- AU-rich element (1)
- Abdominelles Aortenaneurysma (1)
- Abductor pollicis longus (1)
- Ablation (1)
- Ablation Techniques (1)
- Abrasion (1)
- Abusive head trauma (AHT) (1)
- Access® immunoassay system (1)
- Access®-Immunoassaysystem (1)
- Accident (1)
- Accidents (1)
- Accumulated degree days (1)
- Acetabulumdefekt (1)
- Achtundsechzig (1)
- Achtundsechziger (1)
- Acide gamma-aminobutyrique (1)
- Acidic Dissociation (1)
- Acidic Amino Acids (1)
- Acquired resistance (1)
- Actaea cimicifuga (1)
- Activated partial thromboplastin time (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute (1)
- Acute Myeloid Leukemia (AML) (1)
- Acute appendicitis (1)
- Acute decompensation (1)
- Acute elbow dislocation (1)
- Acute inflammation (1)
- Acute injuries (1)
- Acute kidney failure (1)
- Acute myeloid leukaemia (1)
- Acute renal failure (1)
- Acute respiratory distress syndrom (1)
- Acute-on-chronic liver failure (1)
- Acute-on-chronic subdural hematoma (1)
- Adeno associated virus (1)
- Adenylate Kinase (1)
- Adherence (1)
- Adhesins (1)
- Adhesion Factor (1)
- Adhärenz (1)
- Adiposity (1)
- Adjuvant procedure (1)
- Adjuvantes Verfahren (1)
- Administrative claims data (1)
- Adrenal crisis (1)
- Adrenale Krise (1)
- Adrenocorticotropic hormone (1)
- Adrenokortikotropes Hormon (1)
- Adult neurogenesis (1)
- Adult-onset ADHD (1)
- Adults (1)
- Advanced stage (1)
- Adverse drug reaction (1)
- Adverse effects (1)
- Aedes aegypti (1)
- Aedes albopictus (1)
- Aeroplysinin-1 (1)
- Aerosolspektrometrie (1)
- Affect (1)
- Affective Misattribution Procedure (1)
- Affinity Chromatography (1)
- Afrikanische Schlafkrankheit (1)
- Ag-RDT (1)
- Aganglionosis (1)
- Agardiffusion (1)
- Age determination (1)
- Ageing (1)
- Aggression (1)
- Agitation (1)
- Airport-related emissions (1)
- Akkreditierung (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Aktivierte partielle Thromboplastinzeit (1)
- Akute (1)
- Akute Niereninsuffizienz (1)
- Akute Nierenschädigung (1)
- Akute Verletzungen (1)
- Akute lymphatische Leukämie (1)
- Albumin (1)
- Albumin ratio (1)
- Algorithms (1)
- Alkaline phosphatase (1)
- Alkalische Phosphatase (1)
- Alkaloid (1)
- Alkylating NAD-Analogs (1)
- All-oral therapy (1)
- Allergie (1)
- Allergische Rhinitis (1)
- Allgemeinmedizin (1)
- Allgemeinmedizin Forschung (1)
- Allogeneic (1)
- Allopregnanolon (1)
- Allosteric inhibition (1)
- Alpha power (1)
- Alpha-fetoprotein (AFP) (1)
- Alte Medizin (1)
- Alzheimer's disease (1)
- Ambient air (1)
- Amblyopia (1)
- Ambulatory Assessment (1)
- Amino acids (1)
- Amisulpride (1)
- Amitriptyline (1)
- Amniotic fluid (1)
- Amphetamine (1)
- Anaemia (1)
- Anahuasca (1)
- Anakinra (1)
- Anal cancer (1)
- Analgesia (1)
- Analgesie (1)
- Analkarzinom (1)
- Analogue modelling (1)
- Analysis tool (1)
- Anamneseerhebung (1)
- Anatomy (1)
- Anderson–Fabry (1)
- Anemia management (1)
- Anerkennung (1)
- Anfall (1)
- Anfallsserie (1)
- Anfallsunterbrechende (1)
- Anfallsunterbrechende Medikamente (1)
- Angeborene Fehlbildungen (1)
- Angiectasia (1)
- Angiodysplasia (1)
- Angiomyolipoma (1)
- Angststörungen (1)
- Animal disease models (1)
- Animal experiment (1)
- Anion and Zwitterion Transport (1)
- Ankylosierende Spondylitis (1)
- Ankylosing spondylitis (1)
- Anomalous venous atrial connections (1)
- Anorexia Nervosa (1)
- Anti-inflammatory (1)
- Anti-rheumatic agents (1)
- Antibiotic steward-ship (1)
- Antibiotika (1)
- Antibiotikaresistenz (1)
- Antibodies (1)
- Antibody avidity (1)
- Antibody detection (1)
- Antibody therapy (1)
- Anticholinergic (1)
- Anticoagulant (1)
- Anticoagulation (1)
- Anticonvulsant (1)
- Antidepressiva (1)
- Antigen (1)
- Antigen- und Nukleinsäurenachweis (1)
- Antigene Virale/Immunologie (1)
- Antigennachweis (1)
- Antigens,Viral/immunology (1)
- Antikörpernachweis (1)
- Antimicrobial treatment (1)
- Antineoplastic agents (1)
- Antioxidant (1)
- Antioxidants (1)
- Antiproliferative (1)
- Antiretroviral therapy (1)
- Antiseizure medication (1)
- Antiseizure medication Instructions for action (1)
- Antiviral treatment (1)
- Antivirale Therapie (1)
- Anwendbarkeit (1)
- Anxiolytic pharmacological therapy (1)
- Aortendissektion (1)
- Aortic aneurysm (1)
- Aortic input function (1)
- Aperiodic (1)
- Aphantasia (1)
- Aphasia (1)
- Aphasie (1)
- Apixaban (1)
- Apoptotic cell death (1)
- Appendectomy (1)
- Appendizitis (1)
- Ara h2-specific IgE (1)
- Arbeitsbedingt erworbene Infektion (1)
- Arbeitsgedächtnis (1)
- ArchT (1)
- Archaebacterial Lipids (1)
- Arcuate fascicle (1)
- Aromatase inhibitors (1)
- Arrhythmia syndromes (1)
- Arteria ophthalmica (1)
- Arteriosclerosis (1)
- Arteriovenous malformation (1)
- Arthrodese (1)
- Arthroplasty (1)
- Arthroskopischer Bankart-Repair (1)
- Artificial feeding bioassays (1)
- Asparaginase (1)
- Aspirin (1)
- Astrocytoma (1)
- Astrozyten (1)
- Ataxia (1)
- Ataxia score (1)
- Atherosklerose (1)
- Athlete (1)
- Atm (1)
- Atomoxetine (1)
- Atrial Fibrillation (1)
- Atrial fibrillation (1)
- Atrial fibrillation classification (1)
- Attention (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention deficit (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Attentional bias (1)
- Audiologie (1)
- Auditory system (1)
- Aufmerksamkeit (1)
- Aufmerksamkeitsleistung (1)
- Augenerkrankungen (1)
- Aurora kinase (1)
- Ausbildung (1)
- Autism (1)
- Autism Spectrum disorder (1)
- Autismus-Spektrum-Störungen (1)
- Autoimmun (1)
- Autoimmune response (1)
- Autoimmune vasculopathy (1)
- Autoimmunity (1)
- Automated sRNA analysis (1)
- Automation (1)
- Automatisation (1)
- Autonomes Nervensystem (1)
- Autophagie (1)
- Awareness campaign (1)
- Axial spondyloarthritis (1)
- Axiale Spondyloarthritis (1)
- Axiography (1)
- Ayahuasca (1)
- Ayurveda (1)
- Ayurvedic herbal products (1)
- Azan (1)
- B cell cancer (1)
- B cell differentiation (1)
- B cells (1)
- B-cell (1)
- B-cell transcription factors (1)
- B.1.1.529 (1)
- B.1.1.7 (1)
- B.1.617.1 (1)
- B.1.617.2 (1)
- B3GNT2 (1)
- BA.4 (1)
- BA.5 (1)
- BACTEC™ 9000 (1)
- BCG (1)
- BCORL1 (1)
- BCX7353 (1)
- BEACOPP (1)
- BET proteins (1)
- BEZ235 (1)
- BH3 mimetics (1)
- BMP4 (1)
- BNT2b2 (1)
- BPO (1)
- BPTF (1)
- BRD4 (1)
- BRD7 (1)
- BSP (1)
- Bachelorabschluss (1)
- Bachelor’s degree (1)
- Bacillus subtilis (1)
- Back pain (1)
- Back scan (1)
- Bacteraemia (1)
- Bacteremia/diagnosis (1)
- Bacteria (1)
- Bacteria-host interaction (1)
- Bacterial abundance (1)
- Bacterial adhesion (1)
- Bacterial leakage (1)
- Bacteriological techniques (1)
- Bagatelltrauma (1)
- Bakterien (1)
- Bakterientest (1)
- Bakteriologische Techniken (1)
- Bakteriämie/Diagnostik (1)
- Balance (1)
- Ballon-assisted enteroscopy (1)
- Balloon-expandable TAVI (1)
- Bamlanivimab (1)
- Bankart-Läsion (1)
- Barrier (1)
- Bartonella adhesin A (1)
- Bartonella grahamii (1)
- Bartonella schoenbuchensis (1)
- Basal ganglia (1)
- Basalzellkarzinom (1)
- Beck Depression Inventory (1)
- Beckwith–Wiedemann syndrome (1)
- Bedburg-Hau, Anstalt (1)
- Beginners (1)
- Begriffsbestimmung (1)
- Behandlungskontrolle (1)
- Behandlungspfad (1)
- Behavioral tests (1)
- Behavioural ecology (1)
- Behinderung (1)
- Bence Jones (BJ) proteinuria (1)
- Bence Jones-Proteinurie (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Benign prostatic hyperplasia (1)
- Bentall operation (1)
- Berner, Friedrich (1)
- Berotralstat (1)
- Berufliche Gesundheit (1)
- Berufskrankheit (1)
- Berufszufriedenheit (1)
- Beschäftigte (1)
- Bestrahlung (1)
- Betriebliches Wiedereingliederungsmanagement (1)
- Bevacizumab (1)
- Bevölkerungsschutz (1)
- Bewegungsstörung (1)
- Biceps brachii (1)
- Big Five (1)
- Biglycan (1)
- Bilateral sagittal split osteotomy (1)
- Bildgebung (1)
- Bildqualität (1)
- Bilirubinbestimmung (1)
- Billroth II gastroenterostomy (1)
- Billroth papillotome (1)
- Billroth’s operation-II (1)
- Bio safety (1)
- Bioelektrische Impedanzanalyse (1)
- Bioenergetics (1)
- Biofilm (1)
- Biological sciences (1)
- Biologisches Profil (1)
- Biomarker Discovery Study (1)
- Biomarker Lipoprotein(a) (1)
- Biomarker TIMP‑2 und IGFBP7 (1)
- Biomarkers (1)
- Biomarkers TIMP‑2 and IGFBP7 (1)
- Biophysical models (1)
- Biophysics (1)
- Bipolar (1)
- Bipolare Störung (1)
- Birth (1)
- Birth weight (1)
- Bis-azido-NAD+ Analog (1)
- Black cohosh (1)
- Black cohosh induced liver injury (1)
- Bleeding Risk (1)
- Blindness (1)
- Blocked occlusion (1)
- Blog (1)
- Blood Banks/standards (1)
- Blood Transfusion, Autologous (1)
- Blood coagulation disorder (1)
- Blood loss (1)
- Blood loss calculator (1)
- Blood loss formula (1)
- Blood management (1)
- Blood parameters (1)
- Blood plasma (1)
- Blood pressure (1)
- Blood sample handling (1)
- Blood sampling (1)
- Bloodstream infections (1)
- Blot, Western (1)
- Blot, western (1)
- Blut- und Plasmaprodukte (1)
- Blutbanken/Standards (1)
- Blutkulturdiagnostik (1)
- Blutparameter (1)
- Blutpräparate (1)
- Blutspenderscreening (1)
- Bluttransfusion, Autologe (1)
- Blutung (1)
- Blutungskontrolle (1)
- Body image (1)
- Body measurements (1)
- Body sway (1)
- Bone Gla Protein (1)
- Bone cement implantation syndrome (1)
- Bone conduction devices (1)
- Bone defect (1)
- Bone diseases, Metabolic (1)
- Bone dust (1)
- Bone marrow aspiration (1)
- Bone regeneration (1)
- Bone remodelling (1)
- Bone substitute (1)
- Bone tissue engineering (1)
- Bone tumor (1)
- Borrelia burgdorferi (1)
- Borrelien (1)
- Bovine Spongiforme Enzephalopathie (BSE) (1)
- Bovine spongiform, encephalopathy (BSE) (1)
- Brachial artery (1)
- Brachytherapy (1)
- Bradycardia (1)
- Brain DNA methylation (1)
- Brain asymmetry (1)
- Brain injuries (1)
- Brain metastasis (1)
- Brain tumor (1)
- Brain tumor surgery (1)
- Breast cancer survivers (1)
- Breast conserving surgery (1)
- Brodalumab (1)
- Bronchiolitis (1)
- Bronchiolitis obliterans (1)
- Browsertool (1)
- Brustkrebs (1)
- Burkholderia arboris (1)
- Burkitt’s lymphoma (1)
- Burns (1)
- Bühnentanz (1)
- Büroangestellte (1)
- Büroarbeit (1)
- C-reaktive protein (1)
- C-reäktives Protein (1)
- C1 inhibitor (1)
- CAD-CAM (1)
- CAD/ CAM crown (1)
- CAD/CAM (1)
- CAD/CAM crown (1)
- CAM (1)
- CAPON (1)
- CAR (1)
- CBC (1)
- CBCT (1)
- CCC-2 (1)
- CCL2 (1)
- CD107-Assay (1)
- CD16 (1)
- CD34+ cell enumeration (1)
- CD34 + cells (1)
- CD36 (1)
- CD4+ T cells (1)
- CD40 (1)
- CD44 (1)
- CD45RA Depletion (1)
- CD47 (1)
- CD62L (1)
- CD62p+Exosomes (1)
- CD8+ T cells (1)
- CD8+ zytotoxische T-Zellen (1)
- CDH13 (1)
- CDI (1)
- CDK-cyclin axis (1)
- CDK2 (1)
- CDK4/6 inhibitors (1)
- CDK9 (1)
- CE (1)
- CE marking (1)
- CE-Kennzeichnung (1)
- CEBPD (1)
- CEST EPI (1)
- CHAID-Analyse (1)
- CHAID-Analysis (1)
- CHEPs (1)
- CHRDL1 (1)
- CIM (1)
- CIOMS (1)
- CIRS (1)
- CK2α (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CLS (1)
- CMR (1)
- CMV isolation (1)
- CMV risk groups are: pregnancy - blood transfusion - organ transplantation - prostitutes (1)
- CMV-Isolierung (1)
- CNDAC (1)
- CNS tumor (1)
- CNV (1)
- COPD (1)
- COVID (1)
- COVID 19 pandemic (1)
- COVID-19 epitope signatures (1)
- COVID-19 pandemic (1)
- COVID-19 vaccination (1)
- COVID-19, Primary care (1)
- COVID‐19 (1)
- CQL (1)
- CRBN (1)
- CRISPR screen (1)
- CRISPR/Cas (1)
- CRPC (1)
- CRT (1)
- CT dual-energy computed tomography (1)
- CTC (1)
- CTGF (1)
- CTLA-4 (1)
- CTX and NTX (1)
- CTX und NTX (1)
- CXCL12 (1)
- CXCL13 (1)
- CXCR3 antagonism (1)
- CXCR4 (1)
- CYP450 (1)
- CaMPARI (1)
- Cabozantinib (1)
- Caenorhabditis elegans (1)
- Calcium (1)
- Calcium calmodulin kinase (1)
- Calcium gluconate (1)
- Campylobacter (1)
- Cancer check up (1)
- Cancer development (1)
- Cancer genomics (1)
- Cancer progression (1)
- Cancer survivors (1)
- Cancer-specific survival (1)
- Cannabis-based Medicine (1)
- Capacity deficit (1)
- Capillary-Leak-Syndrom (1)
- Capnography (1)
- Capsaicin (1)
- Capsule endoscopy, video (1)
- Carcinoma (1)
- Cardiac arrest (1)
- Cardiac biomarkers (1)
- Cardiac implantable electronic devices (1)
- Cardiac infarction (1)
- Cardiac rehabilitation (1)
- Cardiac remodeling (1)
- Cardiac resynchronization therapy (1)
- Cardiavascular function (1)
- Cardio-oncology (1)
- Cardiology (1)
- Cardiotoxicity (1)
- Cardiovascular biology (1)
- Cardiovascular disease (1)
- Cardiovascular disease risk (1)
- Cardiovaskuläre Erkrankungen (1)
- Care centers (1)
- Care gaps (1)
- Care home (1)
- Carotid injury (1)
- Cartilage (1)
- Cartilage Biology (1)
- Cary-Blair medium (1)
- Cary-Blair-Medium (1)
- Casirivimab (1)
- Caspase-8 (1)
- Catel, Werner (1)
- Catheters (1)
- Catumaxomab (1)
- Causality assessment. (1)
- Cell Biology (1)
- Cell Death (1)
- Cell Metabolism (1)
- Cell Migration (1)
- Cell Signaling (1)
- Cell Surface Receptor (1)
- Cell division (1)
- Cell proliferation (1)
- Cell surface proteoglycans (1)
- Cell-based Assays (1)
- Cellular Immune Response (1)
- Cellular energy metabolism (1)
- Cellular network formation (1)
- Cement gap (1)
- Centers for Disease Control and Prevention (1)
- Central Europe (1)
- Cephalometry via electromagnetic induction (1)
- Cephalometry without x-rays (1)
- Ceramides (1)
- Cerebral hypoperfusion (1)
- Cerebral oxygen saturation (1)
- Cerebrospinal Fluid (1)
- Cerebrospinal fluid (1)
- Cerebrospinal fluid diagnostics (1)
- Cerebrovascular disorders (1)
- Cezanne (1)
- ChAdOx1-S (1)
- Chaperone (1)
- Checkliste (1)
- Checkpoint Inhibitor (1)
- Chemilumineszenz (1)
- Chemokines (1)
- Chemotherapie (1)
- Chemotherapy (1)
- Chikungunya (1)
- Child abuse (1)
- Child and adolescent psychotherapy (1)
- Children and adolescents (1)
- Chimeric Antigen Receptor (CAR) (1)
- Chimiothérapie (1)
- Chlamydia-Infections/urine (1)
- Chlamydien (1)
- Chlamydieninfektionen/Urin (1)
- Cholinergic (1)
- Chondrocytes (1)
- Chrna7 knockout (1)
- Chrom (1)
- Chromodomains (1)
- Chronic diseases (1)
- Chronic inflammation (1)
- Chronic lymphocytic leukemia (1)
- Chronisch aktive/Diagnostik (1)
- Chronische Fehl- und Überlastungsschäden (1)
- Cigarette (1)
- Cine (1)
- Circadian (1)
- Circulating MiRNA (1)
- Circulating markers (1)
- Cisplatinresistenz (1)
- Citrat (1)
- Civil protection (1)
- Clavien–Dindo classification (1)
- Click chemistry (1)
- Climate inequity (1)
- Clinical (1)
- Clinical Decision Support System (1)
- Clinical Global Impression of Change (1)
- Clinical efficacy (1)
- Clinical genetics (1)
- Clinical management (1)
- Clinical pathway (1)
- Clinical pharmacology (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical tasks (1)
- Clinical trial (1)
- Clinical trials (1)
- Clip (1)
- ClpB (1)
- Coagulation (1)
- Cochlear Implant (1)
- Coenzyme Analogue (1)
- Coenzyme Binding (1)
- Coeval folding and boudinage (1)
- Cognitive (1)
- Cognitive behavioural therapy (1)
- Cognitive dysfunction (1)
- Cognitive enhancers of exposure therapy (1)
- Cognitive impairment (1)
- Coherent infomax (1)
- Cohort studies (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Collagen-based biomaterial (1)
- Colloids (1)
- Colonic neoplasms (1)
- Colony stimulating factor 1 receptor (1)
- Colorimetric blood loss estimation (1)
- Combined surgical therapy (1)
- Combustion (1)
- Commercial Immunoglobulins (1)
- Comorbidities (1)
- Complete response (1)
- Completed suicide (1)
- Complex decongestive therapy (1)
- Complex elbow fractures (1)
- Compliance (1)
- Compliance-Beobachtung (1)
- Complicated stage (1)
- Comprehensive complication index (1)
- Compression stocking (1)
- Computational biophysics (1)
- Computational neuroscience (1)
- Computational sRNA analysis (1)
- Computational science (1)
- Computed Tomography (1)
- Computed tomography (1)
- Computed tomography imaging (1)
- Computed tomography, X-ray (1)
- Computer hardware (1)
- Computer science (1)
- Computer-Assisted (1)
- Computer-unterstützte (1)
- Concurrent CNS diseases (1)
- Cone-beam computed tomography (1)
- Confinement (1)
- Congenital (1)
- Congenital diaphragmatic hernia (1)
- Connective tissue (1)
- Connectivity (1)
- Connectomics (1)
- Conometric connection (1)
- Consensus document (1)
- Consensus statement (1)
- Conservative treatment (1)
- Constipation (1)
- Constitution (1)
- Constriction (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Continuous renal replacement therapy (1)
- Contraceptifs hormonaux (1)
- Contrast agent (1)
- Contrast-medium, injection rate, iodine concentration, hepatic malignancy, multiphasic CT (1)
- Control (1)
- Conventional and unconventional ubiquitination (1)
- Conventional dendritic cells (1)
- Convolutional Neural Networks (1)
- Cooperation (1)
- Copy number (1)
- Corneal tomography (1)
- Corona pandemic (1)
- Corona virus (1)
- Coronary artery disease (1)
- Coronary heart disease (1)
- Coronaviruses (1)
- Cortical degeneration (1)
- Cortical thickness (1)
- Corticotropic axis (1)
- Cost-effectiveness (1)
- Costs (1)
- Course (1)
- Course evaluation (1)
- Craniomaxillofacial injuries (1)
- Creatinine (1)
- Crisis (1)
- Critical size (1)
- Crohn’s disease (1)
- Cross- sectional study (1)
- Cross-frequency coupling (1)
- Cue-P3 (1)
- Culex pipiens (1)
- Culex pipiens biotypes pipiens/molestus (1)
- Culicidae (1)
- Culture positive (1)
- Curcumis sativus (1)
- Curriculum (1)
- Cushing-Syndrom (1)
- Cushing’s syndrome (1)
- Custom-made mouthguard (1)
- Cuticular hydrocarbons (1)
- Cyanoacrylate (1)
- Cyclin T1 (1)
- Cyclosporin A (1)
- CysLTR1 (1)
- Cystatin C (1)
- Cystic fibrosis (1)
- Cytochrome P450 (1)
- Cytochrome P450 enzymes (1)
- Cytokine (1)
- Cytokines (1)
- Cytokines Induction (1)
- Cytomegalie (1)
- Cytomegalie-Virus (1)
- Cytomegalovirus (1)
- Cytomegalovirus Infection (1)
- Cytoreductive nephrectomy (1)
- Cytotoxicity (1)
- D-amino acid oxidase (1)
- DBS (1)
- DC-NK cell interaction (1)
- DCK (1)
- DIN EN ISO 15189 (1)
- DNA Adducts (1)
- DNA integrity (1)
- DNA mismatch repair (1)
- DNA, Virale/Blut (1)
- DNA-PK (1)
- DNA-based identification (1)
- DOMS (1)
- DOT1L (1)
- DPPIV (1)
- DRG (1)
- DST (1)
- DTI (1)
- DVI (1)
- DVT (1)
- DWI (1)
- Dance (1)
- Dark triad (1)
- Data Analysis (1)
- Data preprocessing (1)
- Data processing (1)
- Data reduction (1)
- Data structure detection (1)
- Daubert criteria (1)
- De-isolation (1)
- Dead space (1)
- Death certificate (1)
- Decay (1)
- Decision Confidence (1)
- Decision support (1)
- Decontamination (1)
- Decorin (1)
- Deep learning (1)
- Deep neural network (1)
- Deep vein thrombosis (1)
- Defibrillation (1)
- Deformation oblique layer (1)
- Degrader design (1)
- Dehnen (1)
- Dehntraining (1)
- Dehydrogenase (1)
- Delphi consensus (1)
- Dementia (1)
- Demenz (1)
- Dendritic Cells (1)
- Dengue (1)
- Density equalizing mapping (1)
- Density-equalizing mapping (1)
- Dental Tissues (1)
- Dental air (1)
- Dental assistants (1)
- Dental casts (1)
- Dental education (1)
- Dental implants (1)
- Dental practice (1)
- Dentale Implantate (1)
- Dentin adhesives (1)
- Dentistry (1)
- Depression stigma (1)
- Dermatitis (1)
- Detection (1)
- Detection workflow (1)
- Detraining (1)
- Deutsche Gesellschaft für Chirurgie (1)
- Deutsches Rotes Kreuz (1)
- Developmental Biology (1)
- Developmental programming (1)
- Developmental trajectory (1)
- Developmentally adapted cognitive processing therapy (1)
- Device (1)
- Dexamethasone (1)
- Dexterity (1)
- Diabetes (1)
- Diabetes mellitus Typ 1 und Typ 2 (1)
- Diagnosen ICD-10 Ziffern G41.0, G41.1, G41.2, G41.8, G41.9 (1)
- Diagnoses ICD-10 codes G41.0, G41.1, G41.2, G41.8, G41.9 (1)
- Diagnosezeitpunkt (1)
- Diagnosis related groups (1)
- Diagnostic accuracy (1)
- Diagnostic dye (1)
- Diagnostic error (1)
- Diagnostic test (1)
- Diagnostic tests (1)
- Dialyse (1)
- Diet (1)
- Dietary HDAC inhibitor (1)
- Dietary supplements (1)
- Dieulafoy’s lesion (1)
- Differential Thermoanalysis (1)
- Differenzierung (1)
- Difficult Airway Management (1)
- Diffusion magnetic resonance imaging (1)
- Digital (1)
- Digital pathology (1)
- Digital subtraction angiography (1)
- Digital workshops (1)
- Digitale Volumen Tomographie (1)
- Digitalization (1)
- Digitization (1)
- Dimethyltryptamine (1)
- Diphtheria (1)
- Diptera (1)
- Direct measurement (1)
- Direct oral anticoagulation (1)
- Direct-acting antivirals (1)
- Disaster victim identification (1)
- Discitis (1)
- Disconnection (1)
- Discovery (1)
- Disease progression (1)
- Diseases (1)
- Disintegration (1)
- Diskonnektion (1)
- Dislocations of the knee (1)
- Distance learning (1)
- Distanzunterricht (1)
- Distribution limits (1)
- Dizygotic ectopic (1)
- Dome-and-basin structure (1)
- Donor screening (1)
- Dorsal root ganglia (1)
- Dose response (1)
- Dot-probe task (1)
- Double balloon enteroscopy (1)
- Double suicide (1)
- Double-blind placebo-controlled trial (1)
- Douleur (1)
- Downgrading (1)
- Dravet (1)
- Droplets (1)
- Drospirenon (1)
- Drug addiction (1)
- Drug resistance (1)
- Drug susceptibility testing (1)
- Drug targets (1)
- Drug therapy (1)
- Dual-energy computed tomography (1)
- Duodenum (1)
- Dural onlays (1)
- Dysfibrinogenämia (1)
- Dysfunctional social assumptions (1)
- Dysphagia (1)
- Désir d’enfant (1)
- D’Amico classification (1)
- E-health (1)
- EAA (1)
- EASI (1)
- EBM (1)
- EBRT (1)
- ECMO (1)
- EGFRvIII mutation (1)
- EHL concentrates (1)
- EMR1 (1)
- EMT (1)
- EN ISO 15189 (1)
- ENIGMA (1)
- EP300 (1)
- EQ5D5L (1)
- EQA scheme (1)
- ER-phagy (1)
- ERAL1 (1)
- ERCP (1)
- ERK inhibitor (1)
- ERK1/2 signaling (1)
- ESBL (1)
- ESR Spectroscopy (1)
- ESR and Infrared Studies (1)
- EVAR (1)
- Early (prenatal and postnatal) life experiences (1)
- Early setting (1)
- Ebola (1)
- Eccentric fixation (1)
- Ecological Momentary Assessment (EMA) (1)
- Ectopic pregnancy (1)
- Ectopic varices (1)
- Edinger, Ludwig (1)
- Edoxaban (1)
- Effective half-life (1)
- Efficacy (1)
- Efficiency (1)
- Ego dissolution (1)
- Eicosanoide (1)
- Einstellungen zu Impfungen (1)
- Einwilligungsfähigkeit (1)
- Einzelzahnimplantate (1)
- Eisenbestimmung (1)
- Eisenmangel (1)
- Ejection fraction (1)
- Ektachem® (1)
- Elastographie (1)
- Elderly trauma patient (1)
- Electric stimulation (1)
- Electrical stimulation (1)
- Electroconvulsive Therapy (1)
- Electroencephalography (1)
- Electrophysiology (1)
- Elektrischer Sturm (1)
- Elektrophysilogie (1)
- Elite football (1)
- Ellipticine (1)
- Elternurteil (1)
- Embden, Gustav (1)
- Embolie (1)
- Emergency card (1)
- Emergency care (1)
- Emergency treatment (1)
- Emotional intelligence (1)
- Empathy (1)
- Empfindlichkeitstestung (1)
- Empty puparia (1)
- Ena/VASP proteins (1)
- Encephalitis Viruses (1)
- Endocrine system and metabolic diseases (1)
- Endocrine therapy (1)
- Endodontie (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endometrial carcinoma (1)
- Endometriome (1)
- Endometriose (1)
- Endomicroscopy (1)
- Endométriomes (1)
- Endorectal (1)
- Endoscopic papillotomy (1)
- Endoscopic retrograde cholangiography (1)
- Endoscopic sphincterotomy (1)
- Endoscopic treatment (1)
- Endoscopic ultrasound (1)
- Endoskopie (1)
- Endothelial (1)
- Endothelial progenitor cells (1)
- Endothelial protein C receptor (1)
- Endothelial-to-mesenchymal transition (1)
- Endotoxin (1)
- Endotoxinaktivität (1)
- Endourologie (1)
- Endovascular aortic repair (1)
- Endovaskuläre Behandlung (1)
- Endovaskuläre Versorgung (1)
- Endpoint Urea determination (1)
- Endpunkt-Harnstoffbestimmung (1)
- Energiedefizit (1)
- Energy (1)
- Energy deficit (1)
- Energy metabolism (1)
- Energy-efficiency (1)
- Engraftment (1)
- Enterobacterales (1)
- Enterobacteriaceae (1)
- Environmental biotechnology (1)
- Environmental enrichment (1)
- Environmental impacts (1)
- Environmental sciences (1)
- Enzephalopathie (1)
- Enzymatic Behaviour (1)
- Enzyme Linked Immunosorbent Assay (ELISA) (1)
- Enzyme Preparation (1)
- Eosinophils (1)
- EpCAM positive tumor (1)
- Ephrin-B2–EphB4 (1)
- Epidemie (1)
- Epidemiologische Surveillance (1)
- Epidural abscess (1)
- Epigenetik (1)
- Epilepsiechirurgie (1)
- Epilepsiezentren (1)
- Epilepsy Acute seizure plan Antiseizure medication Instructions for action Self-management (1)
- Epilepsy center (1)
- Epilepsy centers (1)
- Epilepsy surgery (1)
- Epileptic seizure (1)
- Epileptic seizures (1)
- Epithelialization (1)
- Epithelioma Cells (1)
- Epsilon (1)
- Equity (1)
- ErbB-signaling (1)
- Erfolgsfaktoren (1)
- Ergebnisquantifizierung (1)
- Ergometrie (1)
- Ergometry (1)
- Ernährung (1)
- Erprobung (1)
- Erregernachweis (1)
- Erregerspektrum der Tonsillitis (1)
- Erste Hilfe (1)
- Erste-Hilfe-Kurs (1)
- Erythrophagocytosis (1)
- Erythropoetin (1)
- Erythrozytenkonzentrat (1)
- Erythrozytentransfusion (1)
- Estimated glomerular filtration rate (1)
- Estimation of height and sex determination (1)
- Etanercept (1)
- Eugenik (1)
- Eukaryotic sRNA (1)
- Europe (1)
- Euthanasie (1)
- Euthanasie <Nationalsozialismus> (1)
- Euthymic phase (1)
- Evaluation (1)
- Event related potentials (1)
- Event-related potential (1)
- Evidence based medicine (1)
- Evidence-based dentistry (1)
- Evidence-based drug discovery (1)
- Evidenzbasiert (1)
- Evidenzbasierte Medizin (1)
- Evidenzbasierung (1)
- Ewing sarcoma (1)
- Ewing-like (1)
- Exemestane (1)
- Exercise challenge (1)
- Exercise training (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- Exoscope (1)
- Exosomal cytokines (1)
- Expansion (1)
- Expectation violation (1)
- Expert Systems (1)
- Expertensysteme (1)
- Explicit (1)
- External beam radiotherapy (1)
- Extracellular matrix proteins (1)
- Extracorporeal devices (1)
- Extracorporeal membrane oxygenation (1)
- Extraprostatic (1)
- Exudates and transudates (1)
- Eye diseases (1)
- EyesiNet (1)
- Ezrin (1)
- F4/80 (1)
- FABP (1)
- FAM134 (1)
- FAP (1)
- FAPI PET (1)
- FBK-R23 (1)
- FDG-PET/CT (1)
- FDM (1)
- FECD (1)
- FEV1 (1)
- FF-ATP synthase dimer (1)
- FFF (1)
- FFP3 respirator (1)
- FFPE (1)
- FGFR (1)
- FHIR Search (1)
- FIH1 (1)
- FOXO1 (1)
- FOXO3 (1)
- FPR (1)
- FSME-Virus (1)
- FTMT (1)
- FXR (1)
- Face masks (1)
- Facial nerve (1)
- FactorXIII Val34Leu polymorphism (1)
- Faktor V Leiden Mutation (1)
- Faktor XIII Val34Leu Polymorphismus (1)
- Faktorstruktur (1)
- Fall (1)
- Fall Leipzig (Kind Knauer) (1)
- Falls (1)
- Famines (1)
- Farbmuster (1)
- Fasciculus arcuatus (1)
- Fast Healthcare Interoperability Resources (1)
- Fatigue (1)
- Feasibility (1)
- Feasibility studies (1)
- Feinstaub (1)
- Female subjects (1)
- Fendrr (1)
- Ferritinophagy (1)
- Ferroptosis (1)
- Fertigkeit (1)
- Fertility counseling (1)
- Fertilität (1)
- Fertilité (1)
- Fetal heart (1)
- Fettleber (1)
- FibroMax (1)
- Fibroblast (1)
- Fibrous dysplasia (1)
- Field of View (1)
- Field study (1)
- Filariasis (1)
- Filariosis (1)
- Filgrastim (1)
- Filler (1)
- Filtermembranmethode (1)
- Finevo (1)
- Flaubert, Bouvard und Pécuchet (1)
- Flavin mononucleotide (1)
- Fluid overload (1)
- Fluid therapy (1)
- Fluorescence (1)
- Focal Adhesion Kinase (1)
- Focal onset seizure (1)
- Folgeerkrankungen (1)
- Follicular lymphoma (1)
- Follow-ups (1)
- Fondaparinux (1)
- Food and Drug Administration (1)
- Forced expiratory volume in 1 s (1)
- Forensic anthropology (1)
- Forensic examination (1)
- Forensic experts (1)
- Forensic osteology (1)
- Forensic pathology (1)
- Forensische Anthropologie (1)
- Forschung (1)
- Forschungspraxisnetz (1)
- Fracture (1)
- Fracture models (1)
- Fracture type (1)
- Fragebogen (1)
- Frameshift (1)
- Frankfurt am Main, Universität (1)
- Frankfurt am Main, Universitätsmedizin (1)
- Frankfurt, Anatomie (1)
- Frankfurt, Universität (1)
- Frankfurt, Universität, Seminar für Geschichte der Medizin (1)
- Frankfurt, Universitätsmedizin 1933-1945 (1)
- Frauen (1)
- Freie Atmung (1)
- Freud und die Psychoanalyse (1)
- Frontobasal (1)
- Fruit fly (1)
- Frühsommermeningoenzephalitis (1)
- Fuchs endothelial dystrophy (1)
- Fukushima (1)
- Functional characterization (1)
- Functional connectivity (1)
- Functional electrical stimulation (1)
- Functional outcomes (1)
- Fungemia/diagnosis (1)
- Fungämie/Diagnostik (1)
- Funktionelle Bildgebung (1)
- Further education (1)
- G-CSF (1)
- G207 (1)
- G2A (1)
- G3BP1 (1)
- GABA (1)
- GC–MS (1)
- GD2 (1)
- GDF11 (1)
- GFR (1)
- GIIb/IIIa-receptor (1)
- GLA deficiency (1)
- GMP (1)
- GPR4 (1)
- GRAND-SLAM (1)
- GSH (1)
- GTP cyclohydrolase (1)
- Gait analysis (1)
- Gallengangsstenose (1)
- Galvano (1)
- Ganglionic (1)
- Gan–Dou–Fu–Mu decoction (GDFMD) (1)
- Gastric adenoma (1)
- Gastric cancer (1)
- Gastric motility (1)
- Gastritis (1)
- Gastroenterology (1)
- Gastrointestinal (1)
- Gastrointestinal bleeding (1)
- Gaussian graphical models (1)
- Gefäßinflammation (1)
- Gefäßtonus (1)
- Gegenübertragung (1)
- Gehörlosigkeit (1)
- Gelastic seizures (1)
- Gelastische Anfälle (1)
- Genamplifikation (1)
- Gender (1)
- Gender reassigning surgery (1)
- Gene (1)
- Gene ontology (1)
- Gene sequencing (1)
- Gene therapy (1)
- Gene-Amplification (1)
- Gene/Regulation (1)
- General Practitioner (1)
- General practice (1)
- Generalized procrustes analysis (1)
- Generation of reports on special findings in laboratory medicine (1)
- Genetic heart disease (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetic syndromes (1)
- Genetic techniques (1)
- Genome editing (1)
- Genome-wide association study (1)
- Genomic medicine (1)
- Geographical disparities (1)
- Gerinnungsfaktor XIII (1)
- German Society of Surgery (1)
- Gerontologic legal medicine (1)
- Gerontologische Rechtsmedizin (1)
- Gesamteiweißbestimmung im Harn (1)
- Geschichte 1914-2014 (1)
- Geschichte 1933-1945 (1)
- Geschichte 1938 (1)
- Geschichte der Medizin Frankfurt (1)
- Gesprächsführung (1)
- Gestagen-Monopräparate (1)
- Gestationshyperthyreose (1)
- Gesundheitskommunikation (1)
- Gesundheitspersonal (1)
- Gesundheitspolitische Zuständigkeit (1)
- Gesundheitsversorgungseinrichtungen (1)
- Gezielte Therapie (1)
- Giftgas (Lost) (1)
- Glabella (1)
- Glaucoma (1)
- Gleason Grade Group (1)
- Gleason Grade group (1)
- Gleason grade group (1)
- Glia Maturation Factor (1)
- Glioblastoma survival (1)
- Global networking (1)
- Global warming (1)
- Glomerulosclerosis (1)
- Glyceraldehyde-3 Phosphate Dehydrogenase (1)
- Glyceraldehyde-3-phosphate Dehydrogenase (1)
- Glycolysis (1)
- Goldstein, Kurt (1)
- Gradient boosting (1)
- Grading (1)
- Graft (1)
- Graft quality (1)
- Gram-negative bacteria (1)
- Granulocytes (1)
- Graph theory (1)
- Graphical LASSO (1)
- Graves’ disease (1)
- Gravimetric method (1)
- Green Tobacco Sickness (GTS) (1)
- Greenhouse effect (1)
- Groin pain (1)
- Grossesse (1)
- Guidance (1)
- Guide profession (1)
- Guided bone regeneration (GBR) (1)
- Guided tissue regeneration (GTR) (1)
- Guideline-based treatment (1)
- Guidelines (1)
- Gut (1)
- Gut bacteria (1)
- GvL (1)
- Görden, Anstalt (1)
- Güntz, Eduard (1)
- Gütt, Arthur (1)
- HADS (1)
- HAE (1)
- HARS2 (1)
- HCC marker (1)
- HCMV (1)
- HCV-Core-Antigen (1)
- HDAC and BET inhibitor (1)
- HDAC inhibition (1)
- HDAC4 (1)
- HDR-Brachytherapie (1)
- HDR-brachytherapy (1)
- HEOR (1)
- HER2 (1)
- HEUS (1)
- HHUSD (1)
- HHV-8 (1)
- HIF (1)
- HIF-1α (1)
- HIF-2 (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIPPO signalling (1)
- HIT (1)
- HIV protease inhibitors (1)
- HIV-1 Genotypisierung (1)
- HIV-1 genotyping (1)
- HIV-Antigen-Test (1)
- HIV-Infektion (1)
- HIV-Infektionen (1)
- HIV-infection (1)
- HLA antibodies (1)
- HLHS (1)
- HNO (1)
- HNPCC (1)
- HOLEP (1)
- HOSO (1)
- HOTAIR (1)
- HPO (1)
- HPV infection (1)
- HPV-positive OPSCC (1)
- HRCT (1)
- HRM (1)
- HRV (1)
- HSC (1)
- HSCT (1)
- HSP (hereditary spastic paraplegia) (1)
- HSV type specific antibodies (1)
- HSV-1 (1)
- HSV-typenspezifische Antikörper (1)
- HT22 neurons (1)
- HVPG (1)
- Hadamar (1)
- Haematocrit (1)
- Haematologic diseases (1)
- Haemodialysis (1)
- Haemophilia (1)
- Haemophilie A (1)
- Half-of-the-Sites Reactivity (1)
- Halogenobenzimidazoles (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Handlungsanweisungen (1)
- Hard-tissue trauma (1)
- Hardware erosion (1)
- Harnsteinanalyse (1)
- Harnsteinkomponenten (1)
- Hausarztmangel (1)
- Hausarztpraxis (1)
- Hawaii Department of Health (1)
- HeLa cells (1)
- Head and neck cancer (1)
- Head bandage (1)
- Head neck cancer (1)
- Health Communication (1)
- Health care structures (1)
- Health care workers (1)
- Health facilities (1)
- Health personnel (1)
- Health policy (1)
- Health sciences (1)
- Health services (1)
- Health services research (1)
- Health surveys (1)
- Health technology assessment (1)
- Healthcare (1)
- Healthcare resource utilisation (1)
- Healthcare structure (1)
- Healthy Living Index (HLI) (1)
- Healthy men (1)
- Healthy stem cell donors (1)
- Heart defects (1)
- Heart rate (1)
- Heart transplantation (1)
- Heartrate (1)
- Heat Shock Protein (HSP) (1)
- Heat shock protein 27 (1)
- Heimtraining (1)
- Hematologic adverse events (1)
- Hematoma (1)
- Hematopoietic stem cell (1)
- Hematopoietic stem cell transplant (1)
- Hematotoxicity (1)
- Hemispheric specialization (1)
- Hemobilia (1)
- Hemodynamics (1)
- Hemosiderin (1)
- HepG2 Zellen (1)
- Heparan Sulfate (1)
- Heparin (1)
- Heparinsensitivität (1)
- Hepatectomy (1)
- Hepatic stellate cell (1)
- Hepatitis B Antibodies/serum (1)
- Hepatitis B Core-Antigene/Immunologie (1)
- Hepatitis B-Antikörper/Serum (1)
- Hepatitis B-Core-Antigens-immunology (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatitis C-Virus (HCV) (1)
- Hepatitis C; DNA (1)
- Hepatitis G virus (1)
- Hepatitis G-Virus (1)
- Hepatitis, Chronic Active/diagnosis (1)
- Hepatoblastom (1)
- Hepatocellular carcinoma (HCC) (1)
- Herbal medicine (1)
- Herbalife products (1)
- Herbs induced liver injury (1)
- Hereditary angioedema (1)
- Hereditäre Thrombophilie (1)
- Herniated disk (1)
- Herpe-Viren (1)
- Herpes Simplex Virus/isolation and purification . (1)
- Herpes simplex Virus/Isolierung und Anreicherung (1)
- Herpes virus (1)
- Herpesvirus 1, Humanes (1)
- Herpesvirus 2, Human (1)
- Herpesvirus 2, Humanes (1)
- Herpesvirus1, Human (1)
- Herz-Kreislauffunktion (1)
- Herzchirurgie (1)
- Herzkatheteruntersuchung (1)
- Heterogeneity (1)
- Heterologous prime-boost (1)
- Heterotopic pregnancy (1)
- Hidradenitis suppurativa (1)
- Hierarchical drift-diffusion modeling (1)
- Hig1 (1)
- High altitude (1)
- High radon areas (1)
- High-risk prostate cancer (1)
- Highwire (1)
- Himalayas (1)
- Hip hemiarthroplasty (1)
- Hip revision (1)
- Hippocampal excitability (1)
- Hippokrates, Asteroid (1)
- Hirninfarkt (1)
- Hirnkrankheit (1)
- Hirnmetastasen (1)
- Hirschsprung disease (1)
- Hirt, August (1)
- Hispanic–Latino race/ethnicity (1)
- Histological analysis (1)
- Histology (1)
- Histonmethylierung (1)
- Hitachi 705 (1)
- HlV-Infections (1)
- Hochdurchsatz (1)
- Hodgkin lymphoma (1)
- Holmium laser enucleation (1)
- Home Care Services [MeSH] (1)
- Hometraining (1)
- Homicide (1)
- Homicide-suicide (1)
- Homizid-Suizid (1)
- Honolulu Queen’s Medical Center (1)
- Hormonal (1)
- Hormone (1)
- Hormone receptor positive breast cancer (1)
- Hormonelle Kontrazeptiva (1)
- Hormones thyroïdiennes (1)
- Hornhauttransplantation (1)
- Hospital (1)
- Hospital case volume (1)
- HuR (1)
- Human Immunodeficiency Virus (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human pancreas (1)
- Human primary proximal tubular cells (1)
- Human retroelements (1)
- Human visual cortex (1)
- Hyaluronan (1)
- Hybrid Formation (1)
- Hydrocortison (1)
- Hydrocortisone (1)
- Hydrofluoric acid (1)
- Hydromineral (1)
- Hydroxyethyl starch (1)
- Hymenoptera venom allergy (1)
- Hyperactivity (1)
- Hyperlipidemia (1)
- Hyperlipidämie (1)
- Hyperscanning (1)
- Hypertensive disorders in pregnancy (1)
- Hyperthyroïdie gestationnelle (1)
- Hypokalzämie (1)
- Hypoparathyreoidismus (1)
- Hyposensibilisierung (1)
- Hypothyreose (1)
- Hypothyroïdie (1)
- Hypoxia inducible factor 1 alphal (1)
- Hypoxia-inducible factor-1α (HIF-1α) (1)
- Hämatotoxizität (1)
- Hämophile Arthropathie (1)
- Hämophilie (1)
- Händehygiene (1)
- Höchstrichterliche Rechtsprechung (1)
- IAP (1)
- IAP Proteins (1)
- IAP-IAP (1)
- ICAM-1 (1)
- ICD (1)
- ICG (1)
- ICH M13A draft guideline (1)
- ICL (1)
- ICL V4c (1)
- IDH mutation (1)
- IFN-β (1)
- IGF-1 (1)
- IGF1 (1)
- IL-17 (1)
- IL-17A (1)
- IL-1b (1)
- IL-1β (1)
- IL-33 (1)
- IL-38 (1)
- INR (1)
- IPSS (1)
- IR (1)
- IRF-3 (1)
- IRIS (1)
- ISO (1)
- ISRS (1)
- IVD (1)
- IVD directive (1)
- IVD-Richtlinie (1)
- IVUS (1)
- Iatrogen (1)
- Iatrogenic (1)
- Idelalisib (1)
- Identifier (1)
- Identifikation (1)
- Identifizierung von Katastrophenopfern (1)
- Idiopathische Dystonie (1)
- Ig (sub)class-specific antibody determination (1)
- Ig- (sub)klassen-spezifische Antikörperbestimmung (1)
- IgA deficiency (1)
- IgM/Immunologie (1)
- IgM/immunology (1)
- Ileostomy (1)
- Image processing (1)
- Imagery (1)
- Imdevimab (1)
- Immunbiology (1)
- Immunchemie (1)
- Immune Complexes (1)
- Immune checkpoint inhibitors (1)
- Immune complex vasculitis (1)
- Immune paralysis (1)
- Immune status (1)
- Immunfixations-Elektrophorese (1)
- Immunglobulinklassen und -subklassen (1)
- Immunity (1)
- Immunität <Medizin> (1)
- Immunitätsbeurteilung (1)
- Immunkomplexe (1)
- Immunmodulation (1)
- Immunnephelometrie (1)
- Immunoassay (1)
- Immunodeficiency (1)
- Immunofluoreszenz (1)
- Immunogenetics (1)
- Immunoglobulin classes and -subclasses (1)
- Immunoglobulins (1)
- Immunologie (1)
- Immunologie Methods (1)
- Immunomodulatory agents (1)
- Immunonephelometry (1)
- Immunophenotyping (1)
- Immunoseneszenz (1)
- Immunoturbidimetry (1)
- Immuno‑histochemistry (1)
- Impedanzaggregometrie (1)
- Impella (1)
- Impfkurs (1)
- Impfquoten (1)
- Implant osseointegration (1)
- Implantable cardioverter-defibrillator (1)
- Implantat (1)
- Implicit (1)
- Implicit Processing (1)
- Implicit Association Test (1)
- Implicit motives (1)
- Impoverishment (1)
- Impräzision (1)
- Impulse generator (1)
- Imrt (1)
- In vitro (1)
- In vivo (1)
- In vivo electrophysiology (1)
- In-ASK Studie (1)
- In-Hospital Emergencies (1)
- In-TIPS thrombosis (1)
- Inactivation (1)
- IncX (1)
- Incidence rate (1)
- Incidental prostate cancer (1)
- Incontinence (1)
- Indication for fertility preservation (1)
- Indirect treatment comparison (ITC) (1)
- Individual differences (1)
- Individualized therapy (1)
- Indocyanine green (1)
- Indonesia (1)
- Inducible nitric oxide synthase (iNOS) (1)
- Induction therapy (1)
- Inequality (1)
- Infektionen (1)
- Infektionsserologie (1)
- Inferior vena cava thrombus (1)
- Infertilität (1)
- Inflammasome (1)
- Inflammatory bowel disease (1)
- Inflammatory fibroid polyp (1)
- Inflammatory pattern (1)
- Influenza vaccination (1)
- Information theory (1)
- Informationstheorie (1)
- Informiertheit (1)
- Infrared Raman (1)
- Infrarotspektroskopie (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Injuries (1)
- Injury (1)
- Injury Severity Score (ISS) (1)
- Innate immunity (1)
- Inpatient hospital cases (1)
- Instructions for action (1)
- Insulin (1)
- Insulin resistance (1)
- Integrated Pulmonary Index (1)
- Integration (1)
- Integrative Network Analysis (1)
- Intensive care (1)
- Intensivpatient (1)
- Intention attribution (1)
- Interaction (1)
- Interaktionsdatenbanken (1)
- Interferon alpha (1)
- Interferon-free (1)
- Interferon-α (1)
- Interferon-λ, (1)
- Interferonfrei (1)
- Interleukin-10 (1)
- Interleukin-22 (1)
- Interleukin-36 (1)
- Intermediate-risk (1)
- International normalized ratio (1)
- Internet-based therapy (1)
- Interoperability (1)
- Interposition (1)
- Interpretation Bias (1)
- Interrater Reliability (1)
- Interraterreliabilität (1)
- Intersectoral care (1)
- Interstitial pneumonia (1)
- Intervention (1)
- Intervention development (1)
- Interventional oncological treatment (1)
- Intervertebral disc displacement (1)
- Interview (1)
- Interviews (1)
- Intestinal fistula (1)
- Intestinal metaplasia (1)
- Intimal-medial thickness (1)
- Intoxication (1)
- Intoxikation (1)
- Intraoperative blood salvage (1)
- Intraoperative procedure (1)
- Intraoperative test (1)
- Intravenous antibiotic therapy (1)
- Intravenous antiepileptics (1)
- Intravenous iron (1)
- Intravenöse Antiepileptika (1)
- Intrinsic Disorder (1)
- Intrinsic resistance (1)
- Intubation (1)
- Intubation anesthesia (1)
- Intubationsnarkose (1)
- Ionization State (1)
- Iridium-192 (1)
- Iron deficiency (1)
- Iron estimation (1)
- Ischemia (1)
- Ischemic stroke (1)
- Isocitrate dehydrogenase (1)
- Isoflurane (1)
- Isoforms (1)
- Isolierung (1)
- Isothermal amplification (1)
- Ixodes (1)
- Ixodes ricinus (1)
- JAK2V617F (1)
- JNK (1)
- Jaw (1)
- Jaw surgery (1)
- Job satisfaction (1)
- Joint actions (1)
- Joint loading (1)
- Jurkat (1)
- Jüdische Dozenten Frankfurt (1)
- K-homology RNA-binding domain (1)
- K3EDTA plasma sampling (1)
- KCCQ (1)
- KCNQ1 (1)
- KLHL11 (1)
- KPS (1)
- KSHV epidemiology (1)
- KSHV, Epidemiologie (1)
- Kachexie (1)
- Kaiserschnitt (1)
- Kallestad QM 300 (1)
- Kallestad QM 30 (1)
- Kallikrein inhibitor (1)
- Kanzlei des Führers (1)
- Kapazitätsdefizit (1)
- Kapnographie (1)
- Kappa (1)
- Kardiovaskuläres Risiko (1)
- Karzinom (1)
- Katheterablation (1)
- Kava (1)
- Kava hepatotoxicity (1)
- Keap1-Nrf2 (1)
- Kephalometrie mit Magnetinduktion (1)
- Kephalometrie ohne Röntgenstrahlen (1)
- Keratoplastik (1)
- Ki-67 (1)
- Kidney diseases (1)
- Kidneys (1)
- Kinases (1)
- Kind (1)
- Kinder und Jugendliche (1)
- Kinderchirurgie (1)
- Kindes- und Jugendalter (1)
- Klinische Aufgabengebiete (1)
- Klinische Ergebnisse (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knee surgery (1)
- Knees (1)
- Kniegelenkinfekt (1)
- Knieinfekt (1)
- Knochen (1)
- Knochenabbau (1)
- Knochenevaluation (1)
- Knochenmetastasen (1)
- Knochenstoffwechselerkrankungen (1)
- Koch, Richard (1)
- Kognitiv (1)
- Kognitive Beeinträchtigungen (1)
- Kommerzielle Immunglobuline (1)
- Komorbidität (1)
- Komplementbindungsreaktion (KBR) (1)
- Komplikation allogene Stammzelltransplantation (1)
- Komplikationsrate (1)
- Komprimierte Abtastung (1)
- Konformitätsbewertung (1)
- Konsens (1)
- Kontaktallergie (1)
- Kontrazeption (1)
- Konusprothese (1)
- Konversion (1)
- Koronare Herzkrankheit (1)
- Kortikale Dicke (1)
- Kortikotrope Achse (1)
- Krankenhausfallaufkommen (1)
- Krankenversicherung (1)
- Krankheitskosten (1)
- Kreatinin (1)
- Krebs (1)
- Krebststammzelle (1)
- Kupfer (1)
- Kutner, Luis (1)
- Körperbild (1)
- Körpergrößenschätzung, Geschlechtsdiskrimination (1)
- Körperliche Aktivität (1)
- Körpermaße (1)
- Körpermodifizierung (1)
- L1-norm SVM (1)
- LAMTOR1 (1)
- LARS2 (1)
- LASS (1)
- LC-MS-Based Clinical Research (1)
- LC-MS-based lipid mediator analysis (1)
- LCD-Array (1)
- LD 2 Ringe (1)
- LD 2 rings (1)
- LDHB (1)
- LEOSS (1)
- LPS (1)
- LQTS (1)
- LSCC (1)
- LSD1 (1)
- LSEC (1)
- LU-102 (1)
- Labordiagnose (1)
- Labormedizinische Spezialbefundung (1)
- Labororganisation (1)
- Laborpersonal (1)
- Lacunar (1)
- Lagerungsbedingungen (1)
- Lakunär (1)
- Laminin (1)
- LanCL2 (1)
- Landarztprogramm (1)
- Landmark (1)
- Langstreckige Knochendefekte (1)
- Language delay (1)
- Langzeiteffekt (1)
- Laparoskopie (1)
- Large vessel occlusion (1)
- Laryngeal Tube (1)
- Laser interstitial thermal therapy (1)
- Lasers (1)
- Lateral flow antigen testing (1)
- Lateral flow immunoassay (1)
- Laufökonomie (1)
- Learning and memory (1)
- Lebenslimitierende Erkrankungen (1)
- Leberkrebs (1)
- Lebertransplantation (1)
- Leberzirrhose (1)
- Lee type, functional outcome (1)
- Lee-type (1)
- Legal considerations (1)
- Legal medicine (1)
- Legionella pneumophila (1)
- Lehre im klinischen Alltag (1)
- Lehrforschung (1)
- Lehrveranstaltungsevaluation (1)
- Lehrvideos (1)
- Leichenschauschein (1)
- Leigh syndrome (1)
- Leipzig (1)
- Leipzig, Universitätskinderklinik (1)
- Leishmaniasis (1)
- Leistungsfähigkeit (1)
- Leitliniengerechte Behandlung (1)
- Leksell (1)
- Lemperle (1)
- Lennox-Gastaut syndrome (1)
- Lernzuwachs (1)
- Leukaemic Cells (1)
- Leukemia (1)
- Leukocyte depletion filter (1)
- Leukozyt (1)
- Life-limiting conditions (1)
- Lifestyle (1)
- Ligand post-insertion (1)
- Limitation of therapy (1)
- Lipedema (1)
- Lipemia (1)
- Lipid Transition Temperature (1)
- Lipid peroxidation (1)
- Lipid solution (1)
- Lipocalin-2 (1)
- Lipoprotein(a)/Analytik (1)
- Lipoprotein(a)/analysis (1)
- Liposuction (1)
- Lippen-Kiefer-Gaumenspalte (1)
- Lipämie (1)
- Liquor cerebrospinalis (1)
- Liquordiagnostik (1)
- Liver (1)
- Liver Fibrosis (1)
- Liver Transplantation (1)
- Liver biopsy (1)
- Liver cancer (1)
- Liver disease (1)
- Liver fibrosis (1)
- Liver histology (1)
- Liver injury (1)
- Loa loa (1)
- Local field potential (1)
- Lockdown (1)
- Lokales IgE (1)
- Long interspersed nuclear elements (LINE) (1)
- Long non-coding RNA (1)
- Long non-coding RNAs (1)
- Long noncoding RNA (1)
- Long-term continence (1)
- Long-term effect (1)
- Long-term follow-up (1)
- Long-term results (1)
- Long-term-measurements (1)
- Longchain polyunsaturated fatty acids (1)
- Low grade glioma (1)
- Low-dose radiation therapy (1)
- Low-virulent infection (1)
- Lp(a)-Lipoproteinbestimmungen (1)
- Lp(a)-lipoprotein determinations (1)
- Luminex (1)
- Lung Neoplasms/serum (1)
- Lung cancer (1)
- Lung development (1)
- Lung function (1)
- Lung neoplasms (1)
- Lung ultrasound (1)
- Lungenneoplasma/Serum (1)
- Lyme Disease (1)
- Lyme borreliosis (1)
- Lyme disease (1)
- Lyme-Borreliose (1)
- Lymphangiectasia (1)
- Lymphocyte subpopulations (1)
- Lymphom (1)
- Lymphoma (1)
- Lymphoma Cells (1)
- Lymphopenia Mortality (1)
- Lymphozyt (1)
- Lysophosphatidic acids (1)
- Ländlicher Raum (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MAP Kinases (MAPKs) (1)
- MAP kinase (1)
- MCH (1)
- MDD (1)
- MEIS (1)
- MEIS homeodomain protein (1)
- MEK inhibitor (1)
- MEN1 (1)
- MFA (1)
- MGMT (1)
- MGMT promoter (1)
- MID task (1)
- ML-IAP (1)
- MLH1 (1)
- MLKL (1)
- MMPs (1)
- MN1 (1)
- MR spectroscopy (1)
- MRI-negative epilepsy (1)
- MRT (1)
- MS (1)
- MSC (1)
- MT: Non-coding RNAs (1)
- MTHFR-Mutation (1)
- MTHFR-mutation (1)
- MTL30 (1)
- MTOR inhibitor (1)
- MTRasym (1)
- MTT assay (1)
- MUTARS® RS Cup (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- MVPA (1)
- MYC (1)
- MYCBP2 (1)
- MYCN amplification (1)
- Machine Learning (1)
- Macrophage (1)
- Magnet dislocation (1)
- Magnetic resonance (1)
- Magnetresonanztomographie (1)
- Maintenance therapy (1)
- Major Depressive Disorder (1)
- Malaria (1)
- Malate Dehydrogenases (1)
- Malignancy (1)
- Malignant meningioma (1)
- Mammakarzinom (1)
- Management (1)
- Manchester scar scale (1)
- Mandatory Vaccinations (1)
- Mandibula (1)
- Mangel (1)
- Manner of death (1)
- Manuelle Lymphdrainage (1)
- Marburg virus (1)
- Marginal integrity (1)
- Masking effect (1)
- Masquelet technique (1)
- Mass disaster (1)
- Massenkatastrophe (1)
- Massenspektrometrie (1)
- Mastectomy (1)
- Master Plan 2020 (1)
- Masterabschluss (1)
- Masterplan 2020 (1)
- Master’s degree (1)
- Mastoiditis (1)
- Matching-adjusted indirect comparison (MAIC) (1)
- Materials science (1)
- Maternal separation (1)
- Mathematical biosciences (1)
- Mathematical functions (1)
- Maxillofacial reconstruction (1)
- Maxillofacial surgery (1)
- Maxillofacial trauma (1)
- Mean erythrocyte volume (1)
- Mechanical ventilation (1)
- Mechanism of action (1)
- Median nerve (1)
- Medical Oncology (1)
- Medical Physics: Diagnostic (1)
- Medical education (1)
- Medical examiner (1)
- Medical history (1)
- Medical law (1)
- Medical studies (1)
- Medical study (1)
- Medikamente (1)
- Medikamente Handlungsanweisungen (1)
- Medizin (1)
- Medizingeschichte, Lehrbuch (1)
- Medizinische Ausbildung (1)
- Medizinisches Personal (1)
- Medizinkritik in der Literatur (1)
- Medizinrecht (1)
- Medizinstudenten 1968 (1)
- Meersseman test (1)
- Membrane proteins (1)
- Membrane-Phloretin Interaction (1)
- Mengele, Josef (1)
- Meningioma (1)
- Menschenversuche, verbrecherische (1)
- Mental disorder (1)
- Mental health and psychiatry (1)
- Mental health therapies (1)
- Meta-analysis (1)
- Metabolic dysfunction (1)
- Metabolic models (1)
- Metabolic syndrome (1)
- Metabolic vulnerabilities (1)
- Metabolism (1)
- Metabolomic profile (1)
- Metacognition (1)
- Metal clip (1)
- Metalloproteinases (1)
- Metastasen (1)
- Metastasis (1)
- Metastasis-directed therapy (1)
- Metastatic (1)
- Metastatic castration-resistant prostate cancer (1)
- Metastatic renal cell carcinoma (1)
- Metformin (1)
- Methanol (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Method validation (1)
- Methodenvergleich (1)
- Methods (1)
- Methylation (1)
- Methylmercury Containing Inactivator (1)
- Methylphenidate (1)
- MiR-29 (1)
- MiSpEx-network (1)
- Michael acceptor (1)
- Micro computed tomography (1)
- MicroRNAs (1)
- Microbiology and Infectious Disease (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microbiome (1)
- Microenvironment (1)
- Microfilaremia (1)
- Microgap (1)
- Microglia (1)
- Microparticles (1)
- Microplastic (1)
- Microstates (1)
- Microstructural impairment (1)
- Mid-intestinal bleeding (1)
- Migrant health (1)
- Mikroangiopathie (1)
- Mikroneutralisationstest (1)
- Mikropartikel (1)
- Mikrovesikel (1)
- Mikrowellenablation (1)
- Mild chronic inflammation (1)
- Mild hypoxia (1)
- Mindestmengen (1)
- Mindfulness (1)
- Mineralization (1)
- Mineralocorticoids (1)
- Mineralokortikoide (1)
- Mini-monovision (1)
- Minimal invasive dentistry (1)
- Minimal-invasiv (1)
- Minimally invasive (1)
- Minor injury (1)
- Mitochondrial Apoptosis (1)
- Mitochondrial Metabolism (1)
- Mitochondrial Permeability Transition (1)
- Mitochondrial ROS (1)
- Mitochondrial Transport (1)
- Mitochondrial and Cytoplasmic Malate Dehydrogenase (1)
- Mitochondrial complex I (1)
- Mitosis (1)
- Mitral regurgitation (1)
- Mitral valve (1)
- Mitralklappenrekonstruktion (1)
- Mixed Lipid Phases (1)
- Mixed hearing loss (1)
- Mmp12 (1)
- Mobilization (1)
- Model organisms (1)
- Moderne Medizin (1)
- Molecular Biology (1)
- Molecular Chaperone (1)
- Molecular diagnosis (1)
- Molecular diagnostics (1)
- Molecular glue (1)
- Molecular mimicry (1)
- Molecular subtypes (1)
- Moll, Albert (1)
- Molmassenverteilung (1)
- Monetary incentive delay (1)
- Mongolian spot (1)
- Monitoring (1)
- Monoacylglycerol lipase (1)
- Monoclonal antibody (mAb) (1)
- Monocyte gene expression (1)
- Monotherapie (1)
- Monozyten (1)
- Mood (1)
- Morbidity (1)
- Morbus Basedow (1)
- Morbus Cushing Syndrom (1)
- Morphologie (1)
- Mosquito (1)
- Mosquito crop (1)
- Mosquito-plant interaction (1)
- Motility (1)
- Motivation (1)
- Motivational situation (1)
- Motivationslage (1)
- Motor-cognitive (1)
- Mountain (1)
- Mouse (1)
- Mouse models (1)
- Multi-Omics (1)
- Multi-motive grid (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multidrug-resistance (1)
- Multidrug-resistant organisms (1)
- Multiligament instability (1)
- Multimedication (1)
- Multimodal Modeling (1)
- Multimorbidität (1)
- Multiparametric MRI (1)
- Multiple Transport Systems (1)
- Multiple-indication review (1)
- Multiplex immunoassay (1)
- Multiresistente Erreger (1)
- Multisensorische Integrationsleistung (1)
- Multiset independent component analysis (1)
- Multivariate analysis (1)
- Mundhöhlenkarzinome (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle damage (1)
- Muscle pain (1)
- Musculoskeletal abnormalities (1)
- Musculoskeletal mechanics (1)
- Musculoskeletal problems (1)
- Music (1)
- Mutations (1)
- Muttermilch (1)
- Myalgia (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Mycophenolat Mofetil (1)
- Myiasis (1)
- Myocardial infarction (MI) (1)
- Myocardial injury (1)
- Myocardial perfusion (1)
- Myocardial remodeling (1)
- Myopia (1)
- Müdigkeit (1)
- N-glycosylation (1)
- N471D strumpellin knock-in mice (1)
- N501Y (1)
- NAD + Analogues (1)
- NAD Analogs (1)
- NAD+-Analogs (1)
- NADP+ Analogues (1)
- NAD⊕-Isomer (1)
- NAPS (1)
- NAT (1)
- NCOA4 (1)
- NDM (1)
- NET (1)
- NF-kB (1)
- NF-κB pathway (1)
- NFkB (1)
- NFκB (1)
- NGS sequencing (1)
- NIRS (1)
- NIS (1)
- NK Receptor (1)
- NK cell (1)
- NK cell subsets (1)
- NK-92 (1)
- NK-ZELL-BASIERTER IMMUNTHERAPIE (1)
- NK-ZELLEN (1)
- NLPHL (1)
- NLRP3 inflammasomes (1)
- NMOSD (1)
- NO (1)
- NOD (1)
- NOS-I (1)
- NOS1AP (1)
- NR4A2 (1)
- NR4A3 (1)
- NS-Kindereuthanasie (1)
- NS3/4A-Protease (1)
- NSBB (1)
- NTDs (1)
- NTM (1)
- NURF (1)
- NVBP (1)
- Nachteile (1)
- Nachtschattengewächs (1)
- Nachwuchsmangel (1)
- Nackenschmerzen (1)
- Nanoplastic (1)
- Natural Killer (NK) Cell (1)
- Natural killer cells (1)
- Nebennierenrinden-Adenom (1)
- Nebennierenrinden-Hyperplasie (1)
- Neck pain (1)
- Necroptosis (1)
- Necrosis (Necrotic Death) (1)
- Necrotizing enterocolitis (1)
- Needs Assessment [MeSH] (1)
- Negative appendectomy rate (1)
- Neglected tropical diseases (1)
- Negligence (1)
- Nek1 (1)
- Neoadjuvant systemic therapy (1)
- Neoadjuvant treatment (1)
- Neonatal surgery outcome (1)
- Neonatologie (1)
- Neoplasm staging (1)
- Nephelometrie und Turbidimetrie (1)
- Nephelometry and Turbidimetry (1)
- Nephrectomy (1)
- Nephropathie (1)
- Nervenkrankheit (1)
- Netzhaut (1)
- Neugeborene (1)
- Neural coding (1)
- Neural goal function (1)
- Neural stem cells (1)
- NeuroSAFE (1)
- Neuroblastom, SAMHD1, Chemoresistenz (1)
- Neurochirurgie (1)
- Neurodegenerative syndromes (1)
- Neurodevelopmental disorder (1)
- Neuroendocrine tumor (1)
- Neuroepithelial (1)
- Neuroepithelial tumor (1)
- Neurofeedback (1)
- Neurofilament light chain (1)
- Neurofilament light chains (1)
- Neurofilament-Leichtketten (1)
- Neuroligins (1)
- Neurologie (1)
- Neurologiegeschichte (1)
- Neuromodulatorisches Netzwerk (1)
- Neuromodulatory network (1)
- Neuromuscular exercise (1)
- Neuron-Specific Enolase/serum (1)
- Neuron-spezifische Enolase/Serum (1)
- Neuronales Netzwerk (1)
- Neuronspecific Enolase (1)
- Neuronspezifische-Enolase (1)
- Neurooncology (1)
- Neuropathie (1)
- Neuropathologie (1)
- Neuropilin (1)
- Neuropsychiatric disorders (1)
- Neuropsychiatrie (1)
- Neurostimulation (1)
- Neurosurgery (1)
- Neurotoxicity (1)
- Neurovascular damage (1)
- Neurovascular lesion (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- New E3-ligase ligands (1)
- NfL (1)
- Niche (1)
- Nicht-allergische Rhinitis (1)
- Nichtversicherung (1)
- Nicotine (1)
- Nicotine (Nicotiana tabacum/ Nicotiana rustica) (1)
- Nicotinic acetylcholine receptors (1)
- Nierendosimetrie (1)
- Nierentubulusepithelzellen (1)
- Nikotin (Nicotiana tabacum/ Nicotiana rustica) (1)
- Nikotinerge Acetylcholinrezeptoren (1)
- Nitric oxide (1)
- Nkx2-5 (1)
- Non-Hodgkin lymphoma (1)
- Non-abusive head trauma (NAHT) (1)
- Non-apoptotic functions (1)
- Non-cylindrical folds (1)
- Non-diffractive EDOF-IOL (1)
- Non-expert MRI (1)
- Non-small cell lung cancer (1)
- Non-tuberculous mycobacteria (1)
- Non-vitamin K antagonist oral anticoagulants (1)
- Nonaerosolizing treatment (1)
- Nonfermenter (1)
- Nonoperative management (1)
- Nonpenetrating (1)
- Nontuberculous mycobacteria (1)
- Noradrenergic (1)
- Norepinephrine (1)
- Normative modeling (1)
- Notch signaling (1)
- Notfallausweis (1)
- Notfallmedizin (1)
- Notfallversorgung (1)
- Nox (1)
- Nox inhibition (1)
- Nox4 (1)
- Nrf-2 (1)
- Nucleotide Triphosphate Analogue (1)
- Nuklearmedizin (1)
- Nukleinsäure-Amplifikations Testung (NAT) (1)
- Nukleinsäure-Amplifikationstechnik (NAT) (1)
- Nukleinsäureamplifikationstest (NAT) (1)
- Null responder (1)
- Number of platelets (1)
- Nursing (1)
- Nutrition (1)
- OA (1)
- OCT (1)
- OGR1 (1)
- OHIP-G14 (1)
- OHRQoL (1)
- OP capacity (1)
- OP-Kapazität (1)
- ORL (1)
- ORP (1)
- OSA (1)
- OSPE (1)
- OTSC Proctology (1)
- OTU domain-containing protein 7B (OTUD7B) (1)
- OXA-23 (1)
- OXA-484 (1)
- OXA-58 (1)
- OXPHOS (1)
- Obduktion (1)
- Oberflächenantigen-Mutante (1)
- Observational (1)
- Obsessive-compulsive disorder (1)
- Obstetrics and gynecology (1)
- Occlusion (1)
- Occlusion treatment (1)
- Occupational disease (1)
- Occupational reintegration management (1)
- Occupationally acquired infection (1)
- Oceanic boundlessness (1)
- Ocular tuberculosis (1)
- Office work (1)
- Ohrenheilkunde (1)
- Ohrenkrankheit (1)
- Older adult (1)
- Older patient (1)
- Older patients (1)
- Olfactory groove meningioma (1)
- Olfactory system (1)
- Oligodendroglioma (1)
- Oligometastatic (1)
- Omega lipids (1)
- Omicron variant BA.1 (1)
- Omphalocele (1)
- Omphalozele (1)
- Oncogenes (1)
- One-leg stand (1)
- Onkogene (1)
- Onkomodulation (1)
- Online Survey (1)
- Online education (1)
- Online-Magazin (1)
- Online-Umfrage (1)
- Open Science (1)
- Open pulmonary tuberculosis (1)
- Ophthalmoplegia (1)
- Opinion (1)
- Opioid system (1)
- Opioids (1)
- Opportunistic infections (1)
- Opsoclonus-myoclonus syndrome (1)
- Optical phenomena (1)
- Oral and maxillofacial surgery (1)
- Oral anticoagulation (1)
- Oral cancer (1)
- Oral food challenge (1)
- Oral immunotherapy (OIT) (1)
- Oral therapy (1)
- Orale Antikoagulanzien (1)
- Orbital fracture (1)
- Orexin (1)
- Organ failure (1)
- Organ injury (1)
- Organ preservation (1)
- Organ-confined (1)
- Orthodontic tooth movement (1)
- Orthopaedics (1)
- Oscillating saws (1)
- Ossifying fibroma (1)
- Osteoporose (1)
- Osteoporotic fractures (1)
- Otorhinolaryngological (1)
- Otorhinolaryngology (1)
- Outcomes research (1)
- Outpatients (1)
- Ovarian cancer treatment (1)
- Ovarielle Reserve (1)
- Ovartoxizität (1)
- Over-the-scope clip (1)
- Overweight (1)
- Overwintering (1)
- Oxa1/YidC/Alb3 Membrane Insertases (1)
- Oxidative phosphorylation (1)
- OxyELITE Pro (1)
- Oxygen extraction fraction (1)
- P2X7 receptor (1)
- PAC-1 (1)
- PAD-test (1)
- PAM (1)
- PAPR (1)
- PATZ1 (1)
- PBBM (1)
- PBM (1)
- PBSC (1)
- PBX (1)
- PCA (1)
- PD-1 (1)
- PDPK1 (1)
- PFOA (1)
- PFOS (1)
- PGC-1α (1)
- PHGDH (1)
- PHR1 (1)
- PI3K (1)
- PI3K inhibitor (1)
- PI3K/mTor inhibition (1)
- PKCδ (1)
- PLAGL1 (1)
- PMA (1)
- PMI (1)
- PML (1)
- PMMA (1)
- POCT (1)
- POR (1)
- PPAR (1)
- PPAR-γ (1)
- PPTC7 (1)
- PRG5 (1)
- PRNT (1)
- PROTAC (1)
- PRRT (1)
- PSA screening (1)
- PSA-Screening (1)
- PTEN (1)
- PTEN inducible kinase 1 (1)
- PTM (1)
- PTSD (1)
- PV loop (1)
- PWI (1)
- PacBio SMRT sequencing (1)
- Pacemaker (1)
- Paediatric cancer (1)
- Paediatric trauma patients (1)
- Pain management (1)
- Pain prevalence (1)
- Pain scale MWA (1)
- Palacos reaction (1)
- Palliative Care [MeSH] (1)
- Palmitoylethanolamid (1)
- Pancreatic neuroendocrine tumor (1)
- Papillon-Lefèvre syndrome (1)
- Paracelsus, Asteroid (1)
- Paracoccus denitrificans (1)
- Paramyxoviridae (1)
- Paraneoplastic neurological syndromes (1)
- Parasympathetic (1)
- Parenteral nutrition (1)
- Parkinson's disease (1)
- Parodontitis (1)
- Parodontitistherapie (1)
- Particle load reduction (1)
- Particle number size distribution (1)
- Particle size distribution (1)
- Particle toxicity (1)
- Particulate matter (1)
- Particulates (1)
- Passivrauch (1)
- Pathogenicity (1)
- Pathogens (1)
- Pathology (1)
- Pathophysiology (1)
- Patient Blood Management (1)
- Patient Blood Management (PBM) (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient and public Involvement (1)
- Patient care (1)
- Patient manikins (1)
- Patient outcome assessment (1)
- Patient participation (1)
- Patient perspective (1)
- Patient portals (1)
- Patient preference (1)
- Patienten (1)
- Patientenaufklärung (1)
- Patientenportale (1)
- Patientenverfügung (1)
- Pedagogue (1)
- Pediatric fracture (1)
- Pediatric oncology (1)
- Pediatric stem cell transplantation (1)
- Pediatric surgery (1)
- Pelargonium sidoides questionable hepatotoxicity (1)
- Pelvic (1)
- Pentaglobin (1)
- Pentose Pathway (1)
- Per1−/−-mice (1)
- Perceived stigma (1)
- Percutaneous endoscopic gastrostomy (1)
- Percutaneous pinning (1)
- Percutaneous ultrasound (1)
- Performance (1)
- Peri-implant disease (1)
- Perifolliculitis capitis abscedens et suffodiens (1)
- Perinatalzentren (1)
- Periodic (1)
- Periodontal therapy (1)
- Periodontal trauma (1)
- Periodontitis (1)
- Periodontitis grades B and C (1)
- Peripheral arterial occlusive disease (1)
- Peripheral blood smears (1)
- Periphere arterielle Verschlusskrankheit (1)
- Periprocedural anticoagulation (1)
- Peritoneal macrophages (1)
- Peritumoural oedema (1)
- Peri‑implantitis (1)
- Peroxidase (1)
- Perrault syndrome (1)
- Persistence SARS-CoV-2 antibodies (1)
- Persistent organic pollutants (1)
- Persistierender Ductus arteriosus (1)
- Personal medicine (1)
- Personal protective equipment (1)
- Personal stigma (1)
- Personalbelastung (1)
- Personalisierte translationale Therapie (1)
- Personality inventory (1)
- Personalized Medicine (1)
- Personalized medicine (1)
- Personalmangel (1)
- Personnel shortage (1)
- Perspective forum (1)
- Perspektivforum (1)
- Pertussis (1)
- Petri net (1)
- Peutz–Jeghers syndrome (1)
- Pflege (1)
- Phakic (1)
- Phalangeal fractures (1)
- Phantoms (imaging) (1)
- Pharmacokinetics (1)
- Pharmacotherapy (1)
- Pharmacovigilance (1)
- Pharmaka (1)
- Phase 3 (1)
- Phase 3 trial (1)
- Phase I clinical trial (1)
- Phase-Proteine (1)
- Phase-reset (1)
- Phenotypic plasticity (1)
- Phenylketonuria (PKU) (1)
- Philadelphia chromosome-positive acute leukemia (1)
- Philemon and Baucis (1)
- Philemon und Baucis (1)
- Phlyctenule (1)
- Phosphohydrolases (1)
- Phospholipasen A2 (1)
- Phosphopyruvate Hydratase/serum (1)
- Phosphopyruvathydratase/Serum (1)
- Photoaffinity Labeling (1)
- Physical and mental health (1)
- Physical comorbidities (1)
- Physical self-perception (1)
- Physics (1)
- Physiologie (1)
- Physiotherapy (1)
- Pindar, Pythische Ode III (1)
- Placental organoids (1)
- Plantagearbeiter (1)
- Plantation workers (1)
- Plasma (1)
- Plasma proteins (1)
- Plasmapheresis (1)
- Plasmapools (1)
- Plasmaprotein analyzer (1)
- Plasmaproteinanalysensysteme (1)
- Plasmaproteinbestimmung im Harn (1)
- Plasmaproteine (1)
- Plasmapräparate (1)
- Plastic pollution (1)
- Plastics (1)
- Plastikstent (1)
- Platelets (1)
- Plausibilität (1)
- Play (1)
- Pleasure (1)
- Pneumocystis jirovecii (1)
- Podospora anserina (1)
- Poe, Der wahre Sachverhalt im Falle Valdemar (1)
- Point of care (1)
- Point-of-Care Testing (POCT) (1)
- Point-of-care wound diagnostics (1)
- Polarisierung (1)
- Police (1)
- Polioviren (1)
- Polizei (1)
- Poly-Pore (1)
- Polygenic risk score (1)
- Polymerase Chain Reaction (1)
- Polymerase Kettenreaktion (PCR) (1)
- Polymerasekettenreaktion (1)
- Polymorphismen (1)
- Polyposis syndrome (1)
- Polyunsaturated fatty acid mediators (1)
- Polyunsaturated fatty acids (1)
- Ponatinib (1)
- Population dynamics (1)
- Portal veins (1)
- Portuguese population (1)
- Post mortem examination (1)
- Post mortem interval (1)
- Post-cesarean (1)
- Post-mortem genetic screening (1)
- Post-offence drinking (1)
- Post-thaw recovery (1)
- Post-traumatic stress disorder (1)
- Postmortem (1)
- Postmortem interval (1)
- Postoperative Complications (1)
- Postoperative anatomy (1)
- Posttraumatic stress disorder (1)
- Postural sway (1)
- Posture analysis (1)
- Postvention (1)
- Potassium iodide (1)
- Poverty (1)
- Powered air-purifying respirator (1)
- Practice-based Research Network (1)
- Praeklampsie (1)
- Praktische Lehre (1)
- Praktisches Jahr (1)
- Pre-operative radiotherapy (1)
- Precision medicine (1)
- Prediction (1)
- Prediction of locoregional recurrence (1)
- Predictive Modeling (1)
- Predictive model (1)
- Predictive processing (1)
- Predictors (1)
- Predominant polarity (1)
- Preeclampsia (1)
- Presbyopia (1)
- Pressure distribution (1)
- Pressure measuring plate (1)
- Primary Care Research Network (1)
- Primary care (1)
- Primary cilium (1)
- Primary molars (1)
- Primärversorgung (1)
- Principal component analysis (1)
- Prisoners (1)
- Prisons (1)
- Pro.M.D. (1)
- Probability density (1)
- Probability distribution (1)
- Probenidentifikation (1)
- Procedural skills (1)
- Professional dancers (1)
- Professioneller Fußball (1)
- Profi-Tänzer*innen (1)
- Proficiency testing (1)
- Progestatifs synthétiques (1)
- Prognose (1)
- Prognostic markers (1)
- Prognostic models (1)
- Prognostische Marker (1)
- Progranulin (1)
- Projekte Seltene Erkrankungen (1)
- Promoters (1)
- Propensity score matching (1)
- Propensity-Score Matching Analyse (1)
- Proposal (1)
- Propriozeption (1)
- Prostaglandine (1)
- Prostata-specific antigen (1)
- Prostate specific antigen (1)
- Prostatic specific antigen (1)
- Protease inhibitor therapy (1)
- Protein (1)
- Protein Domains (1)
- Protein Expression (1)
- Protein Folding (1)
- Protein Motifs (1)
- Protein Targeting (1)
- Protein Translocation (1)
- Protein interactions (1)
- Protein-Lipid Interaction (1)
- Protein-Protein Interactions (1)
- Protein-translocation (1)
- Proteinbestimmung (1)
- Proteinuria (1)
- Proteinurie (1)
- Protestbewegung (1)
- Prothese (1)
- Prothrombinmutation (1)
- Protocol (1)
- Proton density (1)
- Proximal (1)
- Prä-B-Zellen (1)
- Prädiktive Validität (1)
- Präpulsinhibition (1)
- Präsenzdiagnostik (1)
- Prävalenz (1)
- Präzision und Richtigkeit (1)
- Pseudophakia (1)
- Pseudoprogression (1)
- Psoriatic arthritis (1)
- Psychiatric disorders (1)
- Psychiatric traits (1)
- Psychiatry (1)
- Psychoanalyse (1)
- Psychopharmaka (1)
- Psychophysics (1)
- Psychosomatik (1)
- Pteridine (1)
- Pulmonary edema (1)
- Pulmonary hypertension (1)
- Pulmonary hypoplasia (1)
- Pumpkin seeds (1)
- Purdue Pegboard (1)
- Pyogenic (1)
- Pyogenic spondylodiscitis (1)
- Pyruvate Kinase (1)
- Python (1)
- Pädagoge/in (1)
- Q80K (1)
- Qualifikationsmix (1)
- Qualitative Analyse (1)
- Qualitative Research [MeSH] (1)
- Qualitative analysis (1)
- Qualitative research (1)
- Qualitative study (1)
- Quality control (1)
- Quality indicators (1)
- Quality of Health Care [MeSH] (1)
- Quality standards (1)
- Qualitätsindikator (1)
- Qualitätsindikatoren (1)
- Qualitätsmanagement (1)
- Qualitätsstandards (1)
- Quantitative (q)T2 mapping (1)
- Quantitative Antikörpermessung (1)
- Quantitative Imaging (1)
- Quantitative MRI (1)
- Quantitative features (1)
- Quantitative magnetic resonance imaging (1)
- Quantra (1)
- Quarantine (1)
- Quasi-longitudinal study (1)
- Querschnittsstudie (1)
- Quinolones (1)
- R406 (1)
- RA-1000 (1)
- RAF (1)
- RARP (1)
- RAS (1)
- RAS pathway (1)
- RAS-ID-Gramneg (1)
- RBS-R (1)
- RCC (1)
- RDoC (1)
- RESLES (1)
- RET (1)
- RGAG1 (1)
- RIP (1)
- RIPK1 (1)
- RMS (1)
- RNA chaperone (1)
- RNA sequencing (1)
- RNA stability (1)
- RNA therapy (1)
- RNA turnover (1)
- RNA virus (1)
- RNA, Virale/ Blut (1)
- RNA-Bindeprotein (1)
- RNA-binding protein (1)
- RNA-sequencing (1)
- RNA/MicroRNA (1)
- RNAP II (1)
- RND (1)
- RNF4 (1)
- ROC analyses (1)
- ROC analysis (1)
- ROC-Analysen (1)
- ROS1 (1)
- ROSA (1)
- ROTEM (1)
- RRMS (1)
- RT-PCR (1)
- RT-PCR-detection (1)
- Rab7 (1)
- Rabbit (1)
- Race (1)
- Radiation Oncology (1)
- Radiation Protection Act (1)
- Radiation Protection Ordinance (1)
- Radiation necrosis (1)
- Radiochemotherapy (1)
- Radiofrequency ablation (1)
- Radiofrequenzablation (1)
- Radioiodine therapy (1)
- Radioiodine uptake test (1)
- Radioligandentherapie (1)
- Radiologie (1)
- Radiologie, Universität Frankfurt (1)
- Radiology (1)
- Radiosurgery (1)
- Radiothérapie (1)
- Radon action plan (1)
- Radonmaßnahmenplan (1)
- Radonvorsorgegebiete (1)
- Ragulator complex (1)
- Raketenimmunelektrophorese (1)
- Ramadan (1)
- Ramucirumab (1)
- Random forest (1)
- Randomisation (1)
- Randomized Controlled Trial (1)
- Randomized controlled trial (1)
- Randomized controlled trials (1)
- Rare Diseases/ Orphan Diseases (1)
- Raster (1)
- Rcf1 (1)
- Reactogenicity (1)
- Ready-made mouthguard (1)
- ReagentKits, -Diagnostic (1)
- Reagenzkits, Diagnostische (1)
- Real world (1)
- Real world study (1)
- Real-time MRI (1)
- Real-time polymerase chain reaction (PCR) tests (1)
- Receptors/Nuclear (1)
- Rechtliche Würdigung (1)
- Rechtsmediziner (1)
- Recognition (1)
- Rectal neoplasms (1)
- Recurrence (1)
- Recurrent episodes (1)
- Redox dependent epigenetic modifications (1)
- Redox-sensitive transcription factor (1)
- Reduktion von Komplikationen (1)
- Redundancy (1)
- Reference values (1)
- Referenzwerte (1)
- Referral (1)
- Reflotron® (1)
- Refractive changes (1)
- Refractive lense exchange (1)
- Refractory ALL (1)
- Refractory AML (1)
- Refractory status epilepticus (1)
- Refraktärer Status epilepticus (1)
- RegJoint™ (1)
- Regeneration (1)
- Region (1)
- Region of Interest (1)
- Register (1)
- Registries (1)
- Regret (1)
- Regulatory agencies. (1)
- Rekonstruktion (1)
- Relapse surveillance (1)
- Relaxometrie (1)
- Relaxometry (1)
- Reliabilität (1)
- Remission (1)
- Renal cell carcinoma (1)
- Renal vein thrombus (1)
- Repetitives Verhalten (1)
- Representative survey (1)
- Reproducibility (1)
- Reproducibility/stability (1)
- Research (1)
- Research data (1)
- Research design (1)
- Research investment (1)
- Research patterns (1)
- Research validity (1)
- Resection (1)
- Residency (1)
- Residual myometrial thickness (1)
- Resilience (1)
- Resistenz (1)
- Resistenzprüfung (1)
- Resistenztestung (1)
- Respiratorische Infekte (1)
- Respiratory infections (1)
- Response control (1)
- Responsibility of healthcare policy (1)
- Restenosis (1)
- Resting-state (1)
- Restriktive und Repetitive Verhaltensweisen (1)
- Retikulozytenbestimmung (1)
- Retina (1)
- Retinal diseases (1)
- Retinoic acid (1)
- Retrospective study (1)
- Rettungsdienst (1)
- Return to work (1)
- Reverse electron transfer (1)
- Revisionsprothese (1)
- Reward anticipation (1)
- Reward system (1)
- Rezeptorsignalweg (1)
- Rh Antigens (1)
- Rhabdomyoma (1)
- Rheuma (1)
- Rho-kinase (1)
- Rhythmologie (1)
- Ribosomal RNA (1)
- Richtigkeit (1)
- Richtlinien (1)
- Ridge preservation (1)
- Riftia pachyptila (1)
- Ringversuch (1)
- Risikofaktoren (1)
- Risikogruppen sind: Schwangerschaft - Bluttransfusion - Organtransplantation - Prostituierte (1)
- Risk assessment (1)
- Risk factor (1)
- Risk stratification (1)
- Risk-stratification (1)
- Rivaroxaban (1)
- Roboter (1)
- Robotic-assisted radical prostatectomy (1)
- Robotik (1)
- Rocket immunoelectrophoresis (1)
- Rodents (1)
- Roussel Uclaf Causality Assess- ment Method (RUCAM) (1)
- Routinely Collected Health Data [MeSH] (1)
- Running Economy (1)
- Rural areas (1)
- Récidive (1)
- Réserve ovarienne (1)
- Röntgendiffraktion (1)
- Rückenschmerzen (1)
- S100A12 Hexamer (1)
- S1P (1)
- S1P lyase (1)
- S1P5 (1)
- S1PR5 (1)
- S63845 (1)
- SAH (1)
- SAMHD1 (1)
- SARS (1)
- SARS CoV 2 (1)
- SARS coronavirus (1)
- SARS-COV-2 (1)
- SARS-CoV-2-specific T cells (1)
- SARS-CoV2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCA2 (1)
- SCCHN (1)
- SCD14 (1)
- SCN5A (1)
- SEAP (1)
- SEC (1)
- SEC-ICP-DRC-MS (1)
- SEER (1)
- SELEX (1)
- SENP (1)
- SF-12 (1)
- SF-12 WOMAC KSS (1)
- SF-36 (1)
- SFR (1)
- SGPL1 (1)
- SGPL1 knockout cell line (1)
- SH- (S-S)-Groups (1)
- SH-SY5Y neuroblastoma cells (1)
- SIDS (1)
- SIRPalpha (1)
- SIRS (1)
- SIRT1 (1)
- SKALE score (1)
- SLAM-seq (1)
- SLC6a3 (1)
- SLC7A11 (1)
- SLUG (1)
- SMOC1 (1)
- SNORD95 (1)
- SNV (1)
- SOD (1)
- SPG8 (1)
- SPPL3 (1)
- SSRI (1)
- SSTI (1)
- STAT1 (1)
- STAT3 (1)
- SUD (1)
- Safety culture (1)
- Safety perspectives (1)
- Salivary gland cancer (1)
- Salivary gland carcinoma (1)
- Sampling protocol (1)
- Sandfly (1)
- Sanger Sequencing (1)
- Sapacitabine (1)
- Sarcoma (1)
- Sarcophagidae (1)
- Satisfaction (1)
- Saudi Arabia (1)
- Saure Dissoziation (1)
- Scaffold (1)
- Scalp defect (1)
- Scanner models (1)
- Scheduling of radiotherapy (1)
- Scheimpflug imaging (1)
- Schilddrüse (1)
- Schilddrüsenfunktion (1)
- Schilddrüsenhormone (1)
- Schizophrenie (1)
- Schlaf (1)
- Schlafentzug (1)
- Schlaganfall (1)
- Schlaganfall-Sekundärprophylaxe (1)
- Schmerz (1)
- Schmerzprävalenz (1)
- Schulter (1)
- Schädel-MRT (1)
- Sclerotic glomeruli (1)
- Screening-ELISA (1)
- Screeningfragebogen (1)
- Scrofulous keratitis (1)
- Seasonal variation (1)
- Second donation (1)
- Secondhand Smoke (1)
- Sectio (1)
- Secular trend (1)
- Sedation (1)
- Sedatives (1)
- Sedierung (1)
- Seizure series (1)
- Seizures (1)
- Sektion (1)
- Selbstmordpakt (1)
- Selbstvorstellung (1)
- Selektivmedien (1)
- Selen (1)
- Self-esteem (1)
- Self-expandable TAVI (1)
- Self-introduction (1)
- Self-renewal (1)
- Seltene Erkrankungen in der Lehre (1)
- Seminom (1)
- Senescence (1)
- Separation of ADP-Binding Enzymes (1)
- Sequelae (1)
- Sequencing (1)
- Seralyzer-System (1)
- Seralyzer® (1)
- Serin (1)
- Serious injured children (1)
- Serodiagnostik (1)
- Serology (1)
- Serotonin (1)
- Serum (1)
- Serum biomarker (1)
- Shared information (1)
- Sharp injuries (1)
- Short bowel syndrome (1)
- Shortage of recruits (1)
- Shoulder luxation (1)
- Sialic acid (1)
- Sialinsäure (1)
- Side effect (1)
- Side effects (1)
- Siderosis (1)
- Signal Recognition Particle (1)
- Signal intensity (1)
- Signs and symptoms (1)
- Silver diamine fluoride (1)
- Simulated patients (1)
- Simulation training (1)
- Simulator (1)
- Single nucleotide polymorphism (1)
- Single positive core biopsy (1)
- Single-cell RNA sequencing (1)
- Single-leg hop for distance (1)
- Single-treatment (1)
- Sinus pilonidalis (1)
- Sirolimus (1)
- Sitting posture (1)
- Sitzhaltung (1)
- Skeletal health (1)
- Skeletal joints (1)
- Skeletal muscles (1)
- Skill- and grade mix (1)
- Skull base (1)
- Sleep (1)
- Slow Cortical Potentials, SCP (1)
- Smac mimetics (1)
- Smad (1)
- Small Cell/diagnosis (1)
- Small Leucine-rich Proteoglycan (SLRP) (1)
- Small RNA analysis (1)
- Small vessel disease (1)
- Small-bowel endoscopy (1)
- Smoking habits (1)
- Smooth muscle cells (1)
- Social Media (1)
- Social Phobia (1)
- Social brain (1)
- Social cognition (1)
- Social decision-making (1)
- Social determinants (1)
- Social differences (1)
- Social neuroscience (1)
- Socio-economic analysis (1)
- Sociocognitive predictors (1)
- Sociodemographic characteristics (1)
- Socioeconomic analysis (1)
- Socioeconomic indices (1)
- Socket healing (1)
- Socket preservation (1)
- Sodium chloride (1)
- Soecificity (1)
- Sofortbelastung (1)
- Soft tissue healing (1)
- Soft tissue sarcoma (1)
- Software (1)
- Solanaceae (1)
- Solar insolation (1)
- Soluble epoxide hydrolase (1)
- Sonication (1)
- Sonographie (1)
- Sonography (1)
- Sparse models (1)
- Spatial Attention (1)
- Specialist training (1)
- Specialized outpatient palliative care (1)
- Specific Synthesis (1)
- Speech (1)
- Speicherung (1)
- Spezialisierte ambulante Palliativversorgung (1)
- Speziesbarriere (1)
- Sphk1 (1)
- Sphk2 (1)
- Spinal cord (1)
- Spinal fractures (1)
- Spinal injuries (1)
- Spinal surgery (1)
- Spinalkanalstenose (1)
- Spine care (1)
- Spine fractures (1)
- Spine infection (1)
- Spinocerebellar ataxia type 2 (1)
- Spirochetes (1)
- Spondylitis (1)
- Spondylodiscitis (1)
- Spontan bakterielle Peritonitis (1)
- Sports and exercise medicine (1)
- Spread of Excitation (1)
- Spurenelemente (1)
- Sputum smear-negative (1)
- Stability (1)
- Staff load (1)
- Stage at presentation (1)
- Stakeholder participation (1)
- Stammzelltransplantation (1)
- Standard dataset (1)
- Standard reference values (1)
- Stark verwester Leichnam (1)
- Static MRI (1)
- Statin (1)
- Stationäre Krankenhausfälle (1)
- Statistical analysis (1)
- Status quo Seltene Erkrankungen (1)
- Steinfreiheit (1)
- Stem cell dose (1)
- Stem cell enumeration (1)
- Stereoelektroenzephalographie (1)
- Stereotactic ablative body radiotherapy (1)
- Sterilität (1)
- Sterols (1)
- Stickstoffmonoxid (1)
- Stigma (1)
- Stigma scale (1)
- Stimulant (1)
- Sting challenge (1)
- Stoppa approach (1)
- Strahlendosis (1)
- Strahlenschutzgesetz (1)
- Strahlenschutzverordnung (1)
- Straßburg, Reichsuniversität (1)
- Streptokokken (1)
- Streptomyces hydrogenans (1)
- Stress (1)
- Stress vulnerability/resilience genes (1)
- Stretch training (1)
- Streustrahlung (1)
- Striatum (1)
- Stroke Risk (1)
- Stroke genetics (1)
- Stroke unit (1)
- Structured written feedback (1)
- Student (1)
- Studentenproteste Frankfurt am Main (1)
- Störfaktoren in der serologischen Diagnostik (1)
- Sub-zero exposure (1)
- Subcortical (1)
- Subependymal giant cell astrocytoma (1)
- Subjective effects (1)
- Subjective health status (1)
- Subjektiver Gesundheitszustand (1)
- Subkortikal (1)
- Substitution of Ribose (1)
- Subventricular zone (1)
- Sudden Cardiac Death (SCD) (1)
- Sudden cardiac death (1)
- Sudden infant death syndrome (1)
- Sugar feeding (1)
- Suicide attempt (1)
- Suizid (1)
- Suizidalität (1)
- Sulfhydryl Groups (1)
- Sulforaphane (1)
- Sulphoraphane (1)
- Sunlight (1)
- Supplementation (1)
- Support vector machine (1)
- Supported Decision-making (1)
- Supraglottic Airway Devices (1)
- Supratentorial (1)
- Supreme court ruling (1)
- Surgical APGAR Score (1)
- Surgical blood loss (1)
- Surgical education (1)
- Surgical oncology (1)
- Surgical site infection (1)
- Surgical therapy (1)
- Survey (1)
- Suspension (1)
- Sustained attention (1)
- Sustained virologic response (1)
- Sustained virological response (1)
- Swallowing (1)
- Syk Kinase (1)
- Symmetrical blocked occlusion (1)
- Sympathetic (1)
- Sympathetic nervous system (1)
- Synapse (1)
- Synaptic organizer (1)
- Synaptosomal preparation (1)
- Syndecan-1 (1)
- Synergy (1)
- Synovial sarcoma (1)
- Synthetic biology (1)
- Synthetische Gestagene (1)
- Synthetische Letalität (1)
- Syrian hamster (1)
- Systems & Computational Biology (1)
- Szientometrie (1)
- Säkularer Trend (1)
- Sérotonine (1)
- T Cell Biology (1)
- T cell (1)
- T cell receptor (1)
- T cell response (1)
- T cells (1)
- T helper cell differentiation (1)
- T-Zellen (1)
- T-bet (1)
- T-cell development (1)
- T-cell receptor (1)
- T-cell receptor (TCR) (1)
- T-cells (1)
- T2 (1)
- T4-Bestimmung (1)
- T4-analysis (1)
- TAM (1)
- TAMs (1)
- TAVI Vergleich transapikaler transfemoraler Zugangsweg (1)
- TAVI, Kardiologie, Klappen, Aortenklappenstenose, Prothesen, TTE, Frankfurt, Vergleich, Transkatheter, Mortalität, Herz (1)
- TB-therapy (1)
- TBI (1)
- TBK1 (1)
- TDAG8 (1)
- TDM (1)
- TEPT (1)
- TGF-α (1)
- TGF-β1 (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- TGR(mREN2)27 (1)
- THRLBCL (1)
- TIGAR (1)
- TIRADS (1)
- TLR2 (1)
- TLR4 (1)
- TME (1)
- TMT (1)
- TOR signalling (1)
- TRAIL (1)
- TRIMs (1)
- TRP Channels (1)
- TRP2 (1)
- TRPA1 (1)
- TRPM8 (1)
- TRPV4 (1)
- TSP-4 (1)
- TTFields (1)
- TTW nodules (1)
- TUR-P (1)
- TURP (1)
- TWNK (1)
- Tabak (1)
- Taekwondoka (1)
- Tailored therapy (1)
- Takotsubo Syndrome (1)
- Tamoxifen (1)
- Tanz (1)
- Tar (1)
- Targeted delivery (1)
- Targeted sequencing (1)
- Targeted therapies (1)
- Targeted therapy (1)
- Tattoo (1)
- Teaching in daily surgical routine (1)
- Technical data (1)
- Teilzeit (1)
- Tele-EEG (1)
- Tele-consultation (1)
- Telekonsil (1)
- Tempo-parietal junction (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Terminal ileitis (1)
- Terminology (1)
- Test assay (1)
- Testing (1)
- Teststreifenanalytik (1)
- Tetanus (1)
- Tetrahydro-Aldosteron (1)
- Tetrahydrobiopterin (1)
- Thalidomide (1)
- Theft (1)
- Theranostik (1)
- Therapeutic adherence (1)
- Therapeutic anticoagulation (1)
- Therapeutic competence (1)
- Therapiefreie Remission (1)
- Therapielimitierung (1)
- Therapiemonitoring (1)
- Therapies (1)
- Thermoablation (1)
- Thermogenesis (1)
- Thermoplasma acidophilum Membranes; Tetraetherlipids (1)
- Thoracic aortic aneurysm (1)
- Thoracic trauma (1)
- Thorax (1)
- Thromboembolische Ereignisse (1)
- Thrombophilie (1)
- Thrombotic thrombocytopenic purpura (1)
- Thrombozytentransfusion (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Thyreostatika (1)
- Thyroid (1)
- Thyroid Cancer Cells (1)
- Thyréostatiques (1)
- Tick (1)
- Tick-Borae (1)
- Tick-Born Diseases (1)
- Tick-borne diseases (1)
- Time of death (1)
- Time trend (1)
- Tissue Engineering (1)
- Tissue engineering (1)
- Tissue expander (1)
- Tissue microarray (1)
- Tissue-specificity (1)
- Tobacco (1)
- Tocilizumab (1)
- Toll-like Receptor (TLR) (1)
- Toll-like Rezeptor, Subcommissuralorgan; Circumventriculäre Organe (1)
- Toluidine blue (1)
- Tomography (1)
- Tonsillitis (1)
- Tooth Development (1)
- Tooth segmentation (1)
- Total Quality Managemen (1)
- Total elbow arthroplasty (1)
- Total hip arthroplasty (1)
- Touchscreen (1)
- Toxic liver disease (1)
- Toxicity (1)
- Toxicité ovarienne (1)
- Toxins (1)
- Traditional Chinese Medicine (TCM) (1)
- Traditional Indian Medicine (1)
- Trafficking (1)
- Trail (1)
- Traits of medical students (1)
- Trajectories (1)
- Tranexamsäure (1)
- Transarterial chemoembolization (1)
- Transcatheter stage 1 (1)
- Transcranial direct current stimulation (1)
- Transcription (1)
- Transcription factor (1)
- Transcription regulation (1)
- Transcriptional regulatory elements (1)
- Transcriptomics (1)
- Transdifferentiation (1)
- Transfer learning (1)
- Transfusion practice (1)
- Transfusionsbedingte virale Infektionen (1)
- Transfusionszwischenfall (1)
- Transgender (1)
- Transgenic mice (1)
- Transiente Elastographie (1)
- Transitional fractures 3D printing (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Translation (1)
- Translation proteomics (1)
- Translationsregulation (1)
- Transplant logistics (1)
- Transplantation Centers (1)
- Transplantation/Immunologie (1)
- Transplantation/immunology (1)
- Transplantatnephrektomie (1)
- Transurethral resection of the prostate (1)
- Trauma centre (1)
- TraumaRegister DGU® (1)
- TraumaRegister DGU® (TR-DGU) (1)
- Traumatic brain injury (1)
- Traumatic dental injury (1)
- Traumatology (1)
- Travel regulations (1)
- Travel times (1)
- Treatment costs (1)
- Treatment effectiveness (1)
- Treatment management (1)
- Treatment rates (1)
- Treatment response (1)
- Treg (1)
- Treg cell (1)
- Trennhilfe (1)
- Trikuspidalklappenrekonstruktion (1)
- Trimeric autotransporter adhesins (1)
- Tripyridyltriazin (1)
- Tripyridyltriazin (TPTZ) (1)
- Tris-Teepol-Puffer (1)
- Tris-Teepol-buffer (1)
- Trisomy 21 (1)
- Troponin (1)
- TruGene (1)
- Truncating mutation (1)
- Truncus arteriosus (1)
- Trypanosoma brucei (1)
- Tuberkulose (1)
- Tuberous sclerosis complex (1)
- Tumor cell (1)
- Tumor subtype (1)
- Tumor therapy (1)
- Tumormikromilieu (1)
- Tumour immunology (1)
- Turbidimetric determination (1)
- Typ 1 Diabetes (1)
- Type 1 diabetes (1)
- Type of death (1)
- Type three hypersensitivity (1)
- Tyrosine kinase inhibitor (TKI) (1)
- Tyrosinemia (1)
- Tyrosinkinasen (1)
- Tödlicher Arbeitsunfall (1)
- Tötung (1)
- UBA domain (1)
- UGCG (1)
- UHPLC-MS (1)
- UKF-NB-2 (1)
- UKF-NB-2rVCR20 (1)
- ULK-Inhibition (1)
- UPR (1)
- URS (1)
- USA (1)
- USP28 (1)
- USP32 (1)
- UTUC (1)
- Ubiquitin Ligase (1)
- Ubiquitin ligase (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ubiquitination (1)
- Ubiquitylation (1)
- Ulixertinib (1)
- Ultraschall (1)
- Umfassendes Qualitätsmanagement (1)
- Uncertainty (1)
- Undergraduate (1)
- Undergraduate education (1)
- Understanding (1)
- Undiagnosed patients (1)
- Unfall (1)
- Unfallchirurgie (1)
- Unfälle (1)
- Unique information (1)
- University hospitals (1)
- University medical centers (1)
- Universität Frankfurt (1)
- Universität Frankfurt am Main (1)
- Universität Frankfurt am Main, Geschichte (1)
- Universitätsmedizin Frankfurt am Main (1)
- Unterernährung (1)
- Untersuchungsangst (1)
- Upgrading (1)
- Upper airway infection (1)
- Urachal cancer (1)
- Urachus carcinoma (1)
- Ureterorenoskopie (1)
- Urethra/Mikrobiologie (1)
- Urethra/microbiology (1)
- Urethral cancer (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Urine (1)
- Urologic tumors (1)
- Urological oncology (1)
- Urologie (1)
- Urothelkarzinom (1)
- Uterus (1)
- V4 (1)
- VEGF receptor 2 internalization and signaling (1)
- VEGF receptors (1)
- VF (1)
- VGAT-ChR2 (1)
- VHL (1)
- VIM (1)
- VMO (1)
- VR-Simulation (1)
- VRE (1)
- VUS (1)
- VX-2 (1)
- Vaccine (1)
- Vagus nerve (1)
- Vagus nerve stimulation (1)
- Vakzination (1)
- Validation (1)
- Valvular cardiomyopathy (1)
- Variant of concern (1)
- Variation (Genetics) (1)
- Variation (Genetik) (1)
- Variceal bleeding (1)
- Vascular cognitive disorder (VCD) – Paranoid hallucinatory syndrome – Late-onset trauma-related symptoms – Depression – Assertive community treatment (ACT) (1)
- Vascular disease (1)
- Vasospasm (1)
- Venous Thromboembolism (1)
- Venous thromboembolism (1)
- Venous thrombosis (1)
- Ventilators (1)
- Ventricular arrhythmia (1)
- Ventricular arrhythmias (1)
- Ventricular tachyarrhythmia (1)
- Venöse Thrombose/Genetik (1)
- Versorgungsforschung (1)
- Versorgungslücken (1)
- Versorgungsstruktur (1)
- Versorgungsstrukturen (1)
- Versorgungszentren (1)
- Vertebral body (1)
- Vertreibung jüdischer Dozenten (1)
- Vibroarthrography (1)
- Video rasterstereography (1)
- Videorasterstereography (1)
- Vincristin (1)
- Viral Load (1)
- Viral Matrix Proteins (1)
- Viral hepatitis (1)
- Viral infection (1)
- Viral load (1)
- Viral oncology (1)
- Viral/blood (1)
- Viral/blood; RNA (1)
- Virale Matrixproteine (1)
- Viremia-diagnosis (1)
- ViroSeq (1)
- Virological testing (1)
- Virology (1)
- Virtual noncalcium reconstructions (1)
- Virtual patients (1)
- Virulence (1)
- Virus (genom) nachweis (1)
- Virus infection (1)
- Virus trapping (1)
- Virusinfektionen (1)
- Virusisolierung (1)
- Virusnachweis (1)
- Viruspneumonien (1)
- Vision® (1)
- Visual Perception (1)
- Visual quality (1)
- Visual-field localizer (1)
- Vitamin D-Defizit (1)
- Volume reduction of thyroid nodules (1)
- Volumetrie (1)
- Volunteer donor (1)
- Von Hippel–Landau (1)
- Vorbeugemaßnahmen (1)
- Vorsorgeuntersuchung (1)
- Vorteile (1)
- WASH complex subunit 5 (1)
- WIPI2 (1)
- WIPI2b (1)
- Waldheim, Anstalt (1)
- Wastewater-based epidemiology (WBE) (1)
- Water contamination (1)
- Watertight Dural closure (1)
- Web 2.0 (1)
- Weight distribution (1)
- Western Blotting (1)
- Western diet (1)
- White blood cells (1)
- White matter hyperintensity (1)
- Whole slide images (1)
- Wilson disease (WD) (1)
- Winter survival (1)
- Wirkmechanismus (1)
- Wnt (1)
- Work health promotion (1)
- Working memory capacity (1)
- Workstation comparison (1)
- Wound care (1)
- Wounds and injuries (1)
- Wundversorgung (1)
- X-ray computed (1)
- X-ray crystallography (1)
- X-ray diffraction (1)
- XCL1/XCR1 axis (1)
- XIAP (1)
- Year of practical training (1)
- Yeast-2-Hybrid (1)
- Yoga (1)
- Youtube (1)
- Zahnmedizin (1)
- Zahnmedizinische Fachangestellte (1)
- Zahnmedizinische Fakultäten (1)
- Zahnprothetik (1)
- Zahntechnik (1)
- Zahnärzte (1)
- Zebrafish (1)
- Zeckenübertragene Erkrankungen (1)
- Zellkultur (1)
- Zellproliferation (1)
- Zentralisierung (1)
- Zentrifugalanalysator (1)
- Zika Virus (1)
- Zika fever (1)
- Zone immunoelectrophoresis assay (1)
- Zonen-Immunelektrophorese- Assay (1)
- Zuckerkandl’s tubercle (1)
- Zwangssterilisation (1)
- Zwangssterilisierung (1)
- Zwiefalten, Anstalt (1)
- Zwischenanstalten der Aktion T 4 (1)
- Zymosan-induced peritonitis (1)
- Zytomegalievirus-IgG-Antikörper (1)
- Zöliakie (1)
- [18F]FET PET (1)
- aGVHD (1)
- abdominal aortic aneurysm (1)
- ablation (1)
- abscisic acid (1)
- abscopal effect (1)
- acarboxyprothrombin (1)
- accident (1)
- accreditation (1)
- accuracy (1)
- acetabular fracture (1)
- acetaminophen (1)
- acne inversa (1)
- acoustic radiation force impulse (1)
- acquired LQT syndrome (1)
- acriflavine (1)
- action (1)
- activated clotting time measurement (1)
- activated factor XIII (1)
- acute phase reactants (1)
- acute decompensation (1)
- acute infections (1)
- acute lymphoblastic leukemia (1)
- acute pain (1)
- acute respiratory distress syndrome (1)
- acute stroke (1)
- acute stroke care (1)
- acute-on-chronic liver failure (1)
- additive manufacturing (1)
- adenosine (1)
- adiabatic saturation (1)
- adipocytes (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adjuvante Krebstherapie (1)
- adolescence (1)
- adolescent (1)
- adolescents (1)
- adrenal adenomas (1)
- adrenergic therapy (1)
- adult neurogenesis (1)
- adults (1)
- advanced melanoma (1)
- advantages and shortcomings (1)
- adversity (1)
- agardiffusion (1)
- aged (1)
- agent-based modeling (1)
- agent-based models (1)
- agility (1)
- agreeableness (1)
- air abrasive (1)
- albumin (1)
- alcohol (1)
- alcoholic fatty liver disease (1)
- alcoholic hepatitis (1)
- alcoholic liver disease (1)
- aligners (1)
- allogeneic donor (1)
- allogeneic hematological stem cell transplantation (1)
- allogeneic hematopoietic stem cell transplantation (1)
- allogeneic stem cell transplant (1)
- allostasis (1)
- alpha band (1)
- alpha receptor (1)
- alpha-fetoprotein (1)
- alpha-galactosidase A deficiency (1)
- alpha-synuclein (1)
- alpha7 nicotinic acetylcholine receptor (1)
- alphaSynuclein (1)
- alteplase (1)
- alternative Analysentechniken (1)
- alternative matrices (1)
- alternative splicing (1)
- alveolar ridge augmentation (1)
- amide proton transfer (1)
- amino acids (1)
- amisulpride (1)
- amphiregulin (1)
- amygdalin (1)
- amyotrophic lateral sclerosis (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anaemia walk-in clinic (1)
- analysis of urinary calculi (1)
- analysis of urinary calculi by a microscopic microchemical procedure (1)
- analysis of urinary calculi by chemical procedures (1)
- anaplastic large cell lymphoma (1)
- anesthesia (1)
- aneurysm (1)
- angioedema control test (1)
- angiography (1)
- angiokeratoma diffuse (1)
- animal models (1)
- anorectal malformation (1)
- anorexia nervosa (1)
- anti-CD3 antibody (1)
- anti-EGFR therapy (1)
- anti-HBc (1)
- anti-bacterial agents (1)
- anti-idiotypes (1)
- anti-inflammatory agent (1)
- anti-inflammatory drug (1)
- anti-neural autoantibodies (1)
- anti-p24-Antikörper (1)
- antiadhesive composites (1)
- antiangiogenic therapy (1)
- antiangiogenic therapy resistance (1)
- antibacterial composites (1)
- antibacterial therapy (1)
- antibiotic prophylactic therapy (1)
- antibiotic prophylaxis (1)
- antibiotics (1)
- antibody (1)
- anticipation (1)
- anticoagulant (1)
- anticoagulation (1)
- antiepileptic drug (1)
- antifungal agents (1)
- antifungal therapy (1)
- antigen (1)
- antigen detection (1)
- antihelix shaping (1)
- antimicrobial stewardship (1)
- antioxidant (1)
- antiviral agents (1)
- antiviral drugs (1)
- antiviral signaling (1)
- anxiety (1)
- anxiety disorders (1)
- aortic aneurysm (1)
- aortic root replacement (1)
- aortic valve repair (1)
- aortic valve-sparing (1)
- apex (1)
- aphrodisin (1)
- apical constriction (1)
- apical polarity (1)
- apolipoprotein B (1)
- aptamer (1)
- aptamer modeling (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- arachidonic acid (1)
- arachidonic acid (AA) (1)
- arbeitsbedingte Infektionen (1)
- arterial stiffness (1)
- arteriosclerosis (1)
- articular cartilage (1)
- articular chondrocytes (1)
- artifacts (1)
- artificial feeding (1)
- artificial intelligence (AI) (1)
- aryl hydrocarbon receptor (1)
- asparaginyl endopepdidase (AEP) (1)
- aspiration (1)
- aspirin (1)
- assembly (1)
- assembly factor (1)
- asthma (1)
- asymptomatic temporal encephaloceles (1)
- at-risk mental state (1)
- ataxia (1)
- atezolizumab (1)
- atomic power (1)
- atopic dermatitis (1)
- atrial fibrillation (1)
- attachment (1)
- attachment loss (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- atypical EGFR mutations (1)
- auditory (1)
- auditory cortex (1)
- auditory fMRI (1)
- augmentation (1)
- autism (1)
- autism spectrum disorders (1)
- autoantibodies (1)
- autobiographical memories (1)
- autogenous tooth roots (1)
- autoimmune encephalitis (1)
- autoimmune-mediated psychosis (1)
- automatic scene classification (1)
- autophagy inhibition (1)
- autophagy-dependent cell death (1)
- avian flu (1)
- aviäre Influenza (1)
- awake surgery (1)
- azacitidine (1)
- azoospermia (1)
- bDNA; Hepatitis C-Virus (HCV) (1)
- bacteremia (1)
- bacterial leakage (1)
- bacterial viability (1)
- bacteriophages (1)
- ball (1)
- ballet (1)
- bariatric surgery (1)
- basilar artery occlusion (BAO) (1)
- bats (1)
- behavior (1)
- behavioral inhibition (1)
- behavioural rhythms (1)
- behördliche Anforderungen (1)
- benannte Stelle (1)
- benchmarking (1)
- benfooxythiamine (1)
- best medical treatment (1)
- beta-band activity (1)
- beta-blocker (1)
- beta-lactamases (1)
- beta2-adrenoceptor (1)
- bevacizumab (1)
- bibliometric analysis (1)
- bilateral (1)
- bile (1)
- bile acids (1)
- bilirubin determination (1)
- binocular vision (1)
- bio imaging (1)
- bioactive lipids (1)
- bioavailability (1)
- biochemical relapse free survival (1)
- biocompatibility (1)
- bioequivalence (1)
- biofilm (1)
- bioimaging (1)
- bioinformatics (1)
- biological networks (1)
- biologische Netzwerke (1)
- biologization (1)
- bioluminescence (1)
- biomolecular analysis (1)
- biorelevant dissolution (1)
- biotin deficiency (1)
- bipolar disorder (1)
- bipolare Störung (1)
- bladder neck stenosis (1)
- blended learning (1)
- blinatumomab (1)
- blood cell mutations (1)
- blood coagulation (1)
- blood coagulation factor XIII (1)
- blood components (1)
- blood concentrates (1)
- blood culture (1)
- blood culture diagnostic (1)
- blood donor screening (1)
- blood- and plasma products (1)
- blood-brain barrier (1)
- bloodstream infections (1)
- body plethysmography (1)
- body sway (1)
- body weight distribution (1)
- bone Gla protein (1)
- bone augmentation (1)
- bone barrow (1)
- bone marrow microenvironment (1)
- bone metastasis (1)
- bone tissue (1)
- bone tissue engineering (1)
- bone-regeneration (1)
- booster (1)
- bowel dysfunction (1)
- bowel management (1)
- brachytherapy (1)
- brain (1)
- brain disorders (1)
- brain function (1)
- brain imaging (1)
- brain infection (1)
- brain networks (1)
- brain shift (1)
- brain signal complexity (1)
- brain tumor (1)
- breast tumor (1)
- bromodomain and extraterminal (BET) protein (1)
- bronchial epithelium (1)
- bronchiolitis (1)
- bulimia nervosa (1)
- buparlisib (1)
- burden of disease (1)
- burden of illness (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- bypass (1)
- c-MET (1)
- c-MYC (1)
- c-tkl (1)
- cAMP (1)
- cCMV (1)
- cGMP (1)
- cabazitaxel (1)
- caesarean scar (1)
- caesarean section (1)
- callous-unemotional traits (1)
- calretinin (1)
- cancer cell metabolism (1)
- cancer immunotherapy (1)
- cancer information (1)
- cancer metastases (1)
- cancer surveillance (1)
- cancer therapy (1)
- cancer-associated fibroblasts (1)
- cancer-specific survival (1)
- cannabinoid receptors (1)
- cannabis (1)
- capillary leak syndrome (1)
- carbapenem resistance (1)
- carbapenemases (1)
- cardiac autonomic regulation (1)
- cardiac differentiation (1)
- cardiac magnetic resonance (1)
- cardiac regeneration (1)
- cardiac remodeling (1)
- cardiac reprogramming (1)
- cardiocerebral resuscitation (1)
- cardiomyocyte apoptosis (1)
- cardiomyocyte proliferation (1)
- cardiomyocytes (1)
- cardiopulmonary resuscitation (1)
- cardiothoracic surgery (1)
- cardiovascular management (1)
- cardiovascular system (1)
- casein kinase 2 (1)
- caspase-1 (1)
- castration resistance (1)
- cataract surgery (1)
- cataract surgery workflow (1)
- catecholamine excess (1)
- cathepsin L inhibitor (1)
- cell barrier integrity (1)
- cell differentiation (1)
- cell heterogeneity (1)
- cell lines (1)
- cell proliferation regulating inhibitor of protein phosphatase 2A (1)
- cellular heterogeneity (1)
- cellular inflammatory response (1)
- cellular therapies (1)
- cellular toxicity (1)
- central nervous system (1)
- central spasticity (1)
- ceramide synthase (1)
- cerebral imaging (1)
- cerebral ischemia (1)
- cerebral metastasis (1)
- cerebral palsy (1)
- cerebral pseudoprogression (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- cerebral vasospasm (CVS) (1)
- cerebrovascular disease (1)
- cerumen (1)
- cetuximab (1)
- channelrhodopsin (1)
- chaperone-mediated autophagy (1)
- chelator (1)
- chemiluminescence (1)
- chemisches Harnsteinanalysenverfahren (1)
- chemokines (1)
- chemoprotection (1)
- chemorefractory metastatic colorectal cancer (1)
- chemoresistance (1)
- chemotaxis (1)
- chernobyl (1)
- childhood cancer (1)
- childhood epilepsy (1)
- children and adolescents (1)
- chimeric antigen receptor (CAR) (1)
- chlamydia (1)
- cholangiocarcinoma (1)
- cholesterol (1)
- cholinergic system (1)
- chromaffin cell (1)
- chromatin (1)
- chromium (1)
- chronic (1)
- chronic granulomatous disease (1)
- chronic hepatitis C (1)
- chronic hypoxia (1)
- chronic infections (1)
- chronic inflammation (1)
- chronic myeloid leukemia (1)
- chronische Herzinsuffizienz (1)
- circular RNA (1)
- citrate (1)
- classical Hodgkin lymphoma (1)
- clear cell renal cell carcinoma (1)
- clear cell sarcoma (1)
- clear lens exchange (1)
- climate change genomics (1)
- clindamycin (1)
- clinical communication (1)
- clinical decision support (1)
- clinical decision-making (1)
- clinical high at-risk mental state (1)
- clinical immunology (1)
- clinical node positive (1)
- clinical outcome (1)
- clinical research (1)
- clinical stage (1)
- clinical study (1)
- clinical teaching (1)
- clinically important restrictions and symptoms (1)
- clinically relevant dissolution specifications (1)
- clonal haematopoiesis (1)
- clonal transfer (1)
- cluster analysis (1)
- cluttering (1)
- coagulation (1)
- cochlear implants (1)
- cognitive ability (1)
- cognitive aging (1)
- cognitive impairment (CI) (1)
- cognitive interventions (1)
- cold atmospheric plasma (1)
- collagen (1)
- collagen membranes (1)
- collective cell migration (1)
- colon (1)
- colony formation (1)
- colorectal cancer (CRC) (1)
- colour pattern (1)
- combination therapy (1)
- combined modality therapy (1)
- comorbidities (1)
- comparison (1)
- competition ELISA (1)
- complement fixation assay (CF) (1)
- complementary/alternative medicine (CAM) (1)
- complete response (1)
- complex coronary interventions (1)
- complex systems (1)
- compound screen (1)
- compression bandage (1)
- computational knowledge-discovery (1)
- computational pathology (1)
- computer-assisted (1)
- concordance (1)
- conduct disorder (1)
- conformity assessment (1)
- congenital disorders of autophagy (1)
- congenital duodenal obstruction (1)
- conical coupling (1)
- connective tissue (1)
- connective tissue growth factor (1)
- connectivity (1)
- conometric connection (1)
- consensus (1)
- consensus classification (1)
- consensus data set (1)
- consensus paper (1)
- conservative dentistry (1)
- contamination (1)
- continuity of care (1)
- contraception (1)
- control of menstrual bleeding (1)
- convulsive seizures (1)
- coping (1)
- copper (1)
- copper free strain-promoted azide alkyne cycloaddition (SPAAC) (1)
- core antigen (1)
- core expression (1)
- cornea donor (1)
- corona virus (1)
- coronally advanced flap (1)
- coronary heart disease (1)
- coronary imaging (1)
- corpus callosum (1)
- cortex (1)
- cortex-based alignment (1)
- cortical impact (1)
- corticospinal tracts (1)
- corticosteroid drugs (1)
- corticosteroids (1)
- cost analysis (1)
- cost containment (1)
- cost of illness (1)
- cost-effective (1)
- counselling (1)
- covalent drugs (1)
- criteria (1)
- critical-size defect (1)
- cross reactivity (1)
- cross-frequency coupling (1)
- cross-linking (1)
- cryoelectron microscopy (1)
- cryopreservation (1)
- culpa asociada a trauma (1)
- cyclic nucleotide analogues (1)
- cyclic nucleotide binding proteins (1)
- cyclin Y (1)
- cycling (1)
- cyclooxygenase 2 (1)
- cyclooxygenase-2 (1)
- cyclopentenone prostaglandins (1)
- cystic fibrosis (1)
- cytochrome P450 (1)
- cytochrome P450 enzymes (1)
- cytochrome P450 reductase (1)
- cytochrome c oxidase (complex IV) (1)
- cytochrome c oxidase I (COI) (1)
- cytokine (1)
- cytokine storm (1)
- cytokine(s) (1)
- cytomegalovirus-specific IgG (1)
- cytosolic free calcium (1)
- cytotoxic T lymphocyte (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- dance teacher (1)
- data analysis (1)
- data management (1)
- data quality (1)
- data repositories (1)
- data sharing (1)
- de novo transcription (1)
- death rates (1)
- debris (1)
- decision tree (1)
- decompressive craniectomy (1)
- deep learning (1)
- deep vein thrombosis (1)
- default mode network (1)
- deferred treatment (1)
- deficiency (1)
- degradation (1)
- delay (1)
- delayed cerebral ischemia (DCI) (1)
- delayed diagnosis (1)
- delayed treatment (1)
- delirium (1)
- delivery mode (1)
- delta (1)
- demineralized bone matrix (1)
- demonstration of the infectious agent (1)
- dendrite morphogenesis (1)
- dendritic cell (1)
- dendritic cells (1)
- dengue vector (1)
- dental academic degrees (1)
- dental assistant (1)
- dental education (1)
- dental educationcation (1)
- dental implants (1)
- dental school (1)
- dental schools (1)
- dental treatment concept (1)
- dentist (1)
- dentist’s chair design (1)
- dentoalveolar surgery (1)
- deproteinized bovine bone matrix (DBBM) (1)
- depth perception (1)
- desensitization (1)
- detection of virus antigen and nucleic acid (1)
- detection task (1)
- deubiquitylation (deubiquitination) (1)
- diabetes complication (1)
- diabetes mellitus type 1 and type 2 (1)
- diagnostic imaging (1)
- diagnostic window (1)
- diagnostisches Fenster (1)
- diaphragm development (1)
- diet (1)
- differential expression (1)
- diffuse marrow involvement (1)
- diffusion-weighted magnetic resonance imaging (1)
- digital decision-support (1)
- digital one-piece casting (1)
- digital pressing technology (1)
- digital workflow (1)
- dihydrocannabidiol (1)
- diphtheria toxin (1)
- direct-acting antiviral (DAA) treatment (1)
- discontinuation (1)
- disease outbreaks (1)
- disease progression (1)
- disease vectors (1)
- dislocation (1)
- disordered iron metabolism (1)
- disorders of bone metabolism (1)
- distributed analysis (1)
- disturbing factors in serodiagnosis (1)
- dobutamine stress (1)
- docetaxel (1)
- docetaxel (DX) resistance (1)
- doctoral degrees (1)
- donor safety (1)
- dopamine transporter (1)
- dorsal attention network (1)
- double immune checkpoint inhibition (1)
- double negative (1)
- double-pigtail stents (1)
- downgrading (1)
- doxorubicin (1)
- doxycycline (1)
- drinking (1)
- drospirenone (1)
- drug (1)
- drug abstinence (1)
- drug discovery (1)
- drug repurposing (1)
- drugs (1)
- drug–drug interactions (1)
- drug–gene interactions (1)
- drug–g–gene interactions (1)
- dual-energy (1)
- dynamic causal modeling (1)
- dynamic system (1)
- dysbetalipoproteinemia (1)
- dysfibrinogenemia (1)
- early detection (1)
- early onset (1)
- early-onset prostate cancer (1)
- eating disorders (1)
- echo planar imaging (1)
- economic burden (1)
- edentulous (1)
- education (1)
- efferocytosis (1)
- efficiency (1)
- efflux pump (1)
- egg sampling (1)
- egr-1 (1)
- eicosanoid (1)
- elastin (1)
- elastische Verformung (1)
- electrical coupling (1)
- electroanatomical mapping (1)
- electrode design (1)
- electroencephalography (1)
- electroencephalography (EEG) (1)
- electrolytic cleaning (1)
- electron transfer (1)
- electron transfer chain (1)
- electronic adherence measurement (1)
- electronic diaries (1)
- electrophilic fatty acids (1)
- electrophoresis (1)
- element speciation (1)
- eligibility (1)
- elite athletes (1)
- emergency care (1)
- emicizumab (1)
- enamel matrix derivatives (1)
- encephalopathy (1)
- endodontics (1)
- endodontische Ausbildung (1)
- endodontischer Lehrplan (1)
- endodontology (1)
- endoscopic retrograde cholangiography (1)
- endoscopic retrograde cholangiopancreatography (1)
- endothelial dysfunction (1)
- endourology (1)
- endovascular recanalization (1)
- endovascular thrombectomy (1)
- ensemble cNN (1)
- enteral transmission (1)
- enterale Übertragung (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- enterocytes (1)
- environmental tobacco smoke (1)
- enzyme activity assay (1)
- enzyme linked immunosorbent assay (ELISA) (1)
- epidemic (1)
- epidemics (1)
- epidemlology (1)
- epidermal growth factor (1)
- epidural (1)
- epilepsy surgery (1)
- epileptic encephalopathy (1)
- episodic memory (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- epoxyeicosatrienoic acid (1)
- erectile dysfunction (1)
- erythropoiesis (1)
- essential thrombocythemia (ET) (1)
- essential tremor (1)
- estrogen (1)
- ethanol (1)
- ethnicity (1)
- euthymic (1)
- evaluation (1)
- everyday life (1)
- everyday tasks (1)
- evidence-based guideline (1)
- evolution (1)
- exclusion of very low profiles (1)
- executive functions (1)
- exosome (1)
- experimental pain models (1)
- expert witness statement (1)
- extracellular signal-regulated kinase (1)
- extraskeletal (1)
- eye movements (1)
- eye tracking (ET) (1)
- fMLP (1)
- fMRT (1)
- factor V Leiden mutation (1)
- factor XIII (1)
- faecal microbiota transfer (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- famotidine (1)
- fasting insulin (1)
- fat grafting (1)
- fat pad resection (1)
- fatigue (1)
- fatty acid (1)
- fatty acid synthesis (1)
- feasibility study (1)
- febrile neutropenia (1)
- fecal incontinence (1)
- fecal microbiota transfer (1)
- federated feasibility queries (1)
- feedback control (1)
- female subjects (1)
- females (1)
- fenfluramine (1)
- ferric carboxymaltose (1)
- ferric derisomaltose (1)
- ferritin (1)
- ferritinophagy (1)
- ferroportin (1)
- ferumoxytol (1)
- fetal loss (1)
- fibrin-glue-spray technique (1)
- fibrinolysis (1)
- fibrosis imaging (1)
- filter membrane procedure (1)
- fimaporfin (1)
- first-time shoulder dislocation (1)
- fluorescence (1)
- fluorescence in situ hybridization (FISH) (1)
- focal cortical dysplasia (1)
- focal therapy (1)
- fondaparinux (1)
- fondaparinux sodium (1)
- foreign body reaction (1)
- formula diet (1)
- fractionation (1)
- fracture strength (1)
- fracture strength equation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fragment screening (1)
- fragment-size analyses (ACE2; CQ11) (1)
- frequency of attacks (1)
- frontal fibrosierende Alopezie (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- frontotemporal dementia (1)
- full-arch restoration (1)
- function (1)
- functional connectivity (1)
- functional connectome acute (1)
- functional magnetic resonance imaging (1)
- fungal infection (1)
- fungal sinusitis (1)
- fungal sugar (1)
- fusion (1)
- fusion kinase (1)
- gait symmetry (1)
- gangliosides (1)
- gargle lavage (1)
- gasotransmitters (1)
- gastrointestinal (1)
- gastrointestinal stromal tumours (1)
- gefitinib (1)
- gel (1)
- gemcitabine (1)
- gender (1)
- gender differences (1)
- gene polymorphisms (1)
- gene regulation (1)
- gene signature (1)
- general practitioners (1)
- genetic diversity (1)
- genetic model (1)
- genetic variability (1)
- genetically caused iron imbalance (1)
- genetische Polymorphismen (1)
- genetische Varianten (1)
- genome (1)
- genomic instability (1)
- genotype G (1)
- geriatric patients (1)
- geriatrics (1)
- geriatrischer Ultraschall (1)
- gestational hypertension (1)
- gesundheitsbezogene Lebensqualität HIV (1)
- gingival recession therapy (1)
- glecaprevir (1)
- glioblastoma cells (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- glioma stem-like cells (1)
- global health (1)
- globosides (1)
- glomerulus (1)
- glucose and lipid metabolism (1)
- glucose-6-phosphate dehydrogenase (1)
- glucosylceramide (1)
- glucosylceramides (1)
- glutamate (1)
- glutathione peroxidase 4 (1)
- glycobiology (1)
- glycoconjugate (1)
- glycoproteins (1)
- glycosyltransferase (1)
- gp100 (1)
- graft-vs-host disease (1)
- granule polarization (1)
- graph theory (1)
- graphic 3D models (1)
- gravity (1)
- great height (1)
- grisel syndrome (1)
- growth inhibition (1)
- guided tissue regeneration (1)
- guideline (1)
- guidelines (1)
- haNK (1)
- habitat (1)
- haemophilia (1)
- haemophilia A (1)
- harmonization (1)
- harnwegspathogene Enterobacteriacae (1)
- hatching (1)
- head and neck neoplasms (1)
- head and neck squamous cell carcinoma (1)
- health behavior (1)
- health care (1)
- health data (1)
- health database (1)
- health education (1)
- health information interoperability (1)
- health services research (1)
- health-care personnel (1)
- health-related quality of life (1)
- health-relatedquality of life (1)
- healthcare personnel (1)
- healthcare system (1)
- healthcare workers (1)
- healthy control (1)
- hearing loss (1)
- heart neoplasms (1)
- heart rate (1)
- heart rate control (1)
- hematological (1)
- hematotoxicity (1)
- hemodialysis (1)
- hemophilia (1)
- hemophilia a (1)
- hemorrhagic transformation (1)
- heparan sulfate proteoglycans (1)
- heparin sensitivity (1)
- hepatic stellate cells (1)
- hepatitis (1)
- hepatitis B (1)
- hepatitis B surface antigen (1)
- hepatitis B virus (1)
- hepatitis C-virus (HCV) (1)
- hepatitis D (1)
- hepatocellular cancer (1)
- hepatotoxicity (1)
- herb-induced liver injury (HILI) (1)
- hereditary angioedema (1)
- hereditary dystopic lipidosis (1)
- hereditary thrombophilia (1)
- herpes simplex virus type 1 (1)
- herpes simplex virus type 2 (1)
- heterogeneity (1)
- hidradenitis suppurativa (1)
- hierarchical clustering (1)
- high risk (1)
- high sensitive C-reactive protein (1)
- high throughput screening (1)
- high-altitude adaptation (1)
- high-altitude pulmonary hypertension (1)
- high-content screen (1)
- high-fat-diet (1)
- high-risk (1)
- high-risk neuroblastoma (1)
- high-throughput (1)
- high-throughput screening (1)
- hip osteoarthritis (hip OA) (1)
- hippocampal sclerosis (1)
- histamine (1)
- histological outcomes (1)
- histone deacetylase (1)
- histopathological growth pattern (1)
- holistic treatment (1)
- home training (1)
- homeodomain protein (1)
- homeostasis (1)
- hormones (1)
- hospital admission (1)
- hospital length of stay (1)
- host matrix- pathogen interaction (1)
- host-microbe interaction (1)
- human MSCs (1)
- human allogeneic hematopoietic cell transplantation (1)
- human behaviour (1)
- human factors (1)
- human genomics (1)
- human immunodeficiency virus (1)
- human intestinal microbiota (1)
- human monoclonal antibody (1)
- human olfaction (1)
- human prion diseases (1)
- human research (1)
- human rhabdomyosarcoma (1)
- human subjects (1)
- human-liver chimeric mouse model (1)
- humans (1)
- hybrid abutment (1)
- hybrid materials (1)
- hybrid production (1)
- hybridization (1)
- hybrids (1)
- hydrogen peroxide (1)
- hydrogen sulfide (H2S) (1)
- hydroxylation (1)
- hyperactivity (1)
- hyperalgesia (1)
- hypercholesterolemia (1)
- hypersensitivity (1)
- hypertriglyceridemia (1)
- hypertrophy (1)
- hypnotics and sedatives (1)
- hypobaric hypoxia (1)
- hypocalcemia (1)
- hypoparathyreoidism (1)
- hypophosphatemia (1)
- hyposensitization (1)
- hypoxia inducible factor 1 alpha (1)
- hypoxia-inducible factor-2α (1)
- iCBT (1)
- ibrutinib (1)
- idiopathic pulmonary fibrosis (1)
- idiosyncratic drug-induced liver injury (DILI) (1)
- image-guided tissue acquisition (1)
- imaging (1)
- imaging genetics (1)
- imaging protocol (1)
- immobilization in external rotation and abduction (1)
- immun (1)
- immunchemische Bestimmungsmethoden (1)
- immune assessment (1)
- immune checkpoint (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune checkpoint inhibitors (ICI) (1)
- immune defense (1)
- immune escape (1)
- immune host defense (1)
- immune infiltration (1)
- immune monitoring (1)
- immune related adverse events (irAE) (1)
- immune therapy (1)
- immuno-oncotherapy (1)
- immunoassay (1)
- immunofixation electrophoresis (1)
- immunological risk (1)
- immunosenescence (1)
- immunoturbidimetric inhibition technique (1)
- immunturbidimetrische Inhibitionstechnik (1)
- imprecision (1)
- impulsivity (1)
- in silico (1)
- in situ (1)
- in vitro models (1)
- in vivo (1)
- in vivo dosimetry (1)
- in-cabin exposure (1)
- inborn errors of immunity (1)
- incidence (1)
- incontinence (1)
- individual differences (1)
- indoor air (1)
- induction chemotherapy (1)
- induction regimen (1)
- induction therapy (1)
- inertial motion capture (1)
- inertial motion units (1)
- inertial sensors (1)
- infection control (1)
- infection precaution (1)
- infectious disease (1)
- infectivity (1)
- inferior frontal gyrus (1)
- inflammasome (1)
- inflammatory reaction (1)
- informal care (1)
- infrapatellar fat pad (1)
- infrared spectroscopy (1)
- inguinal hernia (1)
- inherited (1)
- inhibitor (1)
- inhibitors (1)
- inhibitory control (1)
- inhibitory interneurons (1)
- injury (1)
- injury pattern (1)
- injury prevention (1)
- inner membrane morphology (1)
- inosine (1)
- inositol signaling (1)
- instructional film and video (1)
- insula (1)
- insulin resistance (1)
- insulin sensitivity (1)
- insurance data (1)
- integrate-and-fire (1)
- integrated stress response (1)
- integrative neuromotor training (1)
- integrin (1)
- intellectual disability (1)
- intelligence (1)
- intensive care admission and mortality (1)
- inter-individual variability (1)
- interactions (1)
- interferon induction (1)
- interferon sensitivity (1)
- interferon type III (1)
- interim positron emissiontomography (1)
- interleukin-1beta (1)
- interleukin-22 (1)
- internal/external controls (1)
- international transport (1)
- interne/externe Kontrollen (1)
- internet (1)
- interstitial multicatheter brachytherapy (1)
- intervenciones cognitivas (1)
- intestinal iron loss (1)
- intestinal manipulation (1)
- intracellular (1)
- intracellular multiplication (1)
- intracerebral hemorrhage (ICH) (1)
- intracranial hemorrhage (1)
- intrahepatic cholangiocarcinoma (1)
- intranasal administration (1)
- intraoperatively molded (1)
- intraoral scanning (1)
- intrauterine Wachstumsretardierung (1)
- intrauterine growth restriction (1)
- intravenous iron (1)
- intravenous iron therapy (1)
- intrinsic and innate immune response (1)
- invasive fungal disease (1)
- invasive fungal infection (1)
- inverse spacer (1)
- inverse stage migration (1)
- investigational (1)
- inflammation (1)
- iron deficiency anemia (1)
- iron isomaltoside (1)
- iron-trafficking (1)
- irritable bowel syndrome (1)
- isolation (1)
- jejunoileal atresia (1)
- joint contact forces (1)
- joint innervation (1)
- joint load (1)
- juvenile myelomonocytic leukemia (1)
- kaffir lime (1)
- keratinized mucosa (1)
- kidney function (1)
- kidney transplantation (1)
- kleinzelliges/Diagnostik (1)
- knee adduction moment (1)
- knee osteoarthritis (1)
- knowledge based systems (1)
- kolorektal (1)
- kompetitiver ELISA (1)
- konventionelle Analysentechniken (1)
- laboratory diagnosis (1)
- laboratory diagnostic (1)
- laboratory diagnostics (1)
- laboratory organization (1)
- laboratory worker (1)
- lacto/neo-lacto series GSLs (1)
- landrace pigs (1)
- language impairment (1)
- laparoscopic inguinal hernia repair (1)
- laparoscopische Cholezystektomie (1)
- laser-induced thermotherapy (1)
- lasso regression (1)
- late disease (1)
- latent factor mixed model (1)
- layer-specificity (1)
- learning and memory (1)
- left atrial appendage occlusion (1)
- legislation (1)
- legumain (1)
- leisure-time activity (1)
- lenalidomide (1)
- length of stay (1)
- leptin receptor-deficient mouse (1)
- leucocytes (1)
- leukaemia (1)
- leukemia (1)
- leukocytes (1)
- leukodystrophy (1)
- leukotriene (1)
- lichen extracts (1)
- life table (1)
- life-expectancy (1)
- lifestyle (1)
- light irradiation (1)
- limitations (1)
- lipid droplets (1)
- lipidomics (1)
- lipofilling (1)
- lipofuscin (1)
- lipoproteins (1)
- lipoxin (1)
- lipoxin A4 (1)
- lipoxygenase inhibitor (1)
- liquid chromatography–mass spectrometry (1)
- live-cell imaging (1)
- live/dead staining (1)
- liver X receptor (1)
- liver damage (1)
- liver metastasis (1)
- liver steatosis (1)
- liver stiffness (1)
- liver volume (1)
- local antibiotics (1)
- local drug delivery (1)
- local preemptive analgesia (1)
- local recurrence (1)
- local treatment (1)
- location (1)
- locator (1)
- locusts (1)
- logistic models (1)
- long non-coding RNAs (1)
- long term (1)
- long-term outcome (1)
- long-term potentiation (1)
- long-term prophylaxis (1)
- long-term results (1)
- loss of B-cell phenotype (1)
- loss-of-function (1)
- loving-kindness meditation (1)
- low density lipoprotein receptor (1)
- low risk (1)
- low-back-pain (1)
- low-carbohydrate (1)
- low-dose irradiation (1)
- lower leg fracture (1)
- lppr5 (1)
- lung fibrosis (1)
- lung function (1)
- lung tumor heterogeneity (1)
- lungs (1)
- lymph node (1)
- lymph node metastases (1)
- lymphocytes (1)
- lysophospholipids (1)
- lysosomal-dependent cell death (1)
- lysosome (1)
- mCRPC (1)
- mRNA stability (1)
- mRNA-1273 (1)
- mRNA1273 (1)
- mTOR inhibitor (1)
- macaque (1)
- machine learning (ML) (1)
- magnetoencephalography (1)
- male (1)
- malignancies (1)
- malignancy (1)
- malignant melanoma (1)
- mammary carcinoma (1)
- manganese (1)
- mappers (1)
- mapping-algorithms (1)
- marginal fit (1)
- marked lymph node (1)
- marker (1)
- mass spectrometry (1)
- material characterization (1)
- maternity protection law (1)
- mathematical analysis (1)
- mathematical modeling (1)
- matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (1)
- mechanical accuracy (1)
- mechanical recanalization (1)
- mechanical ventilation (1)
- mechanotransduction (1)
- medical device (1)
- medical education (1)
- medical informatics (1)
- medical risk factors (1)
- medication adherence rate (1)
- medication review (1)
- meditación de bondad amorosa (1)
- medizinische Beschäftigte (1)
- medizinisches Personal (1)
- medulloblastoma (1)
- membrane protein complex (1)
- membrane remodeling (1)
- membrane-less organelles (1)
- membranous urethra (1)
- membranous urethral stricture (1)
- meningioma (1)
- menschliche Prionenerkrarikungen (1)
- mental distress (1)
- mental health (1)
- mesangial cells (1)
- mesenchymal stromal cell (1)
- mesenchymal stromal cells (1)
- mesenchymale Stammzellen (1)
- mesial temporal lobe epilepsy (1)
- meta-analysis (1)
- metabolic alterations (1)
- metabolic liver disease (1)
- metabolic rewiring (1)
- metastases (1)
- metastatic renal cell carcinoma (1)
- methacarn (1)
- miR (1)
- miR-122 (1)
- miR-142-3p (1)
- miR-181 (1)
- miR-21 (1)
- miR-6862-5p (1)
- michael acceptor (1)
- microangiopathy (1)
- microbial colonization (1)
- microbiologic agents (1)
- microbiology (1)
- microbiome (1)
- microcentrifugal analyzer (1)
- microdissection (1)
- microlaparoscopy (1)
- microneutralization assay (1)
- microsomal ethanol oxidizing system (1)
- microstates (1)
- microstimulation (1)
- microsurgery (1)
- microvesicles (1)
- microwave ablation (1)
- mid-IR spectroscopy (1)
- mid-term urinary continence (1)
- middle-aged (1)
- migration (1)
- mikrobiologische Erreger (Bakterien, Pilze, Protozoen) (1)
- mikroskopisch-mikrochemisches Harnsteinanalysenverfahren (1)
- mild cognitive impairment (1)
- mineralization (1)
- minimal invasive (1)
- minimal residual disease (1)
- minimally invasive surgery (1)
- minimally invasive therapy (1)
- minocycline (1)
- miscarriage (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- mitochondrial disease (1)
- mitochondrial metabolism (1)
- mitochondrial morphology (1)
- mitochondrial respiration (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- mixed infection (1)
- mixed lineage kinase domain-like (1)
- mobile air quality study (1)
- model builder software (1)
- modeling (1)
- modelling (1)
- models (1)
- molar mass distribution (1)
- mold (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular diagnostic techniques (1)
- molecular dynamics (1)
- molecular marker (1)
- molecular modeling (1)
- molecular neuroscience (1)
- molecular subtyping (1)
- molecular surveillance (1)
- molecular typing (1)
- monkeypox (1)
- monoacylglycerol lipase (1)
- monoclonal antibodies (1)
- monoklonale Antikörper (1)
- monotherapy (1)
- monotype abutment (1)
- monsoon (1)
- mood (1)
- morbidity (1)
- morphometry (1)
- mortality analysis (1)
- mortality risk (1)
- motor functions (1)
- motor-control-exercise (1)
- mouse (1)
- mouse models (1)
- mouse tumor model (1)
- mouthwash (1)
- mouthwash solution (1)
- mtLSU quality control (1)
- mucormycetes (1)
- mucormycosis (1)
- multi-material 3D printing (1)
- multi-scale models (1)
- multicenter study (1)
- multidisciplinary-therapy (1)
- multidrug resistance (1)
- multidrug resistance protein 4 (1)
- multiparametric magnetic resonance imaging (1)
- multiplex immunohistochemistry (1)
- multiplexed immunofluorescence (1)
- multisensory integration (1)
- multislice imaging (1)
- multispectral flow cytometry (1)
- multivoxel pattern analysis (1)
- musclin (1)
- musculoskeletal inflammation (1)
- musculoskeletal modeling (1)
- musculoskeletal repair (1)
- musculoskeletal system (1)
- mutation (1)
- mutism (1)
- myeloproliferative neoplasms (MPN) (1)
- myocardial efficiency (1)
- myocardial fibrosis (1)
- myocardial ischaemia (1)
- myocardial power (1)
- nNOS (1)
- nasal swab (1)
- natural killer (1)
- natural selection (1)
- natural sounds (1)
- necroptosis (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant chemotherapy (1)
- neoadjuvant immunochemotherapy (1)
- neoadjuvant therapy (1)
- neonate (1)
- neoplasm metastasis (1)
- neovascularization (1)
- nephroureterectomy (1)
- nerve-sparing surgery (1)
- neue Rollenbilder der MFA (1)
- neural correlates (1)
- neural network (1)
- neuregulin 1 (1)
- neurexin (1)
- neuroblast (1)
- neuroblastoma (1)
- neurocognition (1)
- neurocognitive outcome (1)
- neurocritical care (1)
- neurodegenerative diseases (1)
- neurodevelopment (1)
- neurodevelopmental disorde (1)
- neuroendocrine (1)
- neuroendocrine tumor (1)
- neuroethology (1)
- neurogenic bowel (1)
- neuroimaging (1)
- neurological complication (1)
- neurological manifestations (1)
- neurological side effects (1)
- neurology (1)
- neuronal silencing (1)
- neurooncology (1)
- neuropeptide (1)
- neuropeptides (1)
- neuroprotection (1)
- neurotransmitter (1)
- neurysmal subarachnoid hemorrhage (aSAH) (1)
- neutralizing antibody (1)
- neutropenia (1)
- neutrophil elastase (1)
- newborn (1)
- newly diagnosed glioblastoma (1)
- niedermolekulares Heparin (1)
- nitroalkene (1)
- nitroalkylation (1)
- nitroglycerin (1)
- nociceptors (1)
- nodular lymphocyte-predominant Hodgkin lymphoma (1)
- noise (1)
- nomogram (1)
- non-alcoholic fatty liver disease (1)
- non-aneurysmal (1)
- non-aneurysmal SAH (1)
- non-coding RNA (1)
- non-contact injuries (1)
- non-fermenter (1)
- non-neutropenic episode (1)
- non-organ confined stage (1)
- non-perimesencephalic (1)
- non-small cell lung cancer (1)
- non-small-cell lung cancer (1)
- non-surgical periodontal therapy (1)
- noninvasive blood glucose analysis (1)
- nonsense-mediated mRNA decay (1)
- nontraumatic atlantoaxial rotatory subluxation (1)
- noradrenaline (1)
- norepinephrine (1)
- normal liver cells (1)
- notified body (1)
- novel technologies (1)
- nuclear cardiology (1)
- nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2) (1)
- nuclear magnetic resonance (NMR) (1)
- nuclear power plant (1)
- nuclear receptor (1)
- nuclear receptor coactivator 4 (1)
- nuclear receptor-related 1 (1)
- nucleic acid amplification test(NAT) (1)
- nucleic acid amplification test (1)
- nucleic acid amplification test (NAT) (1)
- nucleic acid amplification testing (NAT) (1)
- nucleic acid docking (1)
- nucleic acid lateral flow immunoassay (1)
- nucleolus (1)
- nucleoredoxin (1)
- nutrient endocytosis (1)
- nutrition - clinical (1)
- nymphs (1)
- observational study (1)
- obstetric complications (1)
- obstetric pain (1)
- obstetrics (1)
- occupational immediate-type reactions (1)
- occupationally acquired viral infections (1)
- oedema (1)
- official requirements (1)
- olfactory testing (1)
- olive mill wastewater (OMWW) (1)
- oluble epoxide hydrolase (1)
- oncogenes (1)
- oncogenesis (1)
- oncogenic RAS (1)
- oncogenic signaling (1)
- oncological exercise therapy (1)
- oncomodulation (1)
- online intervention (1)
- online research (1)
- open (1)
- open field behavior (1)
- open science (1)
- open skill exercise (1)
- operating microscope (1)
- optogenetics (1)
- oral and maxillofacial surgery (1)
- oral cavity cancer (1)
- oral drug products (1)
- oral health (1)
- oral health burden (1)
- oral progestins (1)
- orale Gestagene (1)
- ordinary differential equation (1)
- ordinary differential equations (ODE) (1)
- organ preservation (1)
- organic nitrates (1)
- organoids (1)
- organotypic culture (1)
- orthopaedic patients (1)
- orthopoxvirus (1)
- osseoincorporation (1)
- osseointegration (1)
- osteoblast (1)
- osteoclasts (1)
- osteogenic differentiation (1)
- other cause mortality (1)
- otoplasty (1)
- outbreak (1)
- outpatient care (1)
- outpatients (1)
- outside-in signaling (1)
- ovarian cancer (1)
- overdenture (1)
- overtreatment (1)
- overweight (1)
- oviposition (1)
- oviposition substrate (1)
- ovitrap (1)
- oxaliplatin (1)
- oxidized low density lipoprotein (1)
- oxythiamine (1)
- oxytocin, articulation, over reading, affective prosody, neuromodulation (1)
- p-eIF2α (1)
- p16 (1)
- p21Cip1/CDKN1A (1)
- p24-antibodies (1)
- p38 MAPK (1)
- p53 pathway (1)
- pH (1)
- pH-dependent solubility (1)
- pIOL (1)
- pad-test (1)
- pain intensity (1)
- pain management (1)
- paired samples (1)
- palliative care (1)
- palliative care services (1)
- pancreatic ductal adenocarcinoma (1)
- pannexin-1 (1)
- paper-based detection (1)
- parabolic flight (1)
- paracrine signaling (1)
- paramyxoviridae. (1)
- parent rating (1)
- parenteral nutrition (1)
- partial differential equation (1)
- particle size distribution (1)
- particulate matter (1)
- passive smoke (1)
- pathogen (1)
- pathogenicity (1)
- pathology (1)
- patient blood management (PBM) (1)
- patient centered care (1)
- patient data (1)
- patient preferences (1)
- patient safety (1)
- patient-centred care (1)
- patient-reported outcomes (1)
- patient–doctor relationship (1)
- patient’s decree (1)
- pediatric intensive care (1)
- pediatric robotic surgery (1)
- pediatric solid tumors (1)
- pelvic trauma (1)
- pembrolizumab (1)
- pentaerythritol tetranitrate (1)
- peptide receptor radionuclide therapy (1)
- perceptual closure (1)
- percutaneous thermal ablation (1)
- perforant path transection (1)
- peri-implant disease (1)
- peri-implantitis treatment (1)
- pericytes (1)
- periimplantitis (1)
- perimesencephalic (1)
- perinatal (1)
- periodontal diseases (1)
- periodontal risk factors (1)
- periodontal treatment (1)
- periodontal– systemic disease interactions (1)
- peripartal (1)
- peripheral blood stem cell collection (1)
- peripheral injury (1)
- peritoneal macrophages (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- peroxisome proliferator-activated receptor (1)
- persistent periodontal pockets (1)
- personalized (1)
- phagocytes (1)
- phantom study (1)
- pharmaco-fMRI (1)
- pharmacodynamics (1)
- pharmacoepigenetics (1)
- pharmacogenetics (1)
- pharmacological data science (1)
- pharmacological plasticity (1)
- pharmacophore model (1)
- phase I (1)
- phase IV (1)
- phase separation (1)
- phenoconversion (1)
- phenotypic screening; (1)
- pheromone (1)
- phosphatidylethanolamines (1)
- phospholipase A2 (1)
- phospholipid (1)
- phosphoproteomics (1)
- photochemical internalization (1)
- photodynamic therapy (1)
- photothermal detection (1)
- physical performance (1)
- physiotherapy (1)
- phytosterols (1)
- pibrentasvir (1)
- pimozide (1)
- pitch (1)
- placenta (1)
- planimetric measurement (1)
- plasma (1)
- plasma C-peptide (1)
- plasma jet (1)
- plasma pools and products (1)
- plasma protein determination in urine (1)
- plasmid (1)
- platelet hyperactivity (1)
- platelet substitution (1)
- platelet-rich fibrin (1)
- platelet-rich-fibrin (1)
- platinum-based chemotherapy (1)
- plppr5 (1)
- pneumocystis (1)
- point of care (1)
- point-of-care diagnostics (1)
- point-of-care testing (POCT) (1)
- pole concept of goiter growth (1)
- poliovirus (1)
- polo-like kinases (1)
- poly(A)-tail (1)
- poly-LacNAc (1)
- polyQ (1)
- polyclonal antibody (1)
- polycythemia vera (PV) (1)
- polyklonale Antikörper (1)
- polymer infiltrated ceramic network (1)
- polymerase chain reaction (PCR) (1)
- polymeric micelle (1)
- polypept(o)ide (1)
- polyunsaturated fatty acid (1)
- portal pressure (1)
- portal vein (1)
- positron-emissions-tomography (1)
- post-caesarean uterus (1)
- post-exercise hypotension (1)
- post-radiotherapy recurrence (1)
- post-transcriptional regulation (1)
- posterior circulation (1)
- posterior fossa tumor (1)
- posterior horn (1)
- posteroinferior horn (1)
- postgraduate edu (1)
- postinfectious bronchiolitis obliterans (1)
- postmonsoon (1)
- postmortem blood samples (1)
- postnatal care (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- posttranslational modification (PTM) (1)
- potassium channel (1)
- poxvirus (1)
- pre-analytical system (1)
- pre-professional (1)
- precautions (1)
- precision and accuracy (1)
- precision medicine (1)
- precision weighting (1)
- preclinical (1)
- prediabetes and type 2 diabetes (1)
- predictive biomarker (1)
- predictive value (1)
- prefrontal cortex (1)
- prehabilitation (1)
- prenatal diagnostic (1)
- prepontine (1)
- preventive health services (1)
- preventive strategies (1)
- primary aldosteronism (1)
- primary biliary cholangitis (1)
- primary health care (1)
- primary immunodeficiency (1)
- primary myelofibrosis (PMF) (1)
- primary ovarian insufficiency (1)
- primärer Hyperaldosteronismus (1)
- print and press (1)
- prion-like (1)
- private brands (1)
- product performance (1)
- production (1)
- professional dance (1)
- professional soccer players (1)
- proficiency testing (1)
- progestin mono-preparation (1)
- prognostic marker (1)
- prognostic scores (1)
- progranulin (1)
- promyelocytic leukemia nuclear bodies (1)
- prone position (1)
- propensity score matching (1)
- prostaglandin (1)
- prostanoids (1)
- prostate cancer (PCa) (1)
- prostate neoplasia (1)
- prostate neoplasm (1)
- prostatectomy (1)
- protease inhibitor (1)
- proteasom inhibitor (1)
- proteasomal processing escape (1)
- protein aggregation (1)
- protein complexes (1)
- protein evolution (1)
- protein folding (1)
- protein phosphorylation (1)
- protein–protein interaction (1)
- proteoglycan (1)
- proteostasis (1)
- prothrombin induced by vitamin K absence-II (1)
- prothrombin mutation (1)
- proton pumping (1)
- proton-sensing GPCR (1)
- protruding ear (1)
- präanalytische Systeme (1)
- prädiktive Werte (1)
- pseudoaneurysm (1)
- pseudomonas aeruginosa (1)
- psoriatic arthritis (1)
- psychiatric comorbidity (1)
- psychiatric disorder (1)
- psychiatric disorders (1)
- psychischer Stress (1)
- psychogenic non-epileptic seizures (1)
- psychosocial factors (1)
- publication output (1)
- pulmonary failure (1)
- pulmonary fibrosis (1)
- pulmonary hypertension (1)
- pulmonary hypoplasia (1)
- pulmonary ventilation (1)
- pulse wave velocity (1)
- pulsed SILAC (1)
- pulsed-field (1)
- purification (1)
- pädiatrische allogene Stammzelltransplantation (1)
- qRT-PCR (1)
- quality management (1)
- quantitative MRT (1)
- quantitative RUCAM (1)
- quantitative determination of viral antibodies (1)
- quantitative magnetic resonance imaging (1)
- quantum cascade laser (QCL) (1)
- query (1)
- quiescence (1)
- rRNA chaperone ERAL1 (1)
- race (1)
- race/ethnicity disparities (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiation-induced (1)
- radio sensitivity (1)
- radioimmunotherapy (1)
- radiomics (1)
- radiosensitization (1)
- randomized (1)
- randomized controlled trial (1)
- range expansion (1)
- rapid gastric emptying (1)
- rare disease (1)
- rare mendelian disorders (1)
- rat calvaria defect (1)
- rat femur critical size defect (1)
- rat model (1)
- rats (1)
- re-exposure (1)
- re-irradiation (1)
- reactive coordination (1)
- real time analysis (1)
- real world (1)
- real-world (1)
- realist synthesis (1)
- recall (1)
- rechallenge (1)
- recombinase polymerase amplification (1)
- recovery (1)
- recurrence pattern (1)
- recurrent cholangitis (1)
- recurrent urinary tract infections (1)
- red cells (1)
- redox status (1)
- reduced kidney function (1)
- reduction potential (1)
- refractive lens exchange (1)
- refractive surgery (1)
- regenerative therapy (1)
- regulatory T cell (1)
- regulatory T helper cells (1)
- reintroduction (1)
- relapsing–remitting multiple sclerosis (1)
- relaxometry (1)
- remodeling (1)
- renal dysfunction (1)
- renal failure (1)
- renal fibroblasts (1)
- renal inflammation (1)
- renal transplantation (1)
- renal tubular epithelial cells (1)
- replicative fitness (1)
- reproducibility (1)
- research database (1)
- research funding (1)
- research incentives (1)
- resectability (1)
- resin nano ceramics (1)
- resistance (1)
- resistance analysis (1)
- resistance testing (1)
- resistant epilepsy (1)
- resolution (1)
- resolution of inflammation (1)
- resolvin (1)
- respiratorische Infektion (1)
- respiratorische Insuffizienz (1)
- respiratory failure (1)
- respiratory infection (1)
- respiratory insufficiency (1)
- response (1)
- response inhibition (1)
- response to therapy (1)
- rest period (1)
- resting-state fMRI (1)
- result quantitation; (1)
- resveratrol (1)
- reticulocyte count (1)
- reticulocyte haemoglobin (1)
- reticulocyte hemoglobin equivalent (1)
- retinoic acid (1)
- retrospective studies (1)
- retrovirus (1)
- reverberation (1)
- revision knee arthroplasty (1)
- reward (1)
- reward probabilities (1)
- rhabdomyosarcoma (1)
- rhinovirus (1)
- ribonucleotide reductase (1)
- rifampicin (1)
- rifampin (1)
- risk assessment (1)
- risk factor (1)
- risk of malignancy (1)
- risk stratification (1)
- rituximab (1)
- robot-guided stereotaxy (1)
- robotic-assisted (1)
- robotically assisted surgery (1)
- robotics (1)
- room simulation (1)
- rotary ATPase mechanism (1)
- rotational thromboelastometry (1)
- sE-Cadherin (1)
- sEH (1)
- sRNA (1)
- sRNA tool (1)
- safety attitudes questionnaire (1)
- salience network (1)
- saliva (1)
- salvage mastectomy (1)
- sample Identification (1)
- sampling (1)
- sarcoma (1)
- scanner noise (1)
- scar (1)
- schwangerschaftsdepression (1)
- schwangerschaftsinduzierter Hypertonus (1)
- screening ELISA (1)
- screening questionnaire (1)
- sealing zone (1)
- searchlight analysis (1)
- seasonal adaption (1)
- second line therapy (1)
- second-line immunotherapy (1)
- second-line treatment / 2L treatment (1)
- secondary data analysis (1)
- secondary progressive multiple sclerosis (1)
- secreted Ly-6/uPAR-related protein 1 (1)
- secretory phospholipase A (1)
- seed and soil (1)
- segmental ureteral resection (1)
- seizures (1)
- selection (1)
- selective media (1)
- selenium (1)
- self-collected samples (1)
- seminoma (1)
- semiquinone (1)
- sensitivity (1)
- sensorineural hearing loss (1)
- sensory loss (1)
- sensory organ development (1)
- septicemia (1)
- seroconversion (1)
- serologic screening (1)
- serological markers of disease (1)
- serological testing for infectious diseases (1)
- serologische Prognosefaktoren (1)
- serum separator (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- severely injured (1)
- severely injured patient (1)
- sex (1)
- sex differences (1)
- sexual arousal (1)
- sexual dysfunction (1)
- sexual rehabilitation (1)
- shape (1)
- shared decision-making (1)
- shear stress (1)
- shikonin (SHI) (1)
- short bowel (1)
- short linear motif (1)
- short-course antibiotic therapy (1)
- short-term (1)
- shoulder instability (1)
- shoulder stabilization (1)
- siRNA analysis (1)
- siRNA lipid nanoparticles (LNPs) (1)
- siRNA quantification (1)
- sialic acid (1)
- signal transduction (1)
- signaling (1)
- simulation (1)
- single-cell RNA sequencing (1)
- single-cell proteomics (1)
- skin diseases (1)
- sleep (1)
- sleep deprivation (1)
- sleep disordered breathing (1)
- sleep quality (1)
- small bowel (1)
- small leucine-rich proteoglycans (1)
- small ubiquitin-related modifier (1)
- smoking behavior (1)
- smooth muscle cell (1)
- social anxiety (1)
- social communication (1)
- social recognition (1)
- socio-economic influences (1)
- socioeconomic factors (1)
- soft tissue sarcoma (1)
- software (1)
- solid phase reagent chemistry (1)
- solid tumor (1)
- sonoSens (1)
- sonography (1)
- sorafenib (1)
- sound localization (1)
- sound-induced flash illusion (1)
- spared nerve injury (1)
- sparse imaging (1)
- spatial learning (1)
- spatial specificity (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- species barrier (1)
- specificity (1)
- speech and language pathologist (1)
- sphingosine (1)
- sphingosine 1-phosphate homologues (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine kinase (1)
- spike mutation (1)
- spike protein (1)
- spina bifida (1)
- spinal bone metastasis (1)
- spinal infection (1)
- spinal metastasis (1)
- spine injury (1)
- spinocerebellar ataxia (1)
- splicing (1)
- split-mouth (1)
- sport (1)
- spreading (1)
- sprouting (1)
- sprouting angiogenesis (1)
- squamous cell carcinoma (1)
- stage (1)
- stage migration (1)
- stairs (1)
- standard value (1)
- starvation (1)
- statin (1)
- statin treatment (1)
- statins (1)
- statistics (1)
- steady-state condition (1)
- steatosis (1)
- stem cell transplantation (1)
- stem cells (1)
- stent patency (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stoma (1)
- stomach neoplasms (1)
- storage (1)
- store brands (1)
- stress period (1)
- structure constraints (1)
- structure-function (1)
- structured care program (1)
- strumpellin (1)
- student abuse (1)
- student mistreatment (1)
- study protocol (1)
- stuttering (1)
- subarachnoid hemorrhage (1)
- subdural hematoma (1)
- subgrouping (1)
- subpopulation (1)
- sudden cardiac death (1)
- sulfatides (1)
- sulfur-oxidizing symbiont (1)
- sunitinib (1)
- superficial vein (1)
- superparamagnetic iron oxide nanoparticles (1)
- supplementation (1)
- supply (1)
- support (1)
- suprachiasmatic nucleus (1)
- surface antigen mutant (1)
- surgical complications (1)
- surgical procedures (1)
- surrogate ELISA (1)
- susceptibility testing (1)
- swallowing (1)
- swarming (1)
- symbiosis (1)
- sympathetic (1)
- sympathetic nervous system (1)
- symptoms (1)
- synaesthesia (1)
- synoviocytes (1)
- synovitis (1)
- synovium (1)
- tDCS (1)
- tVNS (1)
- tZVK (1)
- tachycardia (1)
- taller-than-wide (1)
- target (1)
- targeted axillary dissection (1)
- targeted sequencing (1)
- taste buds (1)
- tauopathies (1)
- tauopathy (1)
- teambasierte Intervention (1)
- temporal encephaloceles (1)
- testosterone (1)
- tetracycline (1)
- tetrahydroaldosterone (1)
- tetrahydrobiopterin (1)
- tetrahydrocannabinol (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapy monitoring (1)
- therapy response (1)
- thermal ablation (1)
- theta band (1)
- thrombectomy (1)
- thrombin (1)
- thrombin injection (1)
- thromboembolism (1)
- thrombophilia (1)
- thrombospondins (1)
- thromboxane (1)
- thymic selection (1)
- thyroid functioning (1)
- tibial fracture (1)
- tight junctions (1)
- tip cell filopodia formation (1)
- tissue microstructure (1)
- tissue reconstruction (1)
- tissue segmentation (1)
- tivantinib (1)
- toddler’s fracture (1)
- tolerability (1)
- tolerance (1)
- tooth transplantation (1)
- topical administration (1)
- topographical pattern (1)
- topoisomerase inhibitor (1)
- toric intraocular lens (1)
- torticollis (1)
- total knee replacement (1)
- total protein determination in urine (1)
- total thyroidectomy (1)
- total urinary protein (1)
- totale Thyreoidektomie (1)
- toxic milk mice (TX mice) (1)
- toxicity (1)
- trabecular metal (1)
- trace elements (1)
- tracking (1)
- traditional Chinese medicine (TCM) (1)
- traffic emissions (1)
- trafficking (1)
- training (1)
- trans (1)
- transarterielle Chemoembolisation (1)
- transcription (1)
- transcription factors (1)
- transcriptional cyclin-dependent kinase (1)
- transcriptome (1)
- transcriptomics (1)
- transduction (1)
- transfer entropy (1)
- transferrin (1)
- transforming growth factor-β (1)
- transfusion medicine (1)
- transgenic mice (1)
- transglutaminase (1)
- transient elastography (1)
- transjugular intrahepatic portosystemic shunt (1)
- translation (1)
- translational investigation (1)
- translational study (1)
- translatome (1)
- translatomics (1)
- transmission (1)
- transovarial transmission (1)
- transplant-free survival (1)
- transplantation (1)
- transstadial transmission (1)
- trauma registry (1)
- trauma-related guilt (1)
- trauma-related shame (1)
- traumatic injury (1)
- traumaticbraininjury(TBI) (1)
- treatment outcome (1)
- treatment resistance (1)
- treatment response (1)
- trials registry (1)
- triglycerides (1)
- trimeric autotransporters adhesin (1)
- triplex (1)
- trophoblast organoids (1)
- trophoblasts (1)
- trough levels (1)
- tuberous sclerosis complex (1)
- tumor (1)
- tumor growth (1)
- tumor immunity (1)
- tumor immunology (1)
- tumor marker (1)
- tumor spheroids (1)
- tumor stroma (1)
- tumor therapy (1)
- tumor-associated macrophages (TAM) (1)
- tunnel technique (1)
- type 1 diabetes (1)
- type 2 diabetes (1)
- tyrosin kinases (1)
- tyrosine hydroxylase (1)
- tyrosine kinase inhibitor (TKI) (1)
- tyrosine kinase receptor signaling (1)
- ubiquitin hydrolase (1)
- ubiquitin ligase (1)
- ultra-high risk for psychosis (1)
- ultrasonic cleaning (1)
- ultrasound (1)
- unacceptable antigen mismatches (1)
- unangemessene Behandlung (1)
- unconventional T cell (1)
- undifferentiated pleomorphic sarcoma (1)
- unilateral (1)
- unilateral hip osteoarthritis (1)
- unmethylated MGMT (1)
- upper tract urothelial carcinoma (1)
- upstaging (1)
- ureteroscopy (1)
- urethal stricture (1)
- urethral stricture (1)
- urethroplasty (1)
- uropathogenic enterobacteriacae (1)
- urothelial carcinoma (1)
- ursodeoxycholic acid (1)
- uterine wall (1)
- uveal melanoma (1)
- v-ATPase (1)
- vaccination rates (1)
- vaccine uptake rate (1)
- vaccine, (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- vaginal breech (1)
- vaginal hysterectomy (1)
- validation (1)
- variable silent delay (1)
- variant of concern (1)
- variants of concern (1)
- vascular disease (1)
- vascular integrity (1)
- vasodilation (1)
- vector (1)
- vemurafenib (1)
- venous thromboembolic events (1)
- venous thromboembolism (1)
- ventral otoplasty (1)
- ventral striatum (1)
- ventral tegmental area (1)
- ventralis intermedius nucleus (1)
- ventricular tachycardia (1)
- venöse Thromboembolie (1)
- vergence (1)
- vergüenza asociada a trauma (1)
- vertical transmission (1)
- vertigo (1)
- very high-risk (1)
- very low density lipoproteins (1)
- vestibular function (1)
- viral contamination (1)
- viral fitness (1)
- viral load (1)
- viral replication (1)
- virologic agents (1)
- virologic failure (1)
- virologische Erreger (1)
- virology (1)
- virus (1)
- virus (genome) detection. (1)
- virus detection (1)
- virus isolation (1)
- virus pneumonia (1)
- virus-safety (1)
- visual cortex (1)
- visual search (VS) (1)
- vitamin d (1)
- vitamin d-deficiency (1)
- vitamin k antagonists (1)
- vocational (1)
- volumetric measurement technology (1)
- von Willebrand disease (1)
- von Willebrand's disease (1)
- von-Willebrand-Syndrom (1)
- voxel-wise analyses (1)
- wastewater-based epidemiology (WBE) (1)
- wearable sensors (1)
- wearable-cardioverter defibrillator (1)
- whole genome pooled sequencing (1)
- whole-genome sequencing (1)
- wissensbasierte Systeme (1)
- wochenbettdepression (1)
- women (1)
- work place evaluation (1)
- workflow development (1)
- wound exudate (1)
- wound healing (1)
- wound infection (1)
- wound repair (1)
- xenograft (1)
- yellow fever mosquito (1)
- yellow flags (1)
- younger (1)
- zinc (1)
- zinc protoporphyrin (1)
- zirkulierende Tumorzellen (1)
- Öffentlichkeit (1)
- Übergewicht (1)
- Übertragung (1)
- ß-amyloid (1)
- β-HCG (1)
- β-ᴅ-2′-Deoxyribosides (1)
- β2-adrenoceptor (1)
- fibrogenesis (1)
- fingolimod (1)
Institute
- Medizin (2612)
- Biowissenschaften (32)
- Biochemie und Chemie (30)
- Biochemie, Chemie und Pharmazie (29)
- Georg-Speyer-Haus (25)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (19)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (19)
- Präsidium (17)
- Frankfurt Institute for Advanced Studies (FIAS) (16)
- Ernst Strüngmann Institut (12)
• Mexican and German populations of L. sericata differ in their development times.
• Mexican L. sericata had a shorter development time at 20°C than German flies.
• At 30 °C, German L. sericata pupariated and eclosed earlier than the Mexican flies.
• Differences in study design make the comparison of developmental studies difficult.
Abstract
The cosmopolitan blow fly Lucilia sericata is often used in forensic case work for estimating the minimum postmortem interval (PMImin). For this, the age of immature specimens developing on the dead body is calculated by measuring the time taken to reach the sampled developmental stage at a given temperature. To test whether regional developmental data of L. sericata is valid on a global scale, the time taken to reach different developmental stages was compared between a population from Mexico and one from Germany at two different constant temperatures.
The German population of L. sericata was collected in Frankfurt/Main, while the Mexican population originated near Oaxaca de Juarez and was transported to Germany in the larval stage. Only the F1 generation was used to avoid adaption of the Mexican flies. Eggs were immediately placed at 20 °C and 30 °C. Five times 30 freshly eclosed larvae per replicate (n = 5) were then transferred to a cup of minced meat in separate containers. The larvae were checked every 8 h for migration, pupariation or emergence of adult flies. The time at which the first individual and 50 % of the specimens per container entered each of these stages, was recorded.
Significant differences in the time of development between the two populations were observed at both temperatures. At 20 °C, the first specimens of the Mexican population reached all developmental stages a little (< 1 day to < 2 days) earlier than the German L. sericata. At 30 °C, the Mexican flies also reached the post-feeding stage slightly earlier (0.2 days). However, at 30 °C, the German flies started pupariation significantly earlier (after 5 days) than the Mexican flies (6.9 days) and the adults from Germany also emerged earlier (10.5 days compared to 13.1 days). The same pattern was observed when looking at 50 % of the total number of specimens per container. A comparison with previously published developmental studies was difficult as the experimental design varied widely between studies. However, the results were within the range of most studies. Our study has shown that age estimation can vary widely depending on the population on which the reference data used for the calculations are based. This highlights the importance of using local and population-specific developmental data for estimating the age of blow flies in case work.
Highlights
• TAM polarization induces CP RNA.
• CP RNA expression is regulated by HIF-2 and STAT1.
• CP RNA is transferred from TAMs to HT1080 cells.
• CP RNA is translated by HT1080 cells and protects from ferroptosis.
• Co-cultured HT1080 cells decrease iron and lipid peroxidation.
Abstract
Solid tumors are characterized by hypoxic areas, which are prone for macrophage infiltration. Once infiltrated, macrophages polarize to tumor associated macrophages (TAM) to support tumor progression. Therefore, the crosstalk between TAMs and tumor cells is of current interest for the development of novel therapeutic strategies. These may comprise induction of an iron- and lipid peroxidation-dependent form of cell death, known as ferroptosis. To study the macrophage - tumor cell crosstalk we polarized primary human macrophages towards a TAM-like phenotype, co-cultured them with HT1080 fibrosarcoma cells, and analyzed the tumor cell response to ferroptosis induction. In TAMs the expression of ceruloplasmin mRNA increased, which was driven by hypoxia inducible factor 2 and signal transducer and activator of transcription 1. Subsequently, ceruloplasmin mRNA was transferred from TAMs to HT1080 cells via extracellular vesicles. In tumor cells, mRNA was translated into protein to protect HT1080 cells from RSL3-induced ferroptosis. Mechanistically this was based on reduced iron abundance and lipid peroxidation. Interestingly, in naïve macrophages also hypoxia induced ceruloplasmin under hypoxia and a co-culture of HT1080 cells with hypoxic macrophages recapitulated the protective effect observed in TAM co-cultures. In conclusion, TAMs provoke tumor cells to release iron and thereby protect them from lipid peroxidation/ferroptosis.
• Mexican and German populations of L. sericata differ in their development times.
• Mexican L. sericata had a shorter development time at 20°C than German flies.
• At 30 °C, German L. sericata pupariated and eclosed earlier than the Mexican flies.
• Differences in study design make the comparison of developmental studies difficult.
Abstract
The cosmopolitan blow fly Lucilia sericata is often used in forensic case work for estimating the minimum postmortem interval (PMImin). For this, the age of immature specimens developing on the dead body is calculated by measuring the time taken to reach the sampled developmental stage at a given temperature. To test whether regional developmental data of L. sericata is valid on a global scale, the time taken to reach different developmental stages was compared between a population from Mexico and one from Germany at two different constant temperatures.
The German population of L. sericata was collected in Frankfurt/Main, while the Mexican population originated near Oaxaca de Juarez and was transported to Germany in the larval stage. Only the F1 generation was used to avoid adaption of the Mexican flies. Eggs were immediately placed at 20 °C and 30 °C. Five times 30 freshly eclosed larvae per replicate (n = 5) were then transferred to a cup of minced meat in separate containers. The larvae were checked every 8 h for migration, pupariation or emergence of adult flies. The time at which the first individual and 50 % of the specimens per container entered each of these stages, was recorded.
Significant differences in the time of development between the two populations were observed at both temperatures. At 20 °C, the first specimens of the Mexican population reached all developmental stages a little (< 1 day to < 2 days) earlier than the German L. sericata. At 30 °C, the Mexican flies also reached the post-feeding stage slightly earlier (0.2 days). However, at 30 °C, the German flies started pupariation significantly earlier (after 5 days) than the Mexican flies (6.9 days) and the adults from Germany also emerged earlier (10.5 days compared to 13.1 days). The same pattern was observed when looking at 50 % of the total number of specimens per container. A comparison with previously published developmental studies was difficult as the experimental design varied widely between studies. However, the results were within the range of most studies. Our study has shown that age estimation can vary widely depending on the population on which the reference data used for the calculations are based. This highlights the importance of using local and population-specific developmental data for estimating the age of blow flies in case work.
Marjan van den Akker, Gesundheitswissenschaftlerin und Epidemiologin : Goethe, Deine Forscher
(2024)
Highlights
• NCoR1 is the most highly expressed endothelial corepressor.
• Loss of NCoR1 promotes angiogenic function in endothelial cells.
• Loss of NCoR1 promotes a tip cell position during angiogenic sprouting.
Abstract
Corepressors negatively regulate gene expression by chromatin compaction. Targeted regulation of gene expression could provide a means to control endothelial cell phenotype. We hypothesize that by targeting corepressor proteins, endothelial angiogenic function can be improved. To study this, the expression and function of nuclear corepressors in human umbilical vein endothelial cells (HUVEC) and in murine organ culture was studied. RNA-seq revealed that nuclear receptor corepressor 1 (NCoR1), silencing mediator of retinoid and thyroid hormone receptors (SMRT) and repressor element-1 silencing transcription factor (REST) are the highest expressed corepressors in HUVECs. Knockout and knockdown strategies demonstrated that the depletion of NCoR1 increased the angiogenic capacity of endothelial cells, whereas depletion of SMRT or REST did not. Interestingly, the effect was VEGF signaling independent. NCoR1 depletion significantly upregulated angiogenesis-associated genes, especially tip cell genes, including ESM1, DLL4 and NOTCH4, as observed by RNA- and ATAC-seq. Confrontation assays comparing cells with and without NCoR1-deficiency revealed that loss of NCoR1 promotes a tip-cell position during spheroid sprouting. Moreover, a proximity ligation assay identified NCoR1 as a direct binding partner of the Notch-signaling-related transcription factor RBPJk. Luciferase assays showed that siRNA-mediated knockdown of NCOR1 promotes RBPJk activity. Furthermore, NCoR1 depletion prompts upregulation of several elements in the Notch signaling cascade. Downregulation of NOTCH4, but not NOTCH1, prevented the positive effect of NCOR1 knockdown on spheroid outgrowth. Collectively, these data indicate that decreasing NCOR1 expression is an attractive approach to promote angiogenic function.
Highlights
• Since there is only a low level of evidence, it is difficult to agree on state-of-the-art standards or to provide recommendations and guidelines.
• The value of combining several monitoring devices for dual or triple guidance must be challenged.
• The principle of fascial plane blocks is suitable to avoid traumatic needle-to-nerve contact. However, local toxicity must be regarded as a possible mechanism for nerve injuries.
• Block procedures might be conducted during sedation or general anesthesia when considering the individual patients' clinical situations and the expertise of the anesthesiologist.
• The quality of ultrasound equipment and education provided by the corresponding anesthesia department is highly relevant
Highlights
• Out of the six edible pumpkin seeds found in Cameroonian C. sativus showed most potent anti-proliferative effects on prostate cells.
• Its oil conserved almost all the effects of raw seeds and prevented benign prostatic hyperplasia (BPH).
• It exhibited potent anti-inflammatory activities in rat with BPH.
Abstract
Pumpkin seeds are claimed to treat prostate tumour/cancer. The in vitro (ability to inhibit cell growth through MTT assay) and in vivo (ability to prevent testosterone-induced BPH in rats at the doses of 125, 250, 500 and 1000 mg/kg BW) of six edible pumpkin seeds found in Cameroonian were assessed. The endpoints were cell growth arrest, prostate mass and volume, prostatic epithelium height, prostatic proteins, prostate specific antigen (PSA) and inflammatory cytokines. In vitro, C. sativus seeds exhibited the most potent antiproliferative effects on DU145 and PC3 prostate cancer cells and its oil conserved almost all the effects of raw seeds. Further, it prevented the increased of prostate relative mass and volume, prostate epithelium height, PSA and testosterone dose-dependently compared to normal rats. This effect is thought to be mediated through antiandrogenic, estrogenic and anti-inflammatory activities, evidenced by a decreased in IL-1β, IL-6 and TNFα level. Overall, this results justify its traditional use.
Viruses that carry a positive-sense, single-stranded (+ssRNA) RNA translate their genomes soon after entering the host cell to produce viral proteins, with the exception of retroviruses. A distinguishing feature of retroviruses is reverse transcription, where the +ssRNA genome serves as a template to synthesize a double-stranded DNA copy that subsequently integrates into the host genome. As retroviral RNAs are produced by the host cell transcriptional machinery and are largely indistinguishable from cellular mRNAs, we investigated the potential of incoming retroviral genomes to directly express proteins. Here we show through multiple, complementary methods that retroviral genomes are translated after entry. Our findings challenge the notion that retroviruses require reverse transcription to produce viral proteins. Synthesis of retroviral proteins in the absence of productive infection has significant implications for basic retrovirology, immune responses and gene therapy applications.
Bipolar disorder (BD) is a heritable mental illness with complex etiology. While the largest published genome-wide association study identified 64 BD risk loci, the causal SNPs and genes within these loci remain unknown. We applied a suite of statistical and functional fine-mapping methods to these loci, and prioritized 22 likely causal SNPs for BD. We mapped these SNPs to genes, and investigated their likely functional consequences by integrating variant annotations, brain cell-type epigenomic annotations, brain quantitative trait loci, and results from rare variant exome sequencing in BD. Convergent lines of evidence supported the roles of SCN2A, TRANK1, DCLK3, INSYN2B, SYNE1, THSD7A, CACNA1B, TUBBP5, PLCB3, PRDX5, KCNK4, AP001453.3, TRPT1, FKBP2, DNAJC4, RASGRP1, FURIN, FES, YWHAE, DPH1, GSDMB, MED24, THRA, EEF1A2, and KCNQ2 in BD. These represent promising candidates for functional experiments to understand biological mechanisms and therapeutic potential. Additionally, we demonstrated that fine-mapping effect sizes can improve performance and transferability of BD polygenic risk scores across ancestrally diverse populations, and present a high-throughput fine-mapping pipeline (https://github.com/mkoromina/SAFFARI).
Beyond well-established difficulties with working memory in individuals with attention deficit hyperactivity disorder (ADHD), evidence is emerging that other memory processes may also be affected. We investigated, first, which memory processes show differences in adults and adolescents with ADHD in comparison to control participants, focusing on working and short-term memory, initial learning, interference, delayed and recognition memory. Second, we investigated whether ADHD severity, co-occurring depressive symptoms, IQ and physical fitness are associated with the memory performance in the individuals with ADHD.
We assessed 205 participants with ADHD (mean age 25.8 years, SD 7.99) and 50 control participants (mean age 21.1 years, SD 5.07) on cognitive tasks including the digit span forward (DSF) and backward (DSB), the Rey Auditory Verbal Learning Test (RAVLT), and the vocabulary and matrix reasoning subtests of the Wechsler Abbreviated Scale of Intelligence. Participants with ADHD were additionally assessed on ADHD severity, depression symptoms and cardiorespiratory fitness. A series of regressions were run, with sensitivity analyses performed when variables were skewed.
ADHD-control comparisons were significant for DSF, DSB, delayed and recognition memory, with people with ADHD performing less well than the control participants. The result for recognition memory was no longer significant in sensitivity analysis. Memory performance was not associated with greater ADHD or depression symptoms severity. IQ was positively associated with all memory variables except DSF. Cardiorespiratory fitness was negatively associated with the majority of RAVLT variables.
Individuals with ADHD showed difficulties with working memory, short-term memory and delayed memory, as well as a potential difficulty with recognition memory, despite preserved initial learning.
Targeted protein degradation (TPD) has recently emerged as an exciting new drug modality. However, the strategy of developing small molecule-based protein degraders has evolved over the past two decades and has now established molecular tags that are already in clinical use, as well as chimeric molecules, PROteolysis TArgeting Chimeras (PROTACs), based mainly on ligand systems developed for the two E3 ligases CRBN and VHL. The large size of the human E3 ligase family suggests that PROTACs can be developed by targeting a large diversity of E3 ligases, some of which have restricted expression patterns with the potential to design disease- or tissue-specific degraders. Indeed, many new E3 ligands have been published recently, confirming the druggability of E3 ligases. This review summarises recent data on E3 ligases and highlights the challenges in developing these molecules into efficient PROTACs rivalling the established degrader systems.
PET probes targeting fibroblasts are frequently used for varying applications in oncology. In recent years, the clinical spectrum has been expanded towards cardiovascular medicine, e.g., after myocardial infarction, in aortic stenosis or as a non-invasive read-out of atherosclerosis. We herein provide a brief overview of the current status of this PET radiotracer in the context of cardiovascular disease, including translational and clinical evidence. In addition, we will also briefly discuss future applications, e.g., the use of fibroblast-targeting PET to investigate bilateral organ function along the cardiorenal axis.
Highligthts
• Marburg virus infects and replicates in primary human proximal tubular cells (PTC).
• Transcriptome analyses at multiple time points revealed a profound inflammatory response by IFNα, -y and TNFα signaling.
• Among the strongly downregulated gene sets were targets of the transcription factors MYC and E2F, the G2M checkpoint, as well as oxidative phosphorylation.
• Importantly, the downregulated factors comprise PGC-1α, a key factor in mitochondrial biogenesis and renal energy homeostasis, to be substantially downregulated in MARV-infected PTC.
• Our results suggest inflammation-induced changes in tubular energy metabolism as a possible factor in MARV-associated tubular dysfunction.
Abstract
Marburg virus, a member of the Filoviridae, is the causative agent of Marburg virus disease (MVD), a hemorrhagic fever with a case fatality rate of up to 90 %. Acute kidney injury is common in MVD and is associated with increased mortality, but its pathogenesis in MVD remains poorly understood. Interestingly, autopsies show the presence of viral proteins in different parts of the nephron, particularly in proximal tubular cells (PTC). These findings suggest a potential role for the virus in the development of MVD-related kidney injury. To shed light on this effect, we infected primary human PTC with Lake Victoria Marburg virus and conducted transcriptomic analysis at multiple time points. Unexpectedly, infection did not induce marked cytopathic effects in primary tubular cells at 20 and 40 h post infection. However, gene expression analysis revealed robust renal viral replication and dysregulation of genes essential for different cellular functions. The gene sets mainly downregulated in PTC were associated with the targets of the transcription factors MYC and E2F, DNA repair, the G2M checkpoint, as well as oxidative phosphorylation. Importantly, the downregulated factors comprise PGC-1α, a well-known factor in acute and chronic kidney injury. By contrast, the most highly upregulated gene sets were those related to the inflammatory response and cholesterol homeostasis. In conclusion, Marburg virus infects and replicates in human primary PTC and induces downregulation of processes known to be relevant for acute kidney injury as well as a strong inflammatory response.
Background: Urachal cancer (UrC) is a rare disease with limited availability of representative incidence and clinical data. Although, the prevalence is accounting for less than 1% of bladder tumors, the 5-year survival rate is around only 50% for patients with resectable tumors, and even worse for patients with metastatic disease. Due to the lack of comprehensive prospective studies, our current knowledge of UrC is still limited.
Objective: The present study aimed to summarize the available registry-based studies with unselected UrC patients to evaluate its incidence and clinicopathological characteristics.
Material and methods: We conducted a systematic literature search of registry-based UrC publications on the 15th of May 2023 in 5 databases, which identified 4,748 publications. After duplicate removal and selection by 2 independent investigators, 6 publications proved to be appropriate for the final meta-analysis. Estimated incidence and clinicopathological parameters were extracted.
Results: Estimated incidence ranged between 0.022 and 0.060/ 100.000 person-years, with the highest occurrence in Japan and the lowest in Canada, while the random effect model calculated an overall incidence rate of 0.04 (95%CI: 0.03–0.05) 100.000 person-years. The median age at first diagnosis was 60 years (range: 58–64). The female to male ratio was 2:3. Lymph node or distant metastases were present in 9% and 14% of patients. The predominant tumour type was adenocarcinoma (86%) followed by urothelial carcinoma (12%) and squamous cell carcinoma (2%). The 5-year survival rate was 51.0% with 95%CI: 45.2–57.4.
Conclusions: Our study provides an up-to-date comparison of estimated incidence rates between 6 countries of 3 continents based on rigorously selected registry-based studies. The results suggest low incidence rates for UrC with considerable geographic differences. The present meta-analysis provides unbiased registry-based data on the incidence, clinicopathological parameters and survival of UrC.
Understanding the underlying mechanisms that link psychopathology and physical comorbidities in schizophrenia is crucial since decreased physical fitness and overweight pose major risk factors for cardio-vascular diseases and decrease the patients’ life expectancies. We hypothesize that altered reward anticipation plays an important role in this. We implemented the Monetary Incentive Delay task in a MR scanner and a fitness test battery to compare schizophrenia patients (SZ, n = 43) with sex- and age-matched healthy controls (HC, n = 36) as to reward processing and their physical fitness. We found differences in reward anticipation between SZs and HCs, whereby increased activity in HCs positively correlated with overall physical condition and negatively correlated with psychopathology. On the other handy, SZs revealed stronger activity in the posterior cingulate cortex and in cerebellar regions during reward anticipation, which could be linked to decreased overall physical fitness. These findings demonstrate that a dysregulated reward system is not only responsible for the symptomatology of schizophrenia, but might also be involved in physical comorbidities which could pave the way for future lifestyle therapy interventions.
Highlights
• CD62p + exosomes were significantly increased in septic polytrauma-patients, while CD40+, as well as CD49e + exosomes were diminished.
• Exosomal IL-6 concentration in septic patients reflects the systemic IL-6.
• Exosomal IL-10 concentration seemed to be constant in patients and healthy controls.
• Decrease of miR-21 in exosomes was associated with the development of sepsis, while exosomal miR-93, miR-155 and miR-92a were not specifically altered.
Abstract
Sepsis as a severe systemic inflammation leads oftentimes to organ dysfunction and subsequently to death. In polytrauma patients, septic complications represent with 45% the predominant cause of late death and are responsible for extremely high costs in the healthcare system. Therefore, clinicians have to detect as early as possible the begin of sepsis to improve the patient's outcome. One new promising diagnostic tool to diagnose septic complications in polytraumatized patients are exosomes.
Plasma samples from polytraumatized patients (Injury Severity Score (ISS) ≥16) which developed sepsis (n = 10) and without sepsis (n = 10), were collected at emergency room (ER), 24h and 5 days after trauma. The EVs subpopulations were investigated by a bead-based multiplex flow cytometry measurement of surface epitopes and were compared with plasma EVs from healthy controls (n = 10). Moreover, exosomal cytokine concentrations were measured via high-sensitive ELISA and were correlated with systemic concentrations. For miRNA cargo analysis, we analysed the miRNAs miR-1298-5p, miR-1262, miR-125b-5p, miR-92a-3p, miR-93-5p, miR-155-5p and miR-21-5p and compared their exosomal concentrations by means of RT-qPCR.
CD62p + exosomes were significantly increased in septic polytrauma-patients (p ≤ 0.05), while CD40+exosomes, as well as CD49e + exosomes were diminished (p ≤ 0.05). Furthermore, we observed that the exosomal IL-6 concentration reflects the systemic IL-6 concentration (r2 = 0.63) and did not significantly alter between patients with and without sepsis. The exosomal IL-10 concentration seemed to be constant in all patients and healthy controls. We observed that a decrease of miR-21-5p in exosomes was associated with the development of sepsis (p ≤ 0.05), while exosomal miR-93-5p, miR-155-5p and miR-92a-3p were not specifically altered in septic patients.
Taken together, the present study in polytraumatized patients demonstrated that the development of sepsis is associated with an increase of CD62p + exosomes. Furthermore, the exosomal cargo was changed in septic patients: miR-21-5p was diminished.
Highlights
• Artificial intelligence systems for mechanically ventilated patients are increasing.
• The clinical and financial impact of these models are often unexamined.
• We developed a generic health-economic model for artificial intelligence systems.
• This model assesses the cost-effectiveness for many different scenarios.
• The developed framework is easily adjustable to other (clinical) situations.
Abstract
Purpose: The health and economic consequences of artificial intelligence (AI) systems for mechanically ventilated intensive care unit patients often remain unstudied. Early health technology assessments (HTA) can examine the potential impact of AI systems by using available data and simulations. Therefore, we developed a generic health-economic model suitable for early HTA of AI systems for mechanically ventilated patients.
Materials and methods: Our generic health-economic model simulates mechanically ventilated patients from their hospitalisation until their death. The model simulates two scenarios, care as usual and care with the AI system, and compares these scenarios to estimate their cost-effectiveness.
Results: The generic health-economic model we developed is suitable for estimating the cost-effectiveness of various AI systems. By varying input parameters and assumptions, the model can examine the cost-effectiveness of AI systems across a wide range of different clinical settings.
Conclusions: Using the proposed generic health-economic model, investors and innovators can easily assess whether implementing a certain AI system is likely to be cost-effective before an exact clinical impact is determined. The results of the early HTA can aid investors and innovators in deployment of AI systems by supporting development decisions, informing value-based pricing, clinical trial design, and selection of target patient groups.
Highlights
• Deletion of SPPL3 promotes resistance of malignant B cells to NK cell cytotoxicity
• Loss of SPPL3 blocks ligand binding to NK receptors via increased N-glycosylation
• B3GNT2 deletion reduces LacNAc addition and restores SPPL3-KO cell sensitivity to NK cells
• SPPL3-deficient cells are enriched in tetra-antennary N-glycans with LacNAc elongations
Summary
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells can persist by evading immune surveillance. To investigate the genetic mechanisms underlying this evasion, we perform a genome-wide CRISPR screen using B lymphoblastoid cells. SPPL3, a peptidase that cleaves glycosyltransferases in the Golgi, emerges as a top hit facilitating evasion from NK cytotoxicity. SPPL3-deleted cells accumulate glycosyltransferases and complex N-glycans, disrupting not only binding of ligands to NK receptors but also binding of rituximab, a CD20 antibody approved for treating B cell cancers. Notably, inhibiting N-glycan maturation restores receptor binding and sensitivity to NK cells. A secondary CRISPR screen in SPPL3-deficient cells identifies B3GNT2, a transferase-mediating poly-LacNAc extension, as crucial for resistance. Mass spectrometry confirms enrichment of N-glycans bearing poly-LacNAc upon SPPL3 loss. Collectively, our study shows the essential role of SPPL3 and poly-LacNAc in cancer immune evasion, suggesting a promising target for cancer treatment.
Background: Trauma-related guilt and shame are crucial for the development and maintenance of PTSD (posttraumatic stress disorder). We developed an intervention combining cognitive techniques with loving-kindness meditations (C-METTA) that specifically target these emotions. C-METTA is an intervention of six weekly individual treatment sessions followed by a four-week practice phase.
Objective: This study examined C-METTA in a proof-of-concept study within a randomized wait-list controlled trial.
Method: We randomly assigned 32 trauma-exposed patients with a DSM-5 diagnosis to C-METTA or a wait-list condition (WL). Primary outcomes were clinician-rated PTSD symptoms (CAPS-5) and trauma-related guilt and shame. Secondary outcomes included psychopathology, self-criticism, well-being, and self-compassion. Outcomes were assessed before the intervention phase and after the practice phase.
Results: Mixed-design analyses showed greater reductions in C-METTA versus WL in clinician-rated PTSD symptoms (d = −1.09), guilt (d = −2.85), shame (d = −2.14), psychopathology and self-criticism.
Conclusion: Our findings support positive outcomes of C-METTA and might contribute to improved care for patients with stress-related disorders. The study was registered in the German Clinical Trials Register (DRKS00023470).
HIGHLIGHTS
C-METTA is an intervention that addresses trauma-related guilt and shame and combines cognitive interventions with loving-kindness meditations.
A proof-of-concept study was conducted examining C-METTA in a wait-list randomized controlled trial
C-METTA led to reductions in trauma-related guilt and shame and PTSD symptoms.
Background: Despite known clinical benefits, guideline-recommended heart rate (HR) control is not achieved for a significant proportion of patients with HF with reduced ejection fraction. The wearable cardioverter-defibrillator (WCD) provides continuous HR monitoring and alerts that could aid medication titration.
Objective: This study sought to evaluate sex differences in achieving guideline-recommended HR control during a period of WCD use.
Methods: Data from patients fitted with a WCD from 2015 to 2018 were obtained from the manufacturer’s database (ZOLL). The proportion of patients with adequate nighttime resting HR control at the beginning of use (BOU) and at the end of use (EOU) were compared by sex. Adequate HR control was defined as having a nighttime median HR <70 beats/min.
Results: A total of 21,440 women and a comparative sample of 17,328 men (median 90 [IQR 59–116] days of WCD wear) were included in the final dataset. Among patients who did not receive a shock, over half had insufficient HR control at BOU (59% of women, 53% of men). Although the proportion of patients with resting HR ≥70 beats/min improved by EOU, 43% of women and 36% of men did not achieve guideline-recommended HR control.
Conclusion: A significant proportion of women and men did not achieve adequate HR control during a period of medical therapy optimization. Compared with men, a greater proportion of women receiving WCD shocks had insufficiently controlled HR in the week preceding ventricular tachyarrhythmia/ventricular fibrillation and 43% of nonshocked women, compared with 36% of men, did not reach adequate HR control during the study period. The WCD can be utilized as a remote monitoring tool to record HR and inform adequate uptitration of beta-blockers, with particular focus on reducing the treatment gap in women.
Evidence-based and comprehensible health information is a key element of evidence-based medicine and public health. The goal is informed decision-making based on realistic estimations of health risks and accurate expectations about benefits and harms of interventions. In Germany, standards of evidence-based risk information were poorly followed during the COVID-19 pandemic. Frequently, public information was biased, fragmentary and misleading. Pandemic-related threat scenarios induced emotional distress and unnecessary anxiety. A systematic and comprehensive evaluation of the pandemic measures is crucial, but still pending in Germany. A critical analysis of risk communication by experts, politicians and the media during the pandemic should be a key element of the evaluation process. Evaluation of decision making and media reporting during the pandemic should improve preparedness for future crises.
The ICH M13A draft bioequivalence guideline allows the exclusion of very low plasma profiles from the statistical evaluation in exceptional cases, i.e., if such phenomenon occurs due to non-compliance of subjects (not swallowing the product). Moreover, the draft ICH guideline requests additional bioequivalence studies for medicinal products with pH-dependent solubility after concomitant administration of gastric pH modifying preparations, e.g., proton pump inhibitors. Both regulations are scientifically sound, however, would need further specification. Main problem in this context is that compounds with very low solubility and slow intrinsic dissolution in the intestinal environment will cause significant bioavailability problems if their solid oral dosage forms are emptied from the stomach undisintegrated. Also very low plasma profiles may result under these circumstances. Such cases can occur accidentally and are not resultant of non-compliance. Thus, limitation for one case per study only as suggested in the guideline is not justified.
Therapierefraktärer Schmerz ist ein weit verbreitetes, äußerst belastendes Leitsymptom rheumatischer Erkrankungen. Viele Betroffene weichen daher bei Versagen der Standardmedikation selbstständig auf Cannabis oder die strukturell verwandte Substanz Palmitoylethanolamid (PEA) als Add-On- oder Alternativtherapie aus, obwohl dies in Deutschland bisher nur eingeschränkt zulässig ist. Die deutsche Gesetzgebung ist diesbezüglich nicht eindeutig, weshalb Ärzt:innen in ihrer Entscheidung, Cannabis zu verschreiben, auf Leitlinien, Fallberichte und Expert:innenmeinungen zurückgreifen müssen. Dies führt zu schwierigen Einzelfallentscheidungen, da sich die derzeitige Datenlage zu Cannabis-based Medicine (CBM) bzw. PEA und Rheuma als mangelhaft darstellt und die Leitlinien dementsprechend keine klaren Empfehlungen enthalten. Ziel der vorliegenden Arbeit ist es, die vorhandene Evidenz zusammenzufassen, zu ordnen und anhand der Hill-Kriterien den möglichen kausalen Zusammenhang zwischen der Einnahme von CBM bzw. PEA und der analgetischen Wirkung bei Rheumaschmerzen zu prüfen.
Lifestyle factors—such as diet, physical activity (PA), smoking, and alcohol consumption—have a significant impact on mortality as well as healthcare costs. Moreover, they play a crucial role in the development of type 2 diabetes mellitus (DM2). There also seems to be a link between lifestyle behaviours and insulin resistance, which is often a precursor of DM2. This study uses an enhanced Healthy Living Index (HLI) integrating accelerometric data and an Ecological Momentary Assessment (EMA) to explore differences in lifestyle between insulin-sensitive (IS) and insulin-resistant (IR) individuals. Moreover, it explores the association between lifestyle behaviours and inflammation. Analysing data from 99 participants of the mPRIME study (57 women and 42 men; mean age 49.8 years), we calculated HLI scores—ranging from 0 to 4— based on adherence to specific low-risk lifestyle behaviours, including non-smoking, adhering to a healthy diet, maximally moderate alcohol consumption, and meeting World Health Organization (WHO) PA guidelines. Insulin sensitivity was assessed using a Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and C-reactive protein (CRP) levels were used as a proxy for inflammation. Lifestyle behaviours, represented by HLI scores, were significantly different between IS and IR individuals (U = 1529.0; p = 0.023). The difference in the HLI score between IR and IS individuals was mainly driven by lower adherence to PA recommendations in the IR group. Moreover, reduced PA was linked to increased CRP levels in the IR group (r = −0.368, p = 0.014). Our findings suggest that enhancing PA, especially among individuals with impaired insulin resistance, holds significant promise as a preventive strategy.
MicroRNAs (miRNAs) are critical post-transcriptional regulators in many biological processes. They act by guiding RNA-induced silencing complexes to miRNA response elements (MREs) in target mRNAs, inducing translational inhibition and/or mRNA degradation. Functional MREs are expected to predominantly occur in the 3’ untranslated region and involve perfect base-pairing of the miRNA seed. Here, we generate a high-resolution map of miR-181a/b-1 (miR-181) MREs to define the targeting rules of miR-181 in developing murine T-cells. By combining a multi-omics approach with computational high-resolution analyses, we uncover novel miR-181 targets and demonstrate that miR-181 acts predominantly through RNA destabilization. Importantly, we discover an alternative seed match and identify a distinct set of targets with repeat elements in the coding sequence which are targeted by miR-181 and mediate translational inhibition. In conclusion, deep profiling of MREs in primary cells is critical to expand physiologically relevant targetomes and establish context-dependent miRNA targeting rules.
Key Points:
* Deep profiling identifies novel targets of miR-181 associated with global gene regulation.
* miR-181 MREs in repeat elements in the coding sequence act through translational inhibition.
* High-resolution analysis reveals an alternative seed match in functional MREs.
Inflammation is a regulated reaction of the body to control a threat such as infection or injury. An efficient resolution of inflammation is critical to prevent the development of chronic inflammation and to restore tissue homeostasis. Macrophages (Mf) play a crucial role in the onset, but also in the resolution of inflammation, because they phagocytose and eliminate pathogens and tissue debris. Efficient efferocytosis, i.e. the engulfment of apoptotic cells, represents an important trigger for the onset of the resolution response and contributes to the pro-resolving reprogramming of Mf. Despite the importance of post- transcriptional modes of regulation during the resolution phase and translational control as a key node modulating gene expression in immune cells, relevant translational alterations remain largely elusive.
In the present study, I aimed to identify translationally regulated targets in inflammatory primary murine Mf upon resolution-promoting efferocytosis. To this end, I used total RNA-sequencing as well as de novo proteomics analyses to determine global transcriptional and translational changes. Sequencing data confirmed that efferocytosis induced a pro-resolution signature in inflammatory Mf and pointed towards translational regulation because the related integrated stress response was enriched upon efferocytosis. While changes of gene expression between efferocytic and non-efferocytic Mf appeared rather small at the transcriptional level, I observed considerable differences at the level of de novo synthesized proteins. This finding suggests a regulation at the level of translation. Furthermore, the tight connection between translational and metabolic changes was confirmed by enriched metabolism-associated terms of targets upregulated by efferocytosis at both RNA and de novo protein level. Interestingly, analysis of translationally regulated targets in response to inflammatory stimulation showed reduced translation for most targets, with only little impact of efferocytosis. Among those targets, I identified pro-resolving matrix metallopeptidase 12 (Mmp12) as a novel candidate, which showed translational repression during early inflammation and translational increase during the resolution phase. Noteworthy, a first indicator for a potential translation regulatory component of Mmp12 were the extremely high mRNA levels and not overly high de novo protein levels. Validation experiments recapitulated a slight elevation of Mmp12 mRNA expression and a significant downregulation of MMP12 intracellular protein levels in inflammatory Mf, as observed in the RNA-seq and de novo proteomics datasets. To investigate whether the discrepancy in mRNA and protein expression were due to changes in translation, I applied polysomal fractionation analysis to determine the translational status of Mmp12. Inflammatory Mf displayed a significantly lower relative Mmp12 mRNA abundance in the late polysomes compared to naïve Mf, suggesting reduced translational efficiency upon inflammatory stimulation. Consequently, extracellular MMP12 levels in the supernatant of inflammatory Mf decreased, although with a slight delay.
The functional impact of attenuated Mmp12 translation upon inflammatory stimulation was assessed in migration assays. While siRNA-mediated knockdown of Mmp12 did not alter Mf migration on uncoated plates, it increased migration 3-fold on matrigel/elastin-coated plates. Importantly, the increase in migrated distance driven by siMmp12 could be lowered by the addition of exogenous recombinant MMP12 protein. In line with reduced Mmp12 translation and MMP12 protein in inflammatory Mf, I observed a significant increase in cell migration on matrigel/elastin-coated plates, while it remained unaltered on uncoated plates. Consequently, Mf elastase MMP12 degrades elastin, thereby cell migration along elastin fibers is diminished. In inflammatory Mf, Mmp12 is translationally downregulated, thereby enhancing the migratory capacity.
In summary, the present study identifies a substantial contribution of translational regulation in the course of inflammation shown by high changes between inflammatory naïve and efferocytic Mf at the de novo proteomic level. Specifically, I was able to determine the translational regulation of pro-resolving Mmp12, which is repressed during early inflammation and recovers during the resolution phase. Functionally, translational control of MMP12 emerged as a strategy to alter the migratory properties of Mf, enabling enhanced, matrix- dependent migration of Mf during the early inflammatory phase, while restricting migration during the resolution phase.
The human immune system is determined by the functionality of the human lymph node. With the use of high-throughput techniques in clinical diagnostics, a large number of data is currently collected. The new data on the spatiotemporal organization of cells offers new possibilities to build a mathematical model of the human lymph node - a virtual lymph node. The virtual lymph node can be applied to simulate drug responses and may be used in clinical diagnosis. Here, we review mathematical models of the human lymph node from the viewpoint of cellular processes. Starting with classical methods, such as systems of differential equations, we discuss the values of different levels of abstraction and methods in the range from artificial intelligence techniques formalism.
Highlights
• Single nucleotide variants (SNVs) may affect transcription factor (TF) binding
• Fast statistical approach to assess significance of differential TF binding for SNVs
• Validate new approach on in vitro and in vivo TF binding assays
• Applications on GWAS SNVs and large eQTL studies illustrate utility
Summary
Non-coding variants located within regulatory elements may alter gene expression by modifying transcription factor (TF) binding sites, thereby leading to functional consequences. Different TF models are being used to assess the effect of DNA sequence variants, such as single nucleotide variants (SNVs). Often existing methods are slow and do not assess statistical significance of results. We investigated the distribution of absolute maximal differential TF binding scores for general computational models that affect TF binding. We find that a modified Laplace distribution can adequately approximate the empirical distributions. A benchmark on in vitro and in vivo datasets showed that our approach improves upon an existing method in terms of performance and speed. Applications on eQTLs and on a genome-wide association study illustrate the usefulness of our statistics by highlighting cell type-specific regulators and target genes. An implementation of our approach is freely available on GitHub and as bioconda package.
Background: Novel treatments are needed to control refractory status epilepticus (SE). This study aimed to assess the potential effectiveness of fenfluramine (FFA) as an acute treatment option for SE. We present a summary of clinical cases where oral FFA was used in SE.
Methods: A case of an adult patient with Lennox–Gastaut syndrome (LGS) who was treated with FFA due to refractory SE is presented in detail. To identify studies that evaluated the use of FFA in SE, we performed a systematic literature search.
Results: Four case reports on the acute treatment with FFA of SE in children and adults with Dravet syndrome (DS) and LGS were available. We report in detail a 30-year-old woman with LGS of structural etiology, who presented with generalized tonic and dialeptic seizures manifesting at high frequencies without a return to clinical baseline constituting the diagnosis of SE. Treatment with anti-seizure medications up to lacosamide 600 mg/d, brivaracetam 300 mg/d, valproate 1,600 mg/d, and various benzodiazepines did not resolve the SE. Due to ongoing refractory SE and following an unremarkable echocardiography, treatment was initiated with FFA, with an initial dose of 10 mg/d (0.22 mg/kg body weight [bw]) and fast up-titration to 26 mg/d (0.58 mg/kg bw) within 10 days. Subsequently, the patient experienced a resolution of SE within 4 days, accompanied by a notable improvement in clinical presentation and regaining her mobility, walking with the assistance of physiotherapists. In the three cases reported in the literature, DS patients with SE were treated with FFA, and a cessation of SE was observed within a few days. No treatment-emergent adverse events were observed during FFA treatment in any of the four cases.
Conclusions: Based on the reported cases, FFA might be a promising option for the acute treatment of SE in patients with DS and LGS. Observational data show a decreased SE frequency while on FFA, suggesting a potentially preventive role of FFA in these populations.
Key points
* We summarize four cases of refractory status epilepticus (SE) successfully treated with fenfluramine.
* Refractory SE resolved after 4–7 days on fenfluramine.
* Swift fenfluramine up-titration was well-tolerated during SE treatment.
* Treatment-emergent adverse events on fenfluramine were not observed.
* Fenfluramine might be a valuable acute treatment option for SE in Dravet and Lennox–Gastaut syndromes.
Tight control over transcription factor activity is necessary for a sensible balance between cellular proliferation and differentiation in the embryo and during tissue homeostasis by adult stem cells, but mechanistic details have remained incomplete. The homeodomain transcription factor MEIS2 is an important regulator of neurogenesis in the ventricular–subventricular zone (V-SVZ) adult stem cell niche in mice. We here identify MEIS2 as direct target of the intracellular protease calpain-2 (composed of the catalytic subunit CAPN2 and the regulatory subunit CAPNS1). Phosphorylation at conserved serine and/or threonine residues, or dimerization with PBX1, reduced the sensitivity of MEIS2 towards cleavage by calpain-2. In the adult V-SVZ, calpain-2 activity is high in stem and progenitor cells, but rapidly declines during neuronal differentiation, which is accompanied by increased stability of MEIS2 full-length protein. In accordance with this, blocking calpain-2 activity in stem and progenitor cells, or overexpression of a cleavage-insensitive form of MEIS2, increased the production of neurons, whereas overexpression of a catalytically active CAPN2 reduced it. Collectively, our results support a key role for calpain-2 in controlling the output of adult V-SVZ neural stem and progenitor cells through cleavage of the neuronal fate determinant MEIS2.
Highlights
• Reduced evoked theta activity in the deaf.
• Reduced theta-gamma and alpha-gamma cross-frequency couplings in the deaf.
• Stronger delta-alpha coupling in the deaf.
Abstract
Neurons within a neuronal network can be grouped by bottom-up and top-down influences using synchrony in neuronal oscillations. This creates the representation of perceptual objects from sensory features. Oscillatory activity can be differentiated into stimulus-phase-locked (evoked) and non-phase-locked (induced). The former is mainly determined by sensory input, the latter by higher-level (cortical) processing. Effects of auditory deprivation on cortical oscillations have been studied in congenitally deaf cats (CDCs) using cochlear implant (CI) stimulation. CI-induced alpha, beta, and gamma activity were compromised in the auditory cortex of CDCs. Furthermore, top-down information flow between secondary and primary auditory areas in hearing cats, conveyed by induced alpha oscillations, was lost in CDCs. Here we used the matching pursuit algorithm to assess components of such oscillatory activity in local field potentials recorded in primary field A1. Additionally to the loss of induced alpha oscillations, we also found a loss of evoked theta activity in CDCs. The loss of theta and alpha activity in CDCs can be directly related to reduced high-frequency (gamma-band) activity due to cross-frequency coupling. Here we quantified such cross-frequency coupling in adult 1) hearing-experienced, acoustically stimulated cats (aHCs), 2) hearing-experienced cats following acute pharmacological deafening and subsequent CIs, thus in electrically stimulated cats (eHCs), and 3) electrically stimulated CDCs. We found significant cross-frequency coupling in all animal groups in > 70% of auditory-responsive sites. The predominant coupling in aHCs and eHCs was between theta/alpha phase and gamma power. In CDCs such coupling was lost and replaced by alpha oscillations coupling to delta/theta phase. Thus, alpha/theta oscillations synchronize high-frequency gamma activity only in hearing-experienced cats. The absence of induced alpha and theta oscillations contributes to the loss of induced gamma power in CDCs, thereby signifying impaired local network activity.
Diese Arbeit hatte das Ziel, die Größe einer DVT-Aufnahme (FOV) mit der Größe der durch die Indikationsstellung definierten Region (ROI) zu vergleichen. Durch eine speziell dafür entwickelte Software sollten Messungen in den Datensätzen ermöglicht werden. Die dazu verwendeten 332 Datensätze wurden zufallsverteilt aus den mit einem Orthophos SL-3D DVT-Gerät der Firma Dentsply Sirona in der Poliklinik für zahnärztliche Chirurgie und Implantologie des ZZMK (Carolinum) in Frankfurt angefertigten Röntgenaufnahmen selektiert.
Es wurde die Auswertungssoftware ExRoi entwickelt, mit der die Werte des axialen Durchmessers, die Höhe (vertikale Dimension) sowie die Distanz der Mittelpunkte von FOV und ROI direkt in den Datensätzen bestimmt werden konnten. Zusätzlich wurde festgehalten, welche rechtfertigenden Indikationen gestellt und welche Auflösungsmodi verwendet wurden.
Die Stichprobe bestand aus Aufnahmen mit einem axialen Durchmesser von 8 cm [VOL 1] (n= 76, entsprechend 46,39%), 5 cm Durchmesser [VOL 2] (n = 102, entsprechend 30,72%) und 11 cm Durchmesser [VOL 3] (n= 154, entsprechend 22,89%). 95,18% der Aufnahmen wurden im HD-Modus mit laut Herstellerangaben vier Mal so vielen Aufnahmen im Vergleich zum SD-Modus angefertigt. Hauptindikationen waren Implantat Planung (45,1%) und Planungen komplizierter Zahn-Extraktionen (25,5%).
Die Messungen zum Vergleich des axialen Durchmessers zeigten, dass bei Verwendung des VOL 2 die ROI im Mittel den größten Anteil der FOV nutzt (78,52 %), den kleinsten Anteil nutzt durchschnittlich VOL 1 (56,04 %). Dazwischen liegt VOL 3 (69,12 %). In der Vertikalen nutzt die ROI von VOL 3 mittelwertig den größten Anteil der FOV (81,87 %), den kleinsten Mittelwert hat VOL 1 (58,76 %). VOL 2 liegt zwischen diesen Werten (64,47 %).
In allen Fällen war das FOV größer als die ROI und die ROI lag im Bereich des gewählten FOV.
Die Mittelpunkte von FOV und ROI lagen im Mittel in der axialen Ebene in Abhängigkeit vom gewählten Volumen um rund 9-13 mm auseinander, in der coronalen und sagittalen Ebene um rund 5-6mm.
Aus diesen Ergebnissen kann für das verwendete Gerät eine gute Trefferquote für die ROI abgeleitet werden. Höhe und Durchmesser des FOV hätten in den meisten Fällen kleiner gewählt werden können, liegen aber angesichts der vorhandenen Auswahl-Optionen des Röntgengeräts zur Dimensionierung der Volumina in einem akzeptablen Bereich.
We conducted a systematic review investigating the efficacy and tolerability of adrenocorticotropic hormone (ACTH) and corticosteroids in children with epilepsies other than infantile epileptic spasm syndrome (IESS) that are resistant to anti-seizure medication (ASM). We included retrospective and prospective studies reporting on more than five patients and with clear case definitions and descriptions of treatment and outcome measures. We searched multiple databases and registries, and we assessed the risk of bias in the selected studies using a questionnaire based on published templates. Results were summarized with meta-analyses that pooled logit-transformed proportions or rates. Subgroup analyses and univariable and multivariable meta-regressions were performed to examine the influence of covariates. We included 38 studies (2 controlled and 5 uncontrolled prospective; 31 retrospective) involving 1152 patients. Meta-analysis of aggregate data for the primary outcomes of seizure response and reduction of electroencephalography (EEG) spikes at the end of treatment yielded pooled proportions (PPs) of 0.60 (95% confidence interval [CI] 0.52–0.67) and 0.56 (95% CI 0.43–0.68). The relapse rate was high (PP 0.33, 95% CI 0.27–0.40). Group analyses and meta-regression showed a small benefit of ACTH and no difference between all other corticosteroids, a slightly better effect in electric status epilepticus in slow sleep (ESES) and a weaker effect in patients with cognitive impairment and “symptomatic” etiology. Obesity and Cushing's syndrome were the most common adverse effects, occurring more frequently in trials addressing continuous ACTH (PP 0.73, 95% CI 0.48–0.89) or corticosteroids (PP 0.72, 95% CI 0.54–0.85) than intermittent intravenous or oral corticosteroid administration (PP 0.05, 95% CI 0.02–0.10). The validity of these results is limited by the high risk of bias in most included studies and large heterogeneity among study results. This report was registered under International Prospective Register of Systematic Reviews (PROSPERO) number CRD42022313846. We received no financial support.
Key points
* Systematic review resulting in low to moderately solid evidence on the efficacy and tolerability of adrenocorticotropic hormone (ACTH) and corticosteroid treatment in children with epilepsy other than infantile spasms.
* Meta-analysis based on aggregate data from 2 controlled prospective, 5 uncontrolled prospective, and 31 retrospective studies.
* Pooled data showing a seizure response in 60% and electroencephalography (EEG) response in 56% of patients, with no major differences between drugs. However, 30%–40% of patients relapse after the cessation of treatment.
* The most frequent adverse effects are obesity and Cushing's syndrome, occurring in 70% of patients under continuous treatment for some weeks, but in less than 10% undergoing pulsed, intermittent regimens.
* More prospective, randomized-controlled studies are needed to improve the level of evidence and define the optimal doses and treatment duration.
In Deutschland leidet ca. jeder zehnte Mensch über 40 Jahren an einer chronischen Einschränkung seiner Nierenfunktion. Nicht wenige davon sind im Laufe der Erkrankung auf eine Nierenersatztherapie angewiesen. Die Ursachen für eine Nierenschädigung sind vielfältig. Als neuartiger und vielversprechender Therapieansatz werden aktuell Mesenchymale Stamm-/Stromazellen (MSC) als Therapeutikum für diverse Nierenerkrankungen getestet. Erste Ergebnisse klinischer Phase-I-Studien zeigen, dass MSC sicher als Immunsuppressivum nach Nierentransplantation angewendet werden können. Auch für weitere Erkrankungen der Niere sind erste klinische Studien am Laufen. MSC gelten als regenerativ, immunsupprimierend und antientzündlich. Dennoch gibt es noch einige Limitationen. Nach der Transplantation der Zellen ist das Wachstum der Zellen oft eingeschränkt und es kommt zur vermehrten Apoptose. Auch wird immer wieder ein paradoxes und entzündungsförderndes Verhalten der MSC am Wirkort beobachtet. Ein wichtiger Lösungsansatz ist eine in vitro Vorbehandlung der MSC zur Modulierung der zellulären Eigenschaften. In dieser Arbeit wurden drei Substanzen und Arzneimittel auf ihre Fähigkeit untersucht, die entzündungshemmenden Eigenschaften der MSC zu verbessern und die entzündungsfördernden zu unterdrücken. Der Fokus lag hierbei auf dem Arzneimittel Niclosamid und den beiden bisher noch nicht zugelassenen Substanzen Berberin und Gedunin, die alle in vitro und in vivo bereits erste vielversprechende antientzündliche Wirkungen bewiesen haben. Für diese Arbeit wurden MSC aus Fettgewebe isoliert (ASC) und mit LPS oder einem Cytokin-Mix (Mischung aus TNF-α, IFN-γ und IL-1β) sowie den drei Substanzen stimuliert. Untersucht wurden im Anschluss die mRNA-Expressionen der gängigsten proinflammatorischen (TNF-α, IL-6, TLR-4, ICAM-1, HLA-DR) und antiinflammatorischen Marker (IDO, IL-10), sowie mittels ELISA die Protein-Freisetzung von IL-6 und IL-8. Die vielversprechendsten Ergebnisse ließen sich durch Berberin hervorrufen. Hier zeigte sich eine deutliche Senkung der IL-8-Konzentration im ELISA. Die Anwendung des Gedunin hatte keine signifikante Wirkung auf die ASC. Niclosamid hingegen scheint widererwarten sogar entzündungsfördernd zu wirken, in dem es die IL-6-, ICAM-1-mRNA-Expression steigerte und die IDO-mRNA-Expression absenkte. Unter den drei getesteten Subtanzen hat Berberin die beste Wirkung bewiesen. Nach weiterer Testung könnte eine Anwendung mit Berberin als in vitro Präkonditionierung von MSC vielversprechend sein. Die Verwendung von Niclosamid hingegen sollte vermieden werden, die Wirkung von Gedunin müsste genauer untersucht werden.
Polygene Risikoscores (PRS) integrieren zahlreiche Einzelnukleotid-Polymorphismen (SNP) von meist geringer Effektstärke, um Auskunft über das Erkrankungsrisiko bestimmter Krankheiten zu geben. In dieser Arbeit wurde der PRS zur genetisch generalisierten Epilepsie (GGE) von Leu et al. aus dem Jahr 2019 untersucht, um festzustellen, ob über das Erkrankungsrisiko hinaus noch Korrelationen mit weiteren phänotypischen Eigenschaften von Patienten bestehen. Der Nachweis solcher Zusammenhänge würde eine Prädiktionsfähigkeit des GGE-PRS demonstrieren, die perspektivisch ein Potential für dessen klinische Anwendbarkeit, beispielsweise im Sinne der personalisierten Medizin, aufzeigen könnte.
Die Identifizierung neuer Korrelationen sollte durch Vergleich der Phänotypen von zwei Gruppen von GGE-Patienten mit extrem hohen, beziehungsweise extrem niedrigen PRS-Werten erfolgen. Hierfür wurden von 2256 Patienten aus der Datenbank von Epi25, einem internationalen Forschungskollaborativ zur Erforschung der Relevanz genetischer Faktoren bei der Entwicklung von Epilepsie, die Patienten mit den höchsten (n=59) und den niedrigsten (n=49) GGE-PRS-Werten ausgewählt. Für diese 108 Patienten wurden retrospektive klinische Daten von den jeweiligen Behandlungszentren akquiriert. Hierzu wurde den Studienleitern der Zentren ein Questionnaire mit Fragen zu zahlreichen phänotypischen Parametern der Patienten übermittelt. Die Rücklaufrate war mit 54% gut.
Die so eingeholten Patientendaten wurden anschließend mittels Exaktem Test nach Fisher und Wilcoxon-Rangsummentest statistisch analysiert, um Unterschiede zwischen den Phänotypen beider Gruppen nachzuweisen. Im Falle der Pharmakoresistenz zeichneten sich hierbei zunächst signifikante Unterschiede ab, die ein selteneres Auftreten dieser Eigenschaft für Patienten mit hohen GGE-PRS-Werten implizierten. Diese Ergebnisse waren jedoch nach einer Bonferroni-Korrektur und bei Validierung in einer größeren Kohorte (n=825) nicht mehr signifikant. Für die anderen untersuchten Parameter waren ebenfalls keine signifikanten Unterschiede nachweisbar.
Das Ergebnis, dass für keinen der untersuchten Parameter signifikante Differenzen bestanden, obwohl zwei Kohorten mit extrem gegensätzlichen PRS-Werten untersucht wurden, spricht gegen eine Verwendung des aktuell verfügbaren GGE-PRS als prädiktiver Biomarker über das Erkrankungsrisiko hinaus und somit gegen dessen klinische Anwendbarkeit. Jedoch können die nicht-signifikanten Korrelationen im Falle der Pharmakoresistenz als Hinweis verstanden werden, dass im Bereich der Pharmakotherapie Zusammenhänge zwischen Score und Phänotyp bestehen könnten, die weiterer Untersuchungen in zukünftigen Studien bedürfen. Bei Verwendung eines verbesserten GGE-PRS mit zusätzlichen risikoassoziierten SNP und verfeinerter Wichtung der Effektstärken sowie größerer Kohorten könnten in diesem Bereich möglicherweise auch signifikante Zusammenhänge nachweisbar werden.
Die Appendizitis stellt mit einer Inzidenz von 115 pro 100000 Einwohnern in Deutschland eine der häufigsten Ursachen für ein akutes Abdomen dar. Bakterielle Infektionen sind ein wesentlicher Faktor für die postoperative Morbidität nach Appendektomie.
Ziel dieser prospektiven Studie war es, das Keimspektrum und insbesondere die Prävalenz resistenter Keime bei der akuten Appendizitis zu bestimmen und die Auswirkungen resistenter Keime auf das Auftreten infektiöser Komplikationen zu analysieren. Alle erwachsenen Patient*innen mit akuter Appendizitis, die zwischen April 2022 und Juli 2023 am Universitätsklinikum Frankfurt operativ behandelt wurden, wurden prospektiv eingeschlossen. Das Keimspektrum der Appendix und die Häufigkeit von MRE in Rektalabstrichen wurden analysiert. Die klinischen Daten wurden extrahiert, um die Korrelation des Keimspektrums mit dem Auftreten von postoperativen Komplikationen, Dauer und Art der Antibiotikatherapie und dem postoperativen Verlauf zu evaluieren. 30 Tage nach der Operation wurde ein Follow-up durchgeführt. Insgesamt wurden 105 Patient*innen in die Studie eingeschlossen.
In den Appendixabstrichen gelang ein Erregernachweis bei 67,6 % aller Fälle. Hierbei betrug die Prävalenz von Keimen mit Antibiotikaresistenz 43,8 %, Multipler-Antibiotikaresistenz (MAR) 27,6 % und bei 5,7 % der Fälle gelang ein MRE-Nachweis nach CDC im Appendixabstrich. Beim MRE-Screening konnten im Rektalabstrich bei 11,4 % der Patient*innen ein MRE nachgewiesen werden. In vier Fällen zeigte sich eine Übereinstimmung zwischen rektalen und appendikulären Abstrich, somit betrug die Sensitivität des MRE-Screenings für einen Nachweis multiresistenter Keime in der Appendix lediglich 33,3 % bei einer Spezifität von 86,7 %. In einer univariaten Analyse konnte das Vorliegen eines Diabetes mellitus als Risikofaktor für das Auftreten von Keimen mit Cefuroxim- Resistenz, Multipler-Antibiotikaresistenz (MAR) und MRE identifiziert werden.
Insgesamt erhielten 47,6 % aller Patient*innen postoperativ eine Antibiotikatherapie, von denen erfolgte bei 46 % eine Umstellung der empirischen Antibiose auf eine antibiogramm-gerechte Therapie nach Erhalt des mikrobiologischen Befundes. Insbesondere Patient*innen mit komplizierter Appendizitis erhielten postoperativ eine Antibiotikatherapie, wobei 28 % eine Antibiotikaeskalation benötigten.
Patient*innen, deren Appendixabstriche eine Resistenz gegen maximal ein Antibiotikum aufwiesen, wurden als nicht multiple Resistenz (Nicht-MAR) definiert und mit Patient*innen verglichen, deren Keime mit multipler Antibiotikaresistenz (MAR) waren. Die MAR-Gruppe zeigte im Vergleich zur Nicht-MAR-Gruppe eine höhere Inzidenz postoperativer Komplikationen, insbesondere eine erhöhte Inzidenz von Clavien-Dindo Grad 3 Komplikationen sowie von tiefen postoperativen Wundinfektionen (CDC Grad A3). Weiterhin benötigten Patient*innen der MAR-Gruppe häufiger eine postoperative Antibiotikatherapie und es erfolgte häufiger eine Eskalation der antibiotischen Therapie. Dies ging auch mit einem signifikant verlängerten Krankenhausaufenthalt einher.
Zusammenfassend kann festgestellt werden, dass eine bakterielle Infektion mit Multipler Antibiotikaresistenz bei der akuten Appendizitis häufig auftritt und die Morbidität nach Appendektomie beeinflusst. Die mikrobiologische Untersuchung mittels Appendixabstrich bei operativ behandelten Fällen von akuter komplizierter Appendizitis, die eine postoperative Antibiotikatherapie erfordern, könnte somit eine gezielte und kürzere Antibiotikatherapie ermöglichen. Dies könnte dazu beitragen, längere Krankenhausaufenthalte zu vermeiden, den unnötigen Einsatz unwirksamer Antibiotika zu reduzieren und die Kosten im Gesundheitswesen zu senken.
Einleitung: Die Zentrale Notaufnahme (ZNA) stellt eine Schnittstelle zwischen prä- und innerklinischer Versorgung dar. Das Spektrum der Krankheitsbilder erstreckt sich über jegliche Fachrichtungen und variiert von harmlosen Banalitäten bis zu akuten Notfällen. Eine sichere und suffiziente Primärversorgung ist die Basis eines qualitativ-hochwertigen Gesundheitssystems.2 Verspätete oder falsche Diagnosen in der ZNA sind mit 10-30 % keine Seltenheit.
Dies ist nicht nur für den individuellen Patienten belastend, es bedeutet auch einen zusätzlichen Ressourcenverbrauch und eine finanzielle Belastung für das Gesundheitssystem. Clinical Decision Support Systems (CDSS) haben das Potenzial, sowohl professionelle Anwender als auch Laien bei ihrer Diagnosefindung zu unterstützen. Fragestellung: Ziel der Arbeit ist es herauszufinden, welchen Einfluss der Diagnosezeitpunkt auf das Outcome von Patienten mit Abdominalschmerzen in der ZNA hat und inwiefern ein CDSS das Potenzial hat, die genannten Punkte zu beeinflussen.
Methoden: Es handelte sich um eine prospektive, doppelt verblindete Beobachtungsstudie. Patienten, die sich mit Abdominalschmerzen in der Notaufnahme vorstellten, gaben ihre Symptome in die Ada-App ein. Sowohl die Diagnosevorschläge der App als auch die Verdachtsdiagnosen des behandelnden Arztes wurden dokumentiert und verglichen. Weitere erhobene Parameter waren die Verwendung von apparativer Diagnostik, die vergangene Zeit bis zur endgültigen Diagnosestellung, das Auftreten von Komplikationen, die Komorbidität und Mortalität sowie die Länge des Krankenhausaufenthalts. Das Follow-Up erfolgte zu verschiedenen Zeitpunkten bis zu Tag 90. Für die Analyse wurden die 450 Patienten anhand des Zeitpunkts ihrer Diagnosestellung in Gruppen "früh" (Tag 0) und "spät" (Tag 1-24) eingeteilt.
Ergebnisse: Im Vergleich zur „frühen“ Gruppe, hatte die Gruppe der „spät“ diagnostizierten Patienten einen höheren Anteil von Männern (45.2% (n=168/372) versus 60.3 % (n=47/78); p=0.018), im Schnitt einen höheren Charlson Comorbidity Index (0.7 versus 1.1; p=0.045) und im Schnitt einen höheren RAI-C Score (8.06 versus 9.9; p<0.001) am Tag ihrer Vorstellung. Bei den „spät“ diagnostizierten blieben weniger Patienten komplikationsfrei (57.0 % 49 (n=212/372) versus 17.9% (n=14/78); p<0.001), es traten mehr Major-Komplikationen auf (8.9% (n=33/372) versus 17.9% (n=14/78); p=0.024), analog dazu war der Comprehensive Complication Index höher (13.1 versus 25.6; p<0.001) und sie verweilten länger im Krankenhaus (2.6 Tage versus 6.7 Tage; p<0.001). Zudem nahmen sie signifikant mehr apparative Diagnostik in Anspruch.
Die behandelnden Ärzte konnten in 82.6% der Fälle (n=372/450) am Tag der Vorstellung die korrekte Diagnose stellen. Die Ada-App konnte in insgesamt 52% der Fälle (n=234/450) die korrekte Diagnose unter ihren Diagnoseverschlägen nennen.
Schlussfolgerung: Multimorbide Patienten scheinen anfälliger zu sein für falsche und verspätete Diagnosen. Ein später Diagnosezeitpunkt korreliert mit der vermehrten Nutzung apparativer Diagnostik, einem komplikationsreicheren Verlauf, einer höheren Komorbidität und einem längeren Krankenhausaufenthalt.
Die Ada-App ist den Ärzten zwar unterlegen, dennoch ist Potenzial vorhanden.
Für Ärzte kann die Ada-App eine Unterstützung im Rahmen der Diagnosefindung darstellen. Neben der Ressourcenentlastung kann sie vor Fehlannahmen und frühzeitigen Schlussfolgerungen schützen und auf weitere mögliche Differentialdiagnosen hinweisen. Die Ada-App stellt für Laien mit Sicherheit eine Weiterentwicklung gegenüber der simplen Symptomsuche über das Internet dar, dennoch sollten weitere Studien den Nutzen und die Sicherheit der App überprüfen.
Background: The Association of the Scientific Medical Societies in Germany (AWMF) clinical practice guideline on cochlear implant (CI) treatment, which was updated in 2020, defined the entire process of CI care for the first time. In the present study, the feasibility and results of very early rehabilitation were examined.
Materials and methods: The intervention group (IG) comprised 54 patients in whom rehabilitation was initiated within 14 (maximally 28) days after implantation. Patients with a significantly longer waiting time were included in the control group (CG, n = 21). In addition to the start and duration of rehabilitation, the speech intelligibility achieved with CI was recorded at different timepoints within a 12-month period. In addition, questionnaires were used to assess the effort of fitting the CI processor and the patients’ satisfaction with the outcome as well as the timing of the start of rehabilitation.
Results: Median waiting time between implantation and start of rehabilitation was 14 days in the IG and 106 days in the CG; 92.6% of IG patients were able to start rehabilitation within 14 days. The effect of rehabilitation in the IG was 35 and in the CG 25 percentage points (Freiburg monosyllabic test). After 6 and 12 months of CI use, both groups showed comparable results in the test condition in quiet (IG/CG 6 months: 70%/70%; 12 months: 70%/60%, Freiburg monosyllabic test) and in noise (IG/CG 6 months: −1.1 dB SNR/–0.85 dB SNR; 12 months: −0.65 dB SNR/+0.3 dB SNR, Oldenburg sentence test). Hearing quality assessment scores collected by SSQ (Speech, Spatial and Qualities of Hearing Scale) questionnaire showed better scores in the IG at 6 months, which converged to CG scores at 12 months. The IG was significantly more satisfied with the timing of the start of rehab than the CG. All other data obtained from questionnaires showed no differences between the two groups.
Conclusion: A very early start of inpatient rehabilitation after cochlear implantation was successfully implemented. The rehabilitation was completed within 7 weeks of CI surgery. Comparison of speech recognition test results before and after rehabilitation showed a significant improvement. A clear rehabilitation effect can therefore be demonstrated. Inclusion of CI rehabilitation in the German catalog of follow-up treatments is thus scientifically justified and therefore strongly recommended.
There has been a growing awareness of the need for scientific research to focus on somatic and mental comorbidities in recent years due to the emerging evidence showing their substantial overlap at numerous levels. In this special issue, initiated by members of the EU-funded PRIME consortium (“Prevention and Remediation of Insulin Multimorbidity in Europe; www.prime-study.eu), the focus is on the comorbidities of metabolic disturbances, especially related to insulin signalling dysregulation and mental and neurological disorders. Thus, while obesity, type 2 diabetes, and metabolic syndrome are commonly known to be insulin-related disorders, the last decades have shown that neurodegenerative disorders, such as Alzheimer’s disease, as well as neurodevelopment disorders, such as obsessive-compulsive disorder (OCD), autism spectrum disorders (ASDs) and attention deficit / hyperactivity disorder (ADHD) also fall into this category. The special issue draws together a series of basic and clinical review articles that describe the current knowledge and future perspectives regarding insulin comorbidities across a multidisciplinary group of experts
Although, during the past decades, substantial advances emerged in identifying major local and systemic factors contributing to initiation and progression of osteoarthritis (OA), some neuroendocrine mechanisms are still not understood or even neglected when thinking about novel therapeutic options. One of which is the sympathetic nervous system that exhibits various OA-promoting effects in different tissues of the joint. Interestingly, the β2-adrenoceptor (AR) mediates the majority of these effects as demonstrated by several in vitro, in vivo as well as in clinical studies. This review article does not only summarize studies of the past two decades demonstrating that the β2-AR plays an OA-promoting role in different tissues of the joint but also aims to encourage the reader to think about next-level research to discover novel and innovative preventive and/or therapeutic strategies targeting the β2-AR in OA.
Das Schilddrüsenkarzinom (SK) ist die häufigste bösartige endokrine Tumorerkrankung. Während das nicht-metastasierte und nicht-mutierte papilläre Schilddrüsenkarzinom (PSK) und das follikuläre Schilddrüsenkarzinom (FSK) eine gute Heilungschance aufweisen, zeigen die mutierten und metastasierten Varianten des PSK und FSK sowie das anaplastische Schilddrüsenkarzinom (ASK) weiterhin eine schlechte Prognose. Die Entwicklung von Therapieresistenzen stellen hierbei ein Hauptproblem in der Behandlung des fortgeschrittenen Schilddrüsenkarzinoms dar.
In den letzten Jahren wurden in Studien zunehmend Tumor-initiierende Zellen (TIZ) beschrieben, welche eine kleine Subpopulation von Zellen mit der Fähigkeit zur Selbsterneuerung, Tumorinitiierung und Entwicklung von Therapieresistenzen von Tumoren darstellen. Die Existenz von TIZ wurde auch im SK nachgewiesen. Ein entscheidender Faktor für die Persistenz von TIZ ist die Hypoxie, welche über eine Veränderung des Tumormikromilieus und des Zellmetabolismus zur Entstehung von Therapieresistenzen beiträgt. Ein durch Hypoxie hochreguliertes Enzym ist die Carboanhydrase IX (CAIX). CAIX wird hauptsächlich von Tumorzellen exprimiert und katalysiert die Reaktion von Kohlendioxid zu Bicarbonat und einem Proton und trägt damit zur Säurepufferung der Tumorzelle bei. CAIX stellt somit einen entscheidenden Faktor für das Überleben von Tumorzellen in einem hypoxischen Milieu dar. Des Weiteren ist eine erhöhte Expression von CAIX mit einem schlechten Patienten-Outcome assoziiert, wie z.B. im Brustkrebs. Diese Eigenschaften machen CAIX zu einem attraktiven Angriffspunkt einer zielgerichteten Tumortherapie. Die vorliegende Studie hat zum Ziel, die Expression von CAIX sowie dessen biologische Rolle im Schilddrüsenkarzinom näher zu untersuchen.
Hierzu wurden Proben von 114 SK-Patienten immunhistochemisch auf eine CAIX-Expression untersucht und mit tumorfreiem Schilddrüsengewebe verglichen. Hierbei waren unterschiedliche SK-Subtypen vertreten. Für eine weitere Validierung der Expressionsdaten erfolgte die Auswertung eines Datasets von „The Cancer Genome Atlas“ (TCGA) mithilfe von cBioportal. Da die Hypoxie ein wichtiger Faktor für die Persistenz von TIZ ist, wurde die CAIX-Expression in Tumorsphären, ein in vitro Nachweis von TIZ-Aktivität, mittels der Durchflusszytometrie bestimmt und mit der CAIX-Expression von Monolayern verglichen. Als SK-Zelllinien wurden BCPAP (PSK), FTC 133 (FSK) und 8505 C (ASK) verwendet. Anschließend wurde mithilfe der Polymerasekettenreaktion und Immunofluoreszenzfärbung untersucht, ob eine CAIX-Expression in den Tumorsphären mit der Expression von bereits bekannten Stammzellmarkern, u.a. NANOG, assoziiert ist. Die Unterschiede der CAIX-Expression, nach Inkubation der Monolayer jeweils in Normoxie und Hypoxie, wurden mittels Durchflusszytometrie bestimmt. Mithilfe eines genetischen CAIX-Knockdowns sowie einer pharmakologischen Inhibition mit dem CAIX-Inhibitor Methazolamid (MZM) wurde die Tumorzellproliferation und -Sphärenbildung unter Normoxie und Hypoxie bestimmt. Zusätzlich wurde der Einfluss von MZM auf die Apoptose und den Zellzyklus untersucht.
Immunhistochemische Färbungen der Gewebeproben von SK-Patienten zeigten, dass die CAIX-Expression sowohl im PSK und FSK als auch im ASK im Vergleich zum tumorfreien Schilddrüsengewebe erhöht war. Des Weiteren zeigte die klinisch-pathologische Datenanalyse, dass eine erhöhte CAIX-Expression mit dem Auftreten von Lymphknotenmetastasen im differenzierten SK assoziiert war. Auch die Analyse des TCGA-Datasets bestätigte, dass eine erhöhte Expression der CAIX-mRNA mit einem fortgeschrittenen Tumorstadium, Fernmetastasen und mit einem kürzeren Gesamt-Überleben von SK-Patienten korrelierte. Die weiteren funktionellen in vitro Untersuchungen ergaben, dass die CAIX-Expression in den Tumorsphären im Vergleich zu Monolayern erhöht und mit einer erhöhten Expression von Stammzellmarkern assoziiert war. Ein genetischer CAIX-Knockdown und eine CAIX-Inhibition mit MZM führten über eine Induktion der Apoptose und eines Zellzyklusarrests zu einer verminderten Tumorzellproliferation und Sphärenbildung.
Zusammenfassend deuten die Ergebnisse darauf hin, dass CAIX ein vielversprechendes Zielmolekül für eine gezielte Tumortherapie des fortgeschrittenen SK ist. Um diese Hypothese bestätigen zu können, sind jedoch weitere prospektive Analysen von Patientenproben sowie funktionelle in vivo Untersuchungen am SK nötig.
Highlights
• Constrictional structures range from dome-and-basin folds to coeval folds and boudins.
• Under bulk constriction, the competent layer rotates slower than a passive plane.
• Extension-parallel and –perpendicular folds grow simultaneously.
• Extension-perpendicular folds affect previous boudins.
Abstract
We conducted scaled analogue modelling to show the influence of varying single layer initial orientation on the geometry of folds and boudins in a bulk constrictional strain field. The initial angle between the plane of shortening and the competent layer (θZ(i)) was incrementally increased from 0° to 90° by multiples of 11.25°. While the amount of layer thickening decreased with increasing θZ(i), the deformation structures produced range from pure dome-and-basin folds to coeval folds and boudins. Based on the attitude of fold axes, there are extension-parallel (FEPR) and extension-perpendicular (FEPP) folds, with axes subparallel and subperpendicular to the principal stretching axis (X), respectively. Coeval growth of FEPR folds and boudins occurred when θZ(i) > ca. 25°. The FEPP folds can be subdivided into a first type which affect the entire layer (if θZ(i) ranges between 11.25 and 78.75°) and a second type, referred to as FBEPP folds, which are affecting pre-existing boudins if θZ(i) > 45°. The interlimb angle of all types of folds increases with increasing θZ(i). Folds and boudins similar to the ones produced in this study can be found in salt domes and in tectonites of subduction zones.